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SUMMARY 
 
Endoplasmic Reticulum (ER)-stress, the accumulation of misfolded proteins in the 
ER, is assumed to be the cause of several diseases. Recently, enough evidence 
accumulated to state that it also plays an important role in idiopathic pulmonary 
fibrosis (IPF). The presence of a maladaptive ER-stress in the alveolar epithelial 
type II cells (AECII) of patients’ lungs has been demonstrated and the ability of this 
mechanism to cause or enhance a fibrotic phenotype has been shown. The 
hypothesis that AECII apoptosis induced by ER-stress or alternative mechanisms 
is a main trigger of this disastrous disease is therefore widely accepted. 
Nevertheless it was a requirement to characterize the diverse pathways of 
ER-stress response (the unfolded protein response, UPR) in the alveolar 
epithelium in detail.  
My studies focus on, but are not limited to, the effects of the UPR- transcription 
factors Atf4, Atf6 and Xbp1 in vitro in the AECII-derived murine cell line MLE12 
and in vivo with conditional over-expression in transgenic mouse lungs of de novo 
generated lines. A broad analysis of the transgene-effect in vitro was assessed, 
based on microarray analysis of transfected cells, including miRNA analysis and 
400K-Exonarrays, which provide first evidence that regulation of miRNAs and 
alternative splicing events are components of the UPR. Induction of cell death by 
the UPR-transcription factors was of special interest, because it is a proposed 
mechanism in the pathogenesis of IPF. However, no increased cell death or strong 
induction of the pro-apoptotic mediator Chop (gene for the C/EBP Homologous 
Protein; CHOP) was observed, the protective effects seemed to dominate in the 
system. Atf4, Atf6 and Xbp1 are not sufficient to mimic or generate a maladaptive 
ER-stress-situation in these cells. In experiments with drug (Thapsigargin, 
Brefeldin A) induced ER-stress the induction of Chop was one of the earliest 
effects and occurred simultaneously with the induction of Atf4 and Xbp1(s). 
Microarrays, addressing the very early effects of Thapsigargin (TG) treatment, 
could reveal an even earlier transcriptional regulation. However, it could not be 
determined which factors make the difference between a “good” and a 
maladaptive ER-stress. Other potential impact of ER-Stress on IPF resulting from 
the expression data was discussed. 
Transgenic mice for inducible over-expression of Atf4, Atf6 and Xbp1 were 
generated. The investigated lines did not develop any phenotype after transgene 
induction. This would fit to the in vitro finding, that the transgenes do not cause 
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AECII death. However, the extend of the transgene induction in vivo has not yet 
been completely assessed.   
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Zusammenfassung 
 
Endoplasmatischer Reticulum (ER)-Stress, die Akkumulation fehlgefalteter 
Proteine im ER, wird als Ursache einer ganzen Reihe von Krankheiten 
angesehen. In letzter Zeit haben sich genug Belege angesammelt, dass er auch 
eine wichtige Rolle in der idiopathischen pulmonalen Fibrose (IPF) spielt. Die 
Präsenz eines maladaptiven ER-Stress in den alveolären Typ II Zellen (AECII) von 
Patientenlungen und die Fähigkeit dieses Mechanismus einen fibrotischen 
Phänotyp zu erzeugen oder zu verstärken, wurden gezeigt. Die Hypothese, dass 
durch ER-Stress oder alternative Mechanismen induzierte AECII Apoptose, ein 
Hauptfaktor bei dieser tödlichen Krankheit ist, wird daher weitgehend anerkannt. 
Dennoch war es erforderlich, die diversen Wege der ER-Stress Antwort (UPR) in 
AECII detailliert zu charakterisieren.   
Meine Forschungen waren auf die Effekte der UPR-Transkriptionsfaktoren Atf4, 
Atf6 und Xbp1 in vitro in der murinen Zelllinie MLE12 fokussiert aber nicht darauf 
begrenzt. Sie umfassten in vivo die konditionale Überexpression dieser Faktoren 
in den Lungen de novo generierter transgener Mauslinien. Eine breit angelegte 
Analyse der Transgeneffekte in vitro, wurde basierend auf Microarray-Analysen 
transfizierter Zellen, inklusive 400K Exonarrays und miRNA-Arrays, 
vorgenommen, die erste Belege liefern, dass miRNA Regulation und alternatives 
Spleißen Teile der UPR sind. Induktion von Zelltod durch diese 
UPR-Transkriptionsfaktoren wird im engen Zusammenhang mit der Pathogenese 
von IPF diskutiert. Daher wurde Zelltod durch UPR-Transkriptionsfaktoren näher 
untersucht. Allerdings wurde kein verstärkter Zelltod oder eine starke Induktion 
des proapoptotischen Mediators CHOP beobachtet, die schützenden Effekte 
schienen in diesem System zu dominieren. Atf4, Atf6 und Xbp1 sind nicht 
hinreichend, um eine maladaptive ER-Stresssituation in diesen Zellen zu 
simulieren oder zu erzeugen. In Experimenten mit durch Chemikalien (Brefeldin A, 
Thapsigargin) erzeugtem ER-Stress war die Induktion von CHOP eines der 
frühesten Ereignisse und trat simultan mit der Induktion von Atf4 und Xbp1(s) auf. 
Microarrays, die auf die sehr frühen Effekte von Thapsigarginbehandlung 
abzielten, konnten noch frühere, transkriptionale Reaktionen zeigen. Allerdings 
konnte nicht bestimmt werden, welche Faktoren den Unterschied zwischen einem 
„guten“ und einem maladaptiven ER-Stress ausmachen. Andere potentielle 
Einflüsse von ER-Stress auf IPF, die sich aus den Expressionsdaten ergaben, 
wurden diskutiert. Transgene Mäuse für die induzierbare Überexpression von Atf4, 
Atf6 und Xbp1 wurden generiert. Die untersuchten Linien entwickelten keinerlei 
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Phänotyp als Reaktion auf die Transgeninduktion. Das würde zu den in vitro 
Befunden passen, dass die Transgene keinen AECII-Zelltod erzeugen. Allerdings 
wurde das Ausmaß der Transgeninduktion in vivo noch nicht vollständig 
untersucht. 
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1. INTRODUCTION 
 
1.1 Idiopathic pulmonary fibrosis (IPF) 
 
Idiopathic pulmonary fibrosis is a unique type of chronic fibrosing lung disease of 
unknown aetiology. IPF is characterized by epithelial injury and activation, the 
formation of distinct sub-epithelial fibroblast / myofibroblast foci and excessive 
ECM (extracellular matrix) accumulation. These progressive and irreversible 
changes in the lung architecture result in progressive respiratory insufficiency and 
a fatal outcome in a relatively short period of time (Pardo, Selman 2002), usually 
2-4 years after diagnosis (American Thoracic Society/European Respiratory 
Society International Multidisciplinary Consensus Classification of the Idiopathic 
Interstitial Pneumonias 2002). Histological, temporal and spatial heterogeneity 
exists, resulting in still regular appearing septae directly adjacent to disease-
defining areas such as fibroblastic foci, honeycomb changes with dense fibrosis 
and hyperplastic epithelium. Some authors carefully propose that IPF and another 
form of idiopathic interstitial pneumonia, the so called Non-specific Interstitial 
Pneumonia (NSIP), represent different forms of manifestation of one and the same 
molecular trigger. Evidence for such reasoning stems from the fact that histologic 
patterns of IPF as well as NSIP can occur simultaneously in the same lung lobe 
and in families with SP (surfactant protein) -C mutations also cases of NSIP 
occurred (reviewed by Thannickal et al. 2004). 
Previous research has largely focused on putative inflammatory mechanisms 
underlying the initiation of the fibrotic response, but recent evidence strongly 
suggests that chronic epithelial injury is the key underlying pathogenic event 
(Pardo, Selman 2002). 
The inflammatory hypothesis suggested that IPF results from chronic inflammation 
in response to a yet undefined stimulus. If left untreated, it would lead to 
progressive lung injury and ultimately fibrosis (American Thoracic 
Society/European Respiratory Society International Multidisciplinary Consensus 
Classification of the Idiopathic Interstitial Pneumonias 2002). This view was based 
on the obvious signs of inflammation on histological, broncho alveolar lavage 
(BAL) (neutrophilic alveolitis) and radiographic (enlarged lymph nodes, modest 
ground glass opacities) findings. However, anti-inflammatory therapies largely 
failed to gain any meaningful clinical effect. This finding is questioning the concept 
that inflammatory events play a causative role may substantially contribute to the 
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progression of the disease (reviewed by Günther et al. 2006; Verma, Slutsky 2007; 
Markart et al. 2006; Selman et al. 2001, Mahavadi 2009).  
However, it must be taken into account that the role of inflammation in IPF is not 
zero (Montaldo et al. 2002) and that also ER-stress (later on introduced as a factor 
in the pathogenesis of IPF) can induce inflammatory responses, mainly by 
activating NFκB-signalling (reviewed by Zhang, Kaufman 2008). 
When inflammation became more and more unlikely as trigger of the disease, 
chronic epithelial injury was still often regarded as an epiphenomenon (example: 
Chua et al. 2005), while other authors valued the role of epithelial injury much 
stronger (examples: Geiser 2003; Myers, Selman 2004; Myers, Katzenstein 1988). 
Others adopted the view, that epithelial injury can play a causative role in IPF but 
still highlighted the ongoing inflammatory events (Gharaee-Kermani, Phan 2005). 
Some other authors focused on the imbalance of anti-fibrotic factors [MMPs 
(matrix metallo-proteinases), CD44] and pro-fibrotic factors (tissue inhibitor of 
MMPs, TGFß and ECM components) without asking for a general trigger 
mechanism (Cook et al. 2002). Indeed, scarring of the lung is a multistep and 
multifactor phenomenon (review by Razzaque, Taguchi 2003). It was also pointed 
out that significant biochemical and biophysical alterations occur predominantly in 
IPF and may contribute to the disturbances of alveolar surface tension stability and 
gas exchange in this disease (Schmidt et al. 2002). 
External factors have also been indicated to contribute to the development of IPF 
(Steele et al. 2005). The strongest evidence exists for exposure to cigarette smoke 
and occupational exposure to metal dust (reviewed by Selman, Pardo 2006). 
Viral infection has also been suggested to play a role in IPF and replicating virus in 
the presence of an exogenous injury may indeed promote the development of 
pulmonary fibrosis (Lok et al. 2002). Diverse viruses were found to be associated 
with IPF, namely EBV (Tsukamoto et al. 2000), for which replication in IPF patients 
AECII was also shown (Egan et al. 1995), cytomegalovirus and human herpes 
viruses (HHV)–7 and HHV-8 (Tang et al. 2003). It has however to be stated that 
these studies do have limitations. In a more recent publication, there was no 
convincing evidence for a distinct pathogene signature in IPF (Wootton et al. 
2011). Also Acid-aspiration (by gastroesophageal reflux)–induced epithelial injury 
may contribute to the development of IPF.  
However, external stimuli are unlikely to cause IPF without accompanying genetic 
alterations. Firstly, telomerase mutations and subsequent shortening of telomeres 
were found to be associated with a subset of familial cases of IPF. This leads to 
apoptosis and cell cycle arrest (Armanios et al. 2007). Shortening of telomere 
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length can also occur independently of those mutations in IPF. TGF-ß can 
suppress human telomerase activity (Li et al. 2006) and oxidative stress 
accelerates telomere loss (von Zglinicki 2002). Secondly, mutations of SP-C have 
been demonstrated to be associated with familial forms of IPF (Nogee et al. 2001; 
Cameron et al. 2005). It has been shown that the mutated SP-C cannot fold 
correctly and induces apoptosis of the alveolar type II cell (AECII) (Mulugeta et al. 
2007). Over-expression of mutated SP-C in vivo results in an exaggerated 
response to profibrotic stimuli (Lawson et al. 2011). As SP-C is exclusively 
produced by AECII, the mechanism clearly starts by affecting this alveolar 
epithelial cell type. Mutations in Surfactant protein A2 have also been associated 
with IPF (Wang et al. 2009) and could trigger the disease by similar mechanisms. 
Furthermore there is evidence, that targeted AECII injury is sufficient to induce a 
fibrotic response (Sisson et al. 2010) even though such drastic consequences do 
not occur in models where alveolar septal cell apoptosis can be outbalanced by 
increased cell turnover (Fehrenbach et al. 2007). 
In sporadic cases of IPF SP-C mutations are rare (Markart et al. 2007; Lawson et 
al. 2004) but a similar injurious mechanism was proposed. Markers for an ongoing 
UPR and epithelial apoptosis are up-regulated in IPF versus donor patients lung 
homogenates and these markers could be localized to the hyperplastic AECII of 
those lungs by immunostaining (see figure 1) (Korfei et al. 2008). Apoptotic AECII 
death also occurs in normal alveoli of IPF / UIP, although on a lower level (Barbas-
Filho et al. 2001).   
As underlying reason, defective processing of SP-C and SP-B and accumulation 
of their pro-forms, viral infection and the impact of reactive oxygen species (ROS) 
have been implicated (Lawson et al. 2008). IPF proteome analysis revealed 
evidence for chronic epithelial ER-, oxidative - and DNA (Deoxyribonucleic acid) 
damage stress, resulting in epithelial instability and cell death, paralleled and 
confirmed by signatures of enhanced infection susceptibility and deterioration of 
alveolar structure (Korfei et al. 2011). 
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Figure 1: Maladaptive endoplasmic reticulum stress in sporadic IPF 
(continued). 
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Figure 1: Maladaptive endoplasmic reticulum stress in sporadic IPF. 1: The 
UPR-transcription factors (cleaved) ATF6 and ATF4 as well as the pro-apoptotic 
mediator CHOP and cleaved caspase-3 were more abundant in IPF-patients 
versus donor lung homogenates. In some samples dimerization of Bax could also 
be demonstrated. Numbers above the columns are patient numbers. 2: Caspase 3 
cleavage (B) and induction of CHOP (C), ATF6 (E) and ATF4 (F) were localized to 
the hyperplastic AECII of IPF patients histologic slides as confirmed by staining of 
parallel sections with the Type II cell marker pro-SP-C (A+D). Bar=50µm. (Korfei et 
al. 2008), modified by the author. 
 
The concept that AECII-apoptosis represents an early step in the IPF 
pathogenesis immediately suggests inhibition of this mechanism as a therapy. 
Indeed caspase inhibitors reduce fibrosis in the bleomycin (BLEO) model of lung 
fibrosis and have been proposed as a therapeutic approach in pulmonary fibrosis 
(Kuwano et al. 2001). They can reduce the number of apoptotic cells, the 
pathological grade of lung inflammation and fibrosis, and the hydroxyproline 
content in lung tissues in this model (Kuwano et al. 2001; Wang et al. 2000). The 
anti-fibrotic agent captopril also acts as an anti-apoptotic agent. This suggests that 
inhibitory actions of captopril on pulmonary fibrosis may be related to prevention of 
lung epithelial cell apoptosis (Uhal et al. 1998a). On the other hand, extent or 
profusion of fibroblastic foci in lung biopsies is strongly correlated with increased 
mortality in patients with IPF. There is evidence that myofibroblasts in IPF acquire 
resistance to apoptosis (reviewed by Thannickal, Horowitz 2006). A caspase 
inhibitor treatment in IPF might therefore actually cause a deterioration of fibrotic 
remodelling. It might therefore be an advantage to study the trigger mechanism for 
AECII apoptosis in IPF first.  
N-acetylcysteine versus placebo for patients under treatment with prednisone plus 
azathioprine significantly slowed the deterioration of pulmonary function and is 
therefore widely used as off-label treatment. However, the anti-fibrotic drug 
pirfenidone has been recently approved for the treatment of adult patients with 
mild to moderate idiopathic pulmonary fibrosis in the European Union (reviewed by 
Costabel, Bonella 2011). 
 
1.2 Endoplasmic reticulum (ER)-stress  
 
1.2.1 General concept 
 
A main function of the ER is the correct folding of ER-localized proteins, namely 
secretory and transmembrane proteins. ER-stress is the accumulation of unfolded 
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or misfolded proteins in the endoplasmic reticulum. This problem generally occurs, 
when the folding machinery cannot match the protein load (reviewed by Harding et 
al. 2002). High expression of large, heavily modified proteins, expression of 
mutant, folding-incompetent proteins and such processes which induce higher 
expression of secretory proteins, like cell differentiation of B-cells to plasma cells 
and viral infection can lead to ER-stress (reviewed by Schröder, Kaufman 2005). 
The ER also synthesizes sterols and lipids. Perturbations in lipid metabolism and 
transport can also lead to an ER-stress response (Ron, Oyadomari 2004; Zhang, 
Kaufman 2003; Shechtman et al. 2011). 
 
1.2.2 The unfolded protein response (UPR) 
 
When ER-stress occurs, the cell responds by the UPR. The UPR is a set of 
reactions, consisting of a general translational attenuation, induction of the 
components of the ER-folding machinery and the ER-associated degradation 
machinery (ERAD) (see figure 2).   
When the ER-stress is to strong or prolonged (Araki et al. 2003; Bernales et al. 
2006) the UPR drives the cells into apoptosis1. This process is called “maladaptive 
ER-stress”. Such “maladaptive ER-stress” may represent an adaptive response. 
For example, UPR mediated apoptosis of ß-cells was identified as a mechanism to 
return the maternal rat pancreas back to a non-pregnant state after delivery 
(Bromati et al. 2011). On the other hand, maladaptive ER-stress clearly represents 
an important event in the pathomechanism of several chronic diseases including 
IPF diabetes and neurodegenerative disease (also see 1.2.4).  
The current model which describes how the UPR is mediated is rather simple. 
Three different receptors in the ER-membrane are activated upon ER-stress. The 
activation of the receptors involves the dissociation of the chaperone Grp78 (BIP) 
from these receptors. Originally the idea was that Grp78 is recruited to unfolded 
proteins and thereby removed from the receptors driven by the concentration 
gradient. However, more recent evidence indicates that the removal of BIP is not a 
passive process (Shen et al. 2005), that reduced levels of BIP are not sufficient to 
induce the UPR (Gewandter et al. 2009) and that inability of mutant Ire1 to bind 
BIP does not result in a constitutive activation (Oikawa et al. 2007). In conclusion, 
the activation is a more complex process (reviewed by Hetz, Glimcher 2009). The 
exact mechanism of activation of the ER-stress-receptors remains unknown. Once 
activated, the receptor PERK dimerizes and catalyzes the phosphorylation of the 
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eukaryotic initiation factor 2 alpha (eIF2α). The result is a general translational 
block on the one hand and paradoxically the up-regulation of the transcription 
factor ATF4 on the other hand. 
 
Figure 2: Principles of the unfolded protein response (UPR). The 
accumulation of unfolded proteins is leading to the UPR, a combination of different 
responses. A) The induction of ER-chaperones like BIP and GRP94 to enhance 
the folding capacities of the ER, B) the up-regulation of the ER-associated protein 
degradation machinery (ERAD) to enhance degradation the of accumulated 
misfolded proteins by the proteasome and C) a general inhibition of protein 
synthesis. D) Induction of apoptosis can also be a part of the UPR. This is 
commonly addressed as “maladaptive ER-stress” and is regarded as a reaction 
against prolonged ER-stress or ER-stress above a certain threshold (Araki et al. 
2003). 
 
The receptor IRE1 also dimerizes, when activated and leads to the splicing of a 
26bp intron from the Xbp1 mRNA (Lee et al. 2002; Back et al. 2006; Zhou et al. 
2006). The splicing process equals tRNA splicing not nuclear mRNA-splicing via 
the spliceosome. Both the spliced form and the unspliced form of the Xbp1 protein 
are expressed. Spliced Xbp1 (Xbp1(s)) is an active transcription factor. Unspliced 
Xbp1 can dimerize with the Xbp1(s) and leads to its nuclear export (via an export 
sequence). Therefore it counteracts the Xbp1(s)-function (Yoshida et al. 2006). 
When activated, the receptor p90-ATF6 is cleaved of the ER-membrane by S1P 
and S2P (Ye et al. 2000). The released 50 kDa (kilo Dalton) fragment (p50ATF6, 
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here usually just referred to as ATF6) can also act as a transcription factor (Haze 
et al. 1999; Shen, Prywes 2005). 
Together ATF4, ATF6 and XBP1 are supposed to be responsible for most of the 
UPR-signalling including the rescue pathways and, paradoxically, the intrinsic 
pro-apoptotic pathways as well (reviewed by Bernales et al. 2006).  
 
 
Figure 3: Pathways of UPR signalling. The three main signalling pathways of 
the UPR are initiated by a process involving the dissociation of the chaperone BIP 
from the ER-membrane localized receptors PERK, p90-ATF6 and IRE1. PERK 
dimerizes when activated and then catalyzes the phosphorylation of eIF2 alpha 
which is responsible for a general translational block and induction of the 
transcription factor ATF4. Activated ATF6 is cleaved to its 50 kDa form which also 
acts as a transcription factor. IRE1 activation catalyzes the splicing of a 26bp 
intron from Xbp1 mRNA, leading to expression of the active transcription factor 
XBP1(s). Together the transcription factors ATF4, p50ATF6 and XBP1(s) 
(highlighted by a red frame) are then responsible for most of the downstream 
target expression of the UPR. They were reported to be responsible for the 
activation of the stress-resolving pathways and, paradoxically, also the 
pro-apoptotic pathways by up-regulation of CHOP (Szegezdi et al. 2006, 
modified). 
 
The activation of NFκB by ER-stress and its downstream signalling events 
represent a separate mechanism for the cell to react to ER-stress and is called 
ER-overload response (EOR) (Knorre 2001; Kuang et al. 2005; Rutishauser, 
Spiess 2002). 
The UPR does not follow a uniform or simple, general scheme. Xbp1 for example 
binds different sets of gene promoters pending on the cell type and the induction 
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of ER-stress. It furthermore binds to target-promoters which participate in 
processes which were described as unexpected, including regulation of gene 
expression and chromosomal architecture, cell growth and differentiation, RNA 
processing and export, signal transduction, ubiquitin-associated processes, ion 
channels, transporters, and proton pumps (Acosta-Alvear et al. 2007). 
ATF4, ATF6 and XBP1 belong to the group of basic leucine zipper (bZIP) 
-transcription factors. Their bZIP domain allows homo- or heterodimerization, also 
with numerous other bZIP-transcription factors. The diverse interactions allow 
condition-specific binding to different target sequence and thereby a very flexible 
and complicated downstream signalling (as summarized by Schröder, Kaufman 
2005; Zhang, Kaufman 2004). 
 
1.2.3 ER-stress and apoptosis 
 
ER-stress can lead to apoptosis of the affected cell through different mechanisms 
(see figure 4). Following the extrinsic pathway, increased phosphorylation of tumor 
necrosis factor receptor-associated factor 2 (TRAF2) induced by c-Jun N-terminal 
inhibitory kinase (JIK) and its interaction with IRE1α and apoptosis 
signal-regulating kinase 1 (ASK1) results in activation of ASK1 and c-Jun amino 
terminal kinase (JNK), which phosphorylates and thereby inactivates BCL2 and 
thereby induces cell death. Furthermore the release of pro-caspase-12 from 
TRAF2 (when TRAF2 is sequestered to IRE1α) is considered to be necessary for 
pro-caspase-12 activation in humans (caspase 4 in mice).  
With regard to the intrinsic pathway, insertion of oligomeric Bak and Bax into the 
ER membrane causes efflux of Ca2+ from the ER. The increase in the cytosolic 
Ca2+ concentration activates calpain, which cleaves and activates ER-localized 
pro-caspase-12. Caspase-12 activation is specific for and necessary in ER-stress 
mediated apoptosis (Nakagawa et al. 2000). Activated caspase-12 cleaves 
pro-caspase-9, and caspase-9 activates the executioner caspase, pro-caspase-3. 
Ca2+ released from the ER is rapidly taken up by mitochondria, which may lead to 
collapse of the inner membrane potential. Ultimately, Ca2+ influx into mitochondria 
opens the permeability transition pore (PTP), which is formed from a complex of 
the multi protein voltage-dependent anion channel, the adenine nucleotide 
translocase, and cyclophilin-D. Cytochrome c is then released through the PTP 
into the cytoplasm, where the apoptosome is formed and pro-caspase-3 is 
activated. In addition, the PTP recruits Bax to the outer mitochondrial membrane. 
Over-expression of an anti-apoptotic Bcl-2 family member, e.g., Bcl-XL, blocked 
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depolarization of the inner mitochondrial membrane in response to ER-stress. 
ATF4, ATF6 and XBP1 induce the expression of the pro-apoptotic bZIP –
transcription factor CHOP2. CHOP represses transcription of anti-apoptotic Bcl-2 
and thus shifts the balance between pro- and anti-apoptotic Bcl-2 family members 
toward the pro-apoptotic family members; chop−/− cells are partially resistant to 
apoptosis, which is consistent with this model (Schröder, Kaufman 2005; Oakes et 
al. 2006; Kaufman 2002). In cooperation with Elk1, CHOP is also up-regulating 
transcription of death receptor 5 (DR5) (Oh et al. 2010; Ohtsuki T et al. 2009). 
It is noteworthy, that according to this model, CHOP is affecting the other 
apoptosis inducing pathways in the sense of an enhancement, but itself is mainly 
regulated by expression of the active ATF4, ATF6 and Xbp1. Indeed the role of 
these factors in Chop induction has been reported in different systems (Allagnat et 
al. 2010; Ma et al. 2002) and the over-expression of Chop was sufficient to induce 
apoptosis or cell cycle arrest in some models (Zinszner et al. 1998; Friedman 
1996; Matsumoto et al. 1996). 
 
Figure 4: ER-stress and apoptosis. ER-stress mediated apoptosis pathways can 
be described as an intrinsic pathway (blue) and an extrinsic pathway (yellow). The 
intrinsic pathway mainly works via induction of CHOP, which was described to be 
induced by ATF4, ATF6 and (not indicated here) XBP1(s). The extrinsic pathway 
is initiated via pro-apoptotic signalling complexes involving the receptor IRE1 
(which is also responsible for Xbp1-splicing). Pro-caspase-12 (pC-12) activation 
and subsequent apoptosis via the effector caspase-3 requires activation of both, 
the extrinsic and the intrinsic pathway. IMP=inner mitochondrial membrane 
potential (Schröder, Kaufman 2005 modified according to Hetz et al. 2011). 
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1.2.4 ER-stress and disease 
 
ER-stress can play very diverse roles. For example, UPR-components gained 
importance in the field of neurosciences. Restraint stress and amphetamine 
administration robustly induce ATF2, ATF3, and ATF4 in the nucleus accumbens 
and dorsal striatum and increase (ATF2) or repress emotional reactivity (Green et 
al. 2008). Lack of eIF2α-phosphorylation increases synaptic plasticity and is 
leading to increased long term memory in mice, without altering brain morphology 
(Costa-Mattioli et al. 2007; Costa-Mattioli 2008). The most intriguing feature of 
ER-stress might be its diverse role in several, very different diseases. ER-stress 
plays a role in such general processes like inflammation (reviewed by Yoshida 
2007), e.g. airway epithelial cells synthesize a Leukocyte-adhesive hyaluronan 
matrix in response to ER-stress (Lauer et al. 2008). In myelodysplastic syndrome, 
down-regulation of Chop is caused by an aberrant methylation of its promoter 
(Wang YL et al. 2010; Lin et al. 2010). The UPR is also involved in cancer 
progression (reviewed by Healy et al. 2009). Indeed chemical induction of 
maladaptive ER-stress can potentially be a therapeutic option in anti-cancer 
therapies (Huang et al. 2011; Wang et al. 2011a). In transgenic mice, 
over-expression of XBP1(s) in B-cells and plasma cells enhances B-cell 
proliferative potential and activates known multiple myeloma-relevant pathways, 
leading to the development of multiple myeloma-like disease, mimicking many of 
the molecular, cellular, and clinical features of the human condition (Carrasco et 
al. 2007). Other examples for ER-Stress associated diseases are Joubert 
syndrome (Sayer et al. 2006b), rheumatic autoimmune disease ankylosing 
spondylitis (Lemin et al. 2007), inflammatory bowel disease (Kaser et al. 2008; 
Namba et al. 2009), artherosclerosis (Erbay et al. 2009; Hotamisligil 2010; Tabas 
2009), non-alcoholic fatty liver disease (Puri et al. 2008), amyotrophic lateral 
sclerosis (Guégan, Przedborski 2003), Parkinson’s disease or bipolar disorders. 
As described above, maldaptive ER-stress was indicated to play a prominent role 
in IPF and represent a key trigger in the pathogenesis. The loss of cells by 
ER-Stress induced apoptosis is, with different levels of evidence and very diverse 
impact on the disease, linked to several other diseases. Importantly it can be 
caused by viral infection (reviewed by He 2006). It is involved in ß-cell death in 
Type I and Type II diabetes (Oyadomari et al. 2002; Oyadomari et al. 2001) 
(reviewed by Oslowski, Urano 2010; Araki et al. 2003; Eizirik et al. 2008; Lipson et 
al. 2006) but is not limited to the pancreas but probably also plays a role in Liver 
(reviewed by Kammoun et al. 2009), adipose tissue (reviewed by van der Kallen et 
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al. 2009) and kidney (Wu et al. 2010). However, in a mouse model of Type I 
diabetes CHOP knockout was not affecting development of diabetes (Satoh et al. 
2011). Treatment of mice with LPS was inducing apoptotic ER-Stress in several 
cell types, including AECII and vascular epithelial cells, indicating a role for a 
maladaptive ER-stress in septic shock lungs (Endo et al. 2005). Maladaptive 
ER-stress can play a role in solid organ transplantation (reviewed by Pallet et al. 
2010) for example it is involved in post-transplant injury in severely steatotic liver 
allografts (Anderson et al. 2011). Other examples for diseases associated with 
maladaptive ER-Stress are osteoarthritis (Takada et al. 2011) (reviewed by 
Kapoor, Sanyal 2009), Alzheimer’s disease (Wiley et al. 2010; Wang et al. 
2011b)(reviewed by Salminen et al. 2009), dilated cardiomyopathy (Hamada et al. 
2004), hereditary Tyrosinemia Type I (Bergeron et al. 2006), proteinuric kidney 
disease (reviewed by Cybulsky 2010), ischemia (heart and neurons) (reviewed by 
Yoshida 2007) including chronic myocardial  ischemia (Xin et al. 2011), alcohol 
induced liver disease and renal injury (reviewed by Yoshida 2007). 
 
1.2.5 ER-stress in the alveolar epithelium 
 
The alveolar epithelium consists of two different cell types, simply called type one 
(AECI) and type two (AECII). AECI cover most of the alveolar surface because 
they are widely stretched and therefore gauzy. Their main function is to cover the 
gas exchange area but they also play a role in water and ion transport (Dahlin et 
al. 2004; Dobbs et al. 1998; Johnson et al. 2002). The more abundant AECII have 
a rather conic shape. They do not only produce the surfactant (surface active 
agent) – film, which is required to reduce the alveolar surface tension and prevent 
the collapse of the alveoli, but also serve as the progenitor cells of the AECI 
(Brody, Williams 1992; Castranova et al. 1988). As secretory cells, especially the 
AECII normally have to handle a big ER-load.    
 
1.3 Goals 
 
ATF4, p50ATF6 and spliced XBP-1 are the three basic transcription factors of the 
UPR. In order to elucidate the downstream signalling pathways and cellular 
consequences of ER-stress, the first aim was to perform an over-expression of the 
above mentioned ER-stress signalling molecules ATF4, p50ATF6 and spliced 
XBP-1 in tumor derived MLE12 cells (generated in mice, harbouring the viral 
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oncogene simian virus 40 under transcriptional control of a promoter region from 
human SP-C). This approach included the co-transfection of two or three factors. 
Aim of in vitro analysis was a broad general analysis of signalling pathways by 
transcriptome analysis (including the long and short-term effects of the ER-stress 
inducer TG), with verification of candidate genes via quantitative PCR (qPCR), 
miRNA-arrays and exon-arrays. The question in how far the over-expression of 
these factors can contribute to cell death (LDH-assay) via apoptotic signalling 
(induction of the pro-apoptotic mediator CHOP) in these cells had to be 
addressed. Knockdown of Atf4 and Atf6 via siRNA technology and investigation of 
its effects on Chop-induction represented another approach to address this 
question.  
Furthermore, generation of transgenic mouse-lines for over-expression of the 
UPR-transcription factors and the pro-apoptotic mediator CHOP was a central 
goal. The over-expression in the transgenic mice had to be both inducible, to 
eliminate deleterious effects of ER-stress during lung development, and specific 
for the alveolar epithelium and, in there, the AECII-cells. This was gained by using 
a TET O7 system. The genes for ATF6 (NTD), ATF4 and spliced XBP-1 had to be 
cloned behind a TET O7-CMV promoter, which is inactive (operator-line). Oocyte 
injection and generation of founders was performed by EMBLEM [Transgenic 
animal facility of EMBL (Heidelberg)] (Monterotondo, Italy). This operator-line was 
crossed with a transactivator-line, which expresses the reverse tetracycline 
transactivator (rtTA) under control of the lung specific SP-C promoter. As a result,  
bi-transgenic mice were obtained, where the expression of the transgene is 
dependent on the application of Doxycycline (Dox), which binds to the rtTA and 
activates it. The breeding of the transgenic mice for experimental purposes, 
including the establishment of appropriate screening methods for transgene 
induction and homocygousity were technical aims of this work. A bidirectional 
vector system should be used to more easily monitor the transgene expression 
under in vivo conditions by in vivo imaging techniques. Dox induced mice should 
be investigated with regard to transgene expression and their potential 
downstream effects, especially eventually occurring fibrotic changes.  
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2. Materials 
 
2.1 Chemicals 
 
product     company  
Acetic acid    Sigma Aldrich, Steinheim, Germany   
Acrylamid / Bisacrylamid 
-solution (30 %, 37.5:1)  Carl Roth, Karlsruhe, Germany   
Agarose    Carl Roth, Karlsruhe, Germany 
Ampicillin (amp) Na-salt,  
molecular biology grade  Serva, Heidelberg, Germany 
APS     Carl Roth, Karlsruhe, Germany 
Ascorbic acid   Merck, Darmstadt, Germany 
Brefeldin A    Sigma-Aldrich, Steinheim, Germany   
Bromophenol blue   Merck, Darmstadt, Germany 
Chloroform    Sigma-Aldrich, Steinheim, Germany   
DMEM (Dulbecco’s Modified  
Eagle Medium)   Invitrogen, Carlsbad, USA 
DMEM F12    Invitrogen, Carlsbad, USA 
Dharmafect 1   Thermo Fisher Scientific, Waltham, USA  
dNTP (Deoxy ribonucleotide  
triphosphate) -mix   Thermo Fisher Scientific, Waltham, USA  
MEM NEAA solution   Invitrogen, Carlsbad, USA 
DMSO (Dimethyl-sulfoxide) Merck, Darmstadt, Germany 
EDTA (Ethylendiamin-tetra- 
acetic acid Ethylendinitrilo- 
N,N,N’,N’,-tetra-acetate)  Sigma-Aldrich, Steinheim, Germany   
ß-estradiol    Sigma-Aldrich, Steinheim, Germany   
Ethanol    Avantor, Deventer, Netherlands 
Ethidiumbromide   Serva, Heidelberg, Germany 
FCS (fetal calf serum)  PAA, Pasching, Austria 
Glycerol    Sigma Aldrich, Steinheim, Germany   
Glycine    Carl Roth, Karlsruhe, Germany 
HCl      Merck, Darmstadt, Germany 
H2O2 solution, 30 %  Carl Roth, Karlsruhe, Germany   
Hydrocortison   Sigma-Aldrich, Steinheim, Germany   
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product     company  
Isopropanol    Sigma-Aldrich, Steinheim, Germany   
ITS-solution (100x)   PAN-Biotech, Aidenbach, Germany  
   
Kanamycin (kan)   Carl Roth, Karlsruhe, Germany 
KCl     Merck, Darmstadt, Germany 
KH2PO4    Merck, Darmstadt, Germany 
L-Glutamin solution (100x) Invitrogen, Carlsbad, USA 
Methanol    Sigma-Aldrich, Steinheim, Germany   
NaCl     Carl Roth, Karlsruhe, Germany 
Na2HPO4    Merck, Darmstadt, Germany 
NaOH     Merck, Darmstadt, Germany 
Optimem     Invitrogen, Carlsbad, USA 
Sacharose    Carl Roth, Karlsruhe, Germany 
2-mercaptoethanol   Sigma-Aldrich, Steinheim, Germany   
Sodium deoxy cholate   Fluka Chemie, Buchs, Switzerland 
Sodium  dodecyl  sulphate  Merck, Darmstadt, Germany 
Skimmed milk powder  Sigma-Aldrich, Steinheim, Germany   
Tetramethylethylen-diamine 
N’,N’,N’,N’-Tetra methyl diamine Sigma-Aldrich, Steinheim, Germany   
Thapsigargin    Invitrogen, Carlsbad, USA 
TRIS (Tris(hydroxyl methyl)-  
amino methane)   Carl Roth, Karlsruhe, Germany 
Triton X-100    Sigma-Aldrich, Steinheim, Germany   
Bacto-Trypton   BD, Sparks, USA    
Tween 20 (Polyoxyethylen(20) 
- sorbitanmonolaurate)  Sigma-Aldrich, Steinheim, Germany   
Bacto Yeast extract   BD, Sparks, USA    
Bacto Agar    BD, Sparks, USA  
Aqua B.Braun    B.Braun, Melsungen, Germany 
PBS (Phosphate-buffered 
 Saline) (sterile)   PAA, Pasching, Austria     
10x Trypsin / EDTA   Invitrogen, Carlsbad, USA 
Developer    Agfa, Mortsel, Belgium 
Fixer     Agfa, Mortsel, Belgium 
Restore Western Blot  
Stripping Buffer   Thermo Fisher Scientific, Waltham, USA  
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S.O.C. Medium    Invitrogen, Carlsbad, USA  
 
2.2 Solutions and Buffers 
 
2.2.1 Solutions 
 
10 x PBS    1.37 M NaCl 
0.027 M KCl 
 
0.081 M Na2HPO4x2H2O 
0.018 M KH2PO4 
     pH 7.5 with NaOH 
 
50 x TAE (TRIS / Acetic acid 
/ EDTA buffer) 2 M TRIS 
57.1 ml Acetic acid 
10 % 0.5 M Na-EDTA, pH 8  
     water add 1 l 
 
Water, dd-water  
(double distilled water)  deionised water   
 
1 x Trypsin / EDTA   5 ml Stock solution + 45 ml PBS  
(sterile filtered) 
 
10 x TBST    0.5 M NaCl 
0.5 M TRIS 
pH 7.5 (HCl) 
 
1 x TBST    10 x TBST diluted 1:10 with water 
 
2.2.2 Loading buffers 
 
5 x Loading buffer for  
Agarose gels   5 ml Glycerol 
200 µl 50xTAE 
400 µl Bromophenol blue solution (1 %) 
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4.4 ml water 
 
4 x Loading buffer for  
Protein gels    TRIS / HCl (pH 6.8)   100 mM 
     Glycerol   20 % 
     SDS (sodium dodecyl- 
sulphate)   4 % 
     Bromophenol blue  0.05 % 
     for reducing gels: 
     2 -Mercaptoethanol  10 %   
 
2.2.3 Running buffers 
 
SDS-PAGE (Polyacrylamide  
Gel Electrophoresis) running  
buffer (2 l 10 x)   0.25 M TRIS 
1.92 M Glycin 
1 % SDS 
Nucleic acid running buffer  
(1 x TAE)    1:50 dilution of 50 x TAE with water 
 
2.2.4 SDS-PAGE-buffer 
 
Stacking- gel buffer   0.625 M TRIS / HCl pH 6.8 
 
Separating- gel buffer  1.125 M TRIS / HCl pH 8.8 
30 % Sacharose 
 
2.2.5 Western blot (WB)-buffer 
 
Blocking buffer    5 % skimmed milk powder in 1 x TBST 
2l Western transfer buffer  0.02 M TRIS 
0.15 M Glycin 
10 % methanol 
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2.2.6 Buffer for Protein extract 
 
Lysis buffer    0.05 M TRIS 
0.15 M NaCl 
5 mM EDTA (Titriplex III) 
1 % Triton X100 
0.5 % Na-Deoxycholate 
     (pH 7.4) 
0.5 % 0.1 M PMSF solutions (freshly added) 
 
2.2.7 Media 
 
Mel188 medium   500 ml DMEM 
50 ml FCS 
5 ml NEAA 
(Sterile filtered) 
 
MLE12 / Mle15 medium  500 ml DMEM F12 
     5 ml ITS solution 
     4 ml 1.25M HEPES (N-2-Hydroxy-ethylpiperazin- 
N-ethansulfonate) solution, pH 7.4 
     5 ml L-glutamin solution 
     10 ml FCS 
     500 µl 10 µM Hydrocortison solution 
     500 µl 10 µM ß-estradiol solution 
     (Sterile filtered) 
 
Starving medium   500 ml DMEM F12 
     5 ml ITS solution 
     4 ml 1.25M HEPES solution, pH 7.4 
     5 ml L-glutamin solution 
     0.5 ml FCS 
     (Sterile filtered) 
 
Transfection medium  50 % MLE12-Medium + 50 % Optimem 
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LB-medium (Luria Bertani- 
complete medium) / agar plates 5 g Bacto Tryptone 
     2.5 g Bacto Yeast Extract 
     5 g NaCl 
     water add 500 ml  
     7.5 g Bacto Agar (for agar plates only) 
     (autoclaved) 
 
LB-amp-medium / agar plates LB-medium / agar plates + 0.1 % amp (10 %) or 
kan (30 mg/ml) solution added at <50 °C 
 
2.2.8 Enzyme buffer  
 
product     company  
NEB2     New England BioLabs, Ipswich, USA 
NEB3     New England BioLabs, Ipswich, USA 
NEB4     New England BioLabs, Ipswich, USA 
 
Ligase buffer    New England BioLabs, Ipswich, USA 
     Promega, Madison, USA 
 
2.3 Length markers 
 
product       company  
page ruler  
(for Protein gels, pre stained) Thermo Fisher Scientific, Waltham, 
USA  
BenchMark (for Protein gels, pre stained) Invitrogen, Carlsbad, USA  
SmartLadder (for nucleic acid gels)  Eurogentec, Seraing, Belgium 
 
2.4 Kits 
 
product       company  
DNeasy blood and tissue kit   QIAgen, Hilden, Germany 
RNeasy plus mini kit    QIAgen, Hilden, Germany 
QIAshredder      QIAgen, Hilden, Germany 
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product       company  
ECL plus western blotting detection kit  GE healthcare, Buckinghamshire, 
UK 
QIAquick Gel Extraction kit   QIAgen, Hilden, Germany 
QIAquick PCR-purification kit   QIAgen, Hilden, Germany 
BCA Protein Assay kit  Thermo Fisher Scientific, Waltham, 
USA  
Cytotoxicity detection kit (LDH)   Roche, Basel, Switzerland   
iQ SYBR Green Supermix    BioRad, Hercules, USA  
  
HotStar Taq DNA Polymerase   QIAgen, Hilden, Germany 
HotStar high fidelity DNA Polymerase  QIAgen, Hilden, Germany 
Omniscript RT (reverse transcription) 
 Kit       QIAgen, Hilden, Germany 
Phire Hotstart Polymerase    Thermo Fisher Scientific, Waltham, 
USA 
Phire Hotstart Polymerase II   Thermo Fisher Scientific, Waltham, 
USA 
 
2.5 Proteins 
 
2.5.1 Restriction endonucleases 
 
product      company  
BsrBI      New England BioLabs, Ipswich, USA  
AatII      New England BioLabs, Ipswich, USA 
DrdI      New England BioLabs, Ipswich, USA 
AseI      New England BioLabs, Ipswich, USA 
NheI      New England BioLabs, Ipswich, USA 
NotI      New England BioLabs, Ipswich, USA 
XmaI      New England BioLabs, Ipswich, USA 
SalI      New England BioLabs, Ipswich, USA 
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2.5.2 Antibodies 
 
target dilution 
WB / IHC 
conditions 
WB 
antibody company 
Atf4 1:1000 / 1:500 
and 1:1000 
reducing sc-200  
Rabbit pAb 
Santa cruz, Santa 
Cruz, USA 
 / 
Aviva, San Diego, 
USA 
Atf6 1:2000 / 1:200 reducing ab 37149 
Rabbit pAb 
Abcam, 
Cambridge, UK 
Xbp1 1:1000 / 1:50 reducing sc-7160 
Rabbit pAb 
Santa cruz, Santa 
Cruz, USA 
 
BIP 1:100000 /  
1:750 
reducing 368673  
Rabbit pAb  
 
Merck, 
Darmstadt, 
Germany 
(Calbiochem) 
Cleaved 
Caspase3 
1:500 / 1:50 reducing 2305  
Rabbit pAb 
Trevigen, 
Gaithersburg, 
USA 
ß-actin 1:25000 / -  reducing Ab8227 
Rabbit pAb 
Abcam, 
Cambridge, UK 
Chop 1:200 / 1:50 non-
reducing 
sc-793 
Rabbit pAb 
Santa cruz, Santa 
Cruz, USA 
 
Pro SP-C - / 1:750 -  AB3786 
Rabbit pAb 
Merck, 
Darmstadt, 
Germany 
(Millipore) 
Rabbit 1:1000 / - secondary 
antibody 
Swine anti 
rabbit, HRP 
(horseradish 
peroxidase) 
Dako, Glostrup, 
Denmark 
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2.5.3 Other Proteins 
 
product      company  
Ribonuclease (RNase) -inhibitor  Roche, Basel, Switzerland  
T4 DNA ligase    New England BioLabs, Ipswich, USA 
T4 DNA ligase    Promega, Madison, USA 
Bovine serum albumin (BSA)  
10mg/ml solution    New England BioLabs, Ipswich, USA 
Albumin Fraktion V (BSA)   Carl Roth, Karlsruhe, Germany 
 
2.6 Primers  
 
Primers were ordered at Metabion (Planegg-Martinsried, Germany). Unless 
mentioned otherwise, the primers were self designed with or without the aid of 
primer-blast software. 
  
2.6.1 Amplification primers 
 
name sequence 
ATF4-FOR-AMPL CACGAGACGAAATCCAGCA 
ATF4-REV-AMPL TACAGCAAACACAGCAACAC 
ATF6-FOR-AMPL TCACCCATCCGAGTTGTGAG 
2nd-ATF6-REV-AMPL CATTATAAATGCTAATACTATCAT   
CHOP-AMPL-FORW GTGTTCCAGAAGGAAGTGCA 
CHOP-AMPL-REV CAAGCCGAGCCCTCTCCT 
 
2.6.2 Cloning primers 
 
name sequence 
ATF4-FORW-CLON-NheI-Koz GATGCTAGCgccaccatgaccgagatgagc
ttc 
ATF4-REV-CLON-NotI-pBI-L GATGCGGCCGCctattacggaactctcttc 
ATF4-REV-CLON-XmaI-pIRES2dsRed2 GATCCCGGGctattacggaactctcttctg 
ATF6-FORW-CLON-NheI-Koz GATGCTAGCgccaccatggagtcgccttttag 
ATF6-REV-CLON-NotI-pBI-L GATGCGGCCGCCTAacagacagctcttcgc
tttg 
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name sequence 
ATF6-REV-CLON-XmaI-pIRES2dsRed2 GATCCCGGGCTAacagacagctcttcgctttg
g 
Xbp1-FORW-CLON-NheI-Koz GATGCTAGCgccaccatggtggtggtg 
Xbp1-REV-CLON-NotI-pBI-L GATGCGGCCGCttagacactaatcagctgg 
Xbp1-REV-CLON-XmaI-pRES2dsRed2 GATCCCGGGttagacactaatcagctgggg 
CHOP-FORW-CLON-NotI-Koz GATGCGGCCGCgccaccatggcagctgag
tccct 
CHOP-REV-CLON-SalI-pBI-L GATGTCGACtcatgcttggtgcaggct 
 
Restriction site- appendix 
Kozak- sequence 
Translation start 
Complementary part 
 
2.6.3 Screening primers 
 
name sequence source 
Luc-RT-FORW CCCAACACCGGCATAAAGAA own design 
Luc-RT-REV TCGGTTGGCAGAAGCTATGA own design 
Luc-RT-PB-FORW  GTGTTCGTCTTCGTCCCAGT own design 
Luc-RT-PB-REV ATGTAAACAATCCGGAAGCG own design 
SP-C rtTA –FORW GACACATATAAGACCCTGGTCA (Tichelaar et al. 
2000) 
SP-C rtTA –REV AAAATCTTGCCAGCTTTCCCC (Tichelaar et al. 
2000) 
pBI-L-Seq-FORW  GGTGGGAGGCCTATATAAGC own design 
pBI-L-Seq-REV CAACACCCTGAAAACTTTGC own design 
pIRES2dsRed2-Seq-
FORW 
GCCCCATTGACGCAAATGG own design 
pIRES2dsRed2-Seq-
REV 
CCCTAGGAATGCTCGTCAAG own design 
HMBS-E4-FORW CACCACGGGAGACAAGATTC own design 
HMBS-E4-REV GGGCGTTTTCTAGCTCCTTG own design 
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2.6.4 qPCR primers 
 
name target sequence source  PCR 
conditions 
mß-AKTIN-
FORW 
murine 
Actb 
CTACAGCTTCAC
CACCACAG 
(Korfei et al. 
2008) 
standard 
mß-AKTIN-REV murine 
Actb 
CTCGTTGCCAAT
AGTGATGAC 
(Korfei et al. 
2008) 
standard 
ß-MICRO-
FORW 
murine 
B2m 
GCTATCCAGAAA
ACCCCTCAA 
(Schmittgen, 
Zakrajsek 
2000) 
standard 
ß-MICRO-REV murine 
B2m 
CATGTCTCGATC
CCAGTAGACGGT 
(Schmittgen, 
Zakrajsek 
2000) 
standard 
HMBS-rt-Forw murine 
Hmbs 
CAAGAGTATTCG
GGGAAACCTCAA 
own design standard 
HMBS-rt-Forw murine 
Hmbs 
CAGGATCGTGCA
ACACACTCACTA 
own design standard 
MU-Xbp1-ACO-
Forw 
murine 
Xbp1(s) 
GCTTTTACGGGA
GAAAACTC   
(Acosta-
Alvear et al. 
2007) 
standard / 
touchdown 
MU-Xbp1-ACO-
Rev 
murine 
Xbp1(s) 
GCCTGCACCTGC
TGCG 
(Acosta-
Alvear et al. 
2007) 
standard / 
touchdown 
ATF4-RT-Forw murine 
Atf4 
TTTGACAGCTAA
AGTGAAGACTGA 
own design standard 
ATF4-RT-Rev murine 
Atf4 
GCTTCTTCTGGC
GGTACCTA 
own design standard 
ATF6-RT-Forw murine 
Atf6 
AATGCCAGTGTC
CCAGCAA 
own design standard 
ATF6-RT-REV murine 
Atf6 
GCGCAGGCTGT
ATGCTGA 
own design standard 
CHOP-FORW murine 
Ddit3 
CTAGCTTGGCTG
ACAGAGGA 
own design standard 
CHOP-REV murine 
Ddit3 
CCTGGGCCATAG
AACTCTGA 
own design standard 
ATF3-FORW-
RT-PB 
murine 
Atf3 
ACAACAGACCCC
TGGAGATG 
own design standard 
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name target sequence source  PCR 
conditions 
ATF3-REV-RT-
PB 
murine 
Atf3 
CCTTCAGCTCAG
CATTCACA 
own design standard 
VCP-FORW-RT-
PB 
murine 
Vcp 
AGGTGCCACAAG
TAACCTGG 
own design standard 
VCP-REV-RT-
PB 
murine 
Vcp 
GCCAGTAAGGTT
TTCCCACA 
own design standard 
EDEM-FORW-
RT-PB 
murine 
Edem1 
TGGAATTTGGGA
TTCTGAGC 
own design standard 
EDEM-REV-RT-
PB 
murine 
Edem1 
CATAGAAGGAAT
CCAGCCCA 
own design standard 
GRP94-FORW-
RT-PB 
murine 
Hsp90b1 
CAGAGACTGTTG
AGGAGCCC 
own design standard 
GRP94-REV-
RT-PB 
murine 
Hsp90b1 
CTTTGGATGGTC
TCTGCCAT 
own design standard 
PPIB-FORW-
RT-PB 
murine 
Ppib 
TTTTGCTGCCCG
GACCCTCC 
own design standard 
PPIB-REV-RT-
PB 
murine 
Ppib 
TCCTGTGCCATC
TCCCCTGGT 
own design standard 
BIP-FORW-RT-
PB 
murine 
Hspa5 
TGGGAGGAGTC
ATGACAAAA 
own design standard 
BIP-REV-RT-PB murine 
Hspa5 
GGGGTCGTTCAC
CTTCATAG 
own design standard 
NFE2l2-FORW murine 
Nfe2l2 
GACTCGGTCCAG
CGCAGTCG 
own design standard 
NFE2l2-REV  murine 
Nfe2l2 
TTCAGGCTCGGG
GGCAGGTT 
own design standard 
BAD-FORW murine 
Bad 
CCACCAACAGTC
ATCATGGA 
own design standard 
BAD- REV murine 
Bad 
AACTCATCGCTC
ATCCTTCG 
own design standard 
DNAJC10 –
FORW  
murine 
Dnajc10 
AGCTGGGGTCTT
GGATTTTT 
own design standard 
DNAJC10 – 
REV 
murine 
Dnajc10 
CGGCTCTCACTT
TTCCTTTG 
own design standard 
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name target sequence source  PCR 
conditions 
ATG12 -FORW murine 
Atg12 
AACAAAGAAATG
GGCTGTGG 
own design standard 
ATG12 – REV murine 
Atg12 
GAAGGGGCAAA
GGACTGATT 
own design standard 
CHKB –FORW murine 
Chkb 
TGACATCCAGGA
AGGAAACA 
own design standard 
CHKB – REV murine 
Chkb 
TCTAGTGGGGTA
GTCCGTGG 
own design standard 
Nf Y A –FORW murine 
Nfya 
AGTCAGTGGAG
GCCAGCTTA 
own design standard 
Nf Y A – REV murine 
Nfya 
CCAGGAGGCAC
CAACTGTAT 
own design standard 
hAKTIN-FORW 
 
human 
Actb 
 
ACCCTGAAGTAC
CCCATCG 
(Korfei et al. 
2008) 
standard 
hAKTIN-REV 
 
human 
Actb 
CAGCCTGGATAG
CAACGT 
(Korfei et al. 
2008) 
standard 
hPPIB-FORW human 
Ppib 
CCATCGTGTAAT
CAAGGACTTC 
(Korfei et al. 
2008) 
standard 
hPPIB-REV 
 
human 
Ppib 
TAGCCAGGCTGT
CTTGACTG 
(Korfei et al. 
2008) 
standard 
hEDEM-FORW 
 
human 
Edem1 
CCAAGACAGGG
ATTCCATATCC 
(Korfei et al. 
2008) 
standard 
hEDEM-REV 
 
human 
Edem1 
TCACGACATTGC
CTAGTAATCC 
(Korfei et al. 
2008) 
standard 
hCHOP-FORW human 
Ddit3 
AAAGATGAGCGG
GTGGCAGCG 
own design 64 °C 
 
hCHOP-REV human 
Ddit3 
TCCCAGCTGACA
GTGTCCGAAGA 
own design 64 °C 
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2.7 Cells 
 
product     company  
Mle12     LGC standards, Wesel, Germany  
Mle15     kindly provided by Tim Weaver, Cincinnati 
Mel188    kindly provided by Tim Weaver, Cincinnati 
One shot Top10 chemically   
competent cells [E. coli  
(Escherichia coli)]   Invitrogen, Carlsbad, USA    
 
2.8 Plasmid vectors 
 
name     source 
pBI-L     Clontech, Saint-Germain-en-Laye, France 
pIRES2dsRed2   Clontech, Saint-Germain-en-Laye, France  
pEGFP-N1    Clontech, Saint-Germain-en-Laye, France 
TETO/CMV/pUC19-Xbp1  Tim Weaver, Cincinnati 
Atf4- pBI-L    own construct 
Atf6- pBI-L    own construct 
Xbp1- pBI-L    own construct 
Chop- pBI-L    own construct 
Atf4- pIRES2dsRed2  own construct 
Atf6- pIRES2dsRed2  own construct 
Xbp1- pIRES2dsRed2  own construct 
 
2.9 siRNAs 
 
All from Thermo Fisher Scientific, Waltham, USA 
 
target  name      target sequence 
Atf4  siGENOME siRNA D-042737-01  AGAUGAGCUUCCUGAACA 
Atf4  siGENOME siRNA D-042737-04  AGCAUUCCUUUAGUUUAG 
Atf6  siGENOME siRNA D-044894-03  AGUAUGGGUUCGGAUAU 
Atf6  siGENOME siRNA D-044894-02  CAAUUGUAUUACCAGCAA 
NT  siGENOME non-Targeting siRNA 1     
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2.10 Machines and tools  
 
product      company  
Autoclave     HMC Europe, Engelsberg, Germany 
Axiovert 25 (microscope)   Carl Zeiss Micro Imaging, Jena, Germany 
Balances 
PB 801    Mettler Toledo, Greifensee, Switzerland 
AB54     Mettler Toledo, Greifensee, Switzerland 
Barnstaed Nanopure     
(deionized water supply)   Thermo Fisher Scientific, Waltham, USA 
BioDoc II [Preparative UV (ultra violet) 
light -table]     Biometra, Göttingen, Germany 
Canon Powershot A570 IS 
(CCD-camera)    Canon, Tokyo, Japan  
Centrifuges 
Univapo 150H  
(vacuum centrifuge)  Montreal Biotech inc., Norwalk, USA 
and pump  
(vacuubrand RC6)   Vacuubrand, Wertheim, Germany Vacuum  
Micro 200R (cooling centrifuge) Hettich, Tuttlingen, Germany 
Varifuge 3.0R  
(cooling centrifuge)   Heraeus, Hanau, Germany 
Centrifuge 5426   Eppendorf, Hamburg, Germany 
chambers for agarose-    Kreutz Labortechnik, Reiskirchen, 
gel electrophoresis  Germany 
Electric pipette holders 
Eppendorf Easypet   Eppendorf, Hamburg, Germany 
Pipetus  Hirschmann Laborgeräte, Eberstadt, 
Germany  
Gel Doc XR+ (Gel imager)   Biorad, Hercules, USA    
Heating block VLM EC2   VLM, Bielefeld, Germany 
Heraeus function line 
(CO2- incubator)    Heraeus, Hanau, Germany HiClave HV50 
HeraSafe (sterile bench)   Heraeus, Hanau, Germany 
iCycler with MyiQ detection system 
(for qPCR)     Biorad, Hercules, USA 
In vivo imaging system (IVIS),  
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product      company  
Night Owl II  Berthold Technologies, Bad Wildbad, 
Germany 
Labogaz 206 (Bunsen burner)  Coleman, Wichita, USA 
Micro pipettes 
Eppendorf reference (10 µl) Eppendorf, Hamburg, Germany 
Eppendorf reference (200 µl) Eppendorf, Hamburg, Germany 
Eppendorf reference (1000 µl) Eppendorf, Hamburg, Germany 
Microwave oven Severin 900  Severin, Sundern, Germany 
Mini-Protean 3 Cell and Tetra Cell  
Electrophoresis chambers (for PAGE)  Biorad, Hercules, USA 
MIRAX DESK (digital slide scanner) Carl Zeiss Micro Imaging, Jena, Germany 
MJ-Mini (PCR-cycler)   Biorad, Hercules, USA    
Neubauer Haemocytometer  Optik Labor, Bad Homburg, Germany  
Power supplies for Electrophoresis 
EV231    Consort, Turnhout, Belgium 
E452     Consort, Turnhout, Belgium 
P30     Biometra, Göttingen, Germany 
PowerPac Basic   Biorad, Hercules, USA 
Unidentified model   unknown 
pH-meters 
pH330    WTW, Weilheim, Germany   
HI221     Hanna instruments, Woonsocket, USA 
pump (cell culture)    Ilmvac, Ilmenau, Germany 
RH basic 2 (magnetic stirrer)  IKA-Werke, Staufen im Breisgau, 
Germany 
Semi Dry Blot (Trans-Blot SD)    
blotting machine    Biorad, Hercules, USA 
Severin folio (sealing machine)  Severin, Sundern, Germany 
Shaker 
Vibrax-VXR with VX7   IKA-Werke, Staufen im Breisgau,  
Germany 
Duomax 1030   Heidolph, Schwabach, Germany 
Stuart mini gyro-rocker  Bibbi scientific, Stone, UK 
Shaking incubators 
OV3     Biometra, Göttingen, Germany 
unidentified model   Infors HT, Bottmingen, Switzerland 
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product      company  
Spectrophotometers 
Uvikon 922    Biotek instruments, Winooski, USA 
Nanodrop 2000C   Thermo Fisher Scientific, Waltham, USA 
Spectrafluor Plus (ELISA-reader) Tecan, Männedorf, Switzerland 
Vortexer 
VWR VV3    VWR, Radnor, USA 
Vibrax-VXR with VX1   IKA-Werke, Staufen im Breisgau,  
Germany 
Precellys 24 (tissue homogenizer) Bertin Technology, Montigny-le-
Bretonneux, France 
 
2.11 Software 
 
name       source 
EBI Pairwise Sequence Alignment http://www.ebi.ac.uk/Tools/psa 
EMBOSS Transeq http://www.ebi.ac.uk/Tools/emboss/transe
 q/ index.html 
Image lab (for Gel Doc)   Biorad, Hercules, USA 
Iq5 Optical system software,   
version 2     Biorad, Hercules, USA    
IVIS software (WinLight32)  Berthold Technologies, Bad Wildbad, 
Germany 
Mirax viewer     Carl Zeiss Micro Imaging, Jena, Germany  
NEB-cutter 2.0    http://tools.neb.com/NEBcutter2 
Primer-Blast     http://www.ncbi.nlm.nih.gov/tools/primer-
      blast       
Reverse-complement   http://www.bioinformatics.org/sms/  
rev_comp.html 
Uniprot      http://www.uniprot.org 
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2.12 Consumables 
 
product      company  
Amersham Hybond-P 
[polyvinylidene  fluoride (PVDF)  
–membrane]     GE healthcare, Buckinghamshire, UK 
Amersham Hyperfilm ECL   GE healthcare, Buckinghamshire, UK 
Aluminium foil    Carl Roth, Karlsruhe, Germany 
Campingaz C206      
(gas cartridges for Bunsen-burner) Coleman, Wichita, USA 
C-Chip (One-way Neubauer counter) NanoEnTek, Seoul, Korea 
Cell culture dishes  
(10cm, 6-well, 12-well)   Sarstedt, Nümbrecht, Germany 
      Greiner Bio-One, Kremsmünster, Austria 
Centrifugation tubes (15 and 50 ml) Sarstedt, Nümbrecht, Germany 
      BD, Sparks, USA 
forceps, spattle, spoons   manufacturer unknown 
Glassware     Carl Roth, Karlsruhe, Germany 
one-way plastic pipettes  
(10ml and 25ml)    Sarstedt, Nümbrecht, Germany 
one way-scalpel    Feather Safety Razor, Osaka, Japan 
Pipette tips 10 µl, 100 µl, 1000 µl  Sarstedt, Nümbrecht, Germany 
Pipette tips (filtered)   
10 µl, 100 µl, 1000 µl   Nerbe Plus, Winsen / Luhe, Germany 
microseal ´B´ Film      
(cover films for qPCR-plates)   Biorad, Hercules, USA 
Microtest plates 96-well Flat Bottom 
(microtiter plates)    Sarstedt, Nümbrecht, Germany 
Millipore Steritop Filter Units  
33 and 45 mm (sterile filters)  Merck, Darmstadt, Germany  
Nobaglove (Latex gloves)   NOBA, Wetter, Germany 
Nunc Sealing tapes      
(cover films for microtiter plates)  Thermo Fisher Scientific, Waltham, USA 
Parafilm (M)     Pechiney Plastic Packing, Menasha, USA 
Pasteur pipettes    VWR, Radnor, USA 
PCR-reaction tubes    Sarstedt, Nümbrecht, Germany 
Peha Soft (Nitrile gloves)   Hartmann, Heidenheim, Germany 
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product      company  
Petri dishes     Carl Roth, Karlsruhe, Germany 
qPCR-plates 
AB-1400/w    Thermo Fisher Scientific, Waltham,  
USA 
iCycler iQ PCR-Plates  Biorad, Hercules, USA 
Reaction tubes (1.5 and 2 ml)   Sarstedt, Nümbrecht, Germany  
      Eppendorf, Hamburg, Germany 
Rotilabo syringe filters   Carl Roth, Karlsruhe, Germany  
Syringe, 20 ml     B.Braun, Melsungen, Germany  
  
weighing paper    Machery-Nagel, Düren, Germany 
Whatman 3 mm filter paper    
(blotting paper)    GE healthcare, Buckinghamshire, UK 
 
 
2.13 Mouse lines   
        
name   function and features    source / reference 
FVB/N  WT (wild type )-inbred line   EMBLEM and Charles  
River Laboratories 
(CRL) (Kisslegg, 
Germany) 
SP-C-rtTA  Transactivator line for production of  (Tichelaar et al. 2000)
   rtTA in AECII, FVB/N background  
Atf4-pBI-L  Line for conditional over-expression  own line 
   of Atf4 , FVB/N background 
Atf6-pBI-L  Line for conditional over-expression  own line 
   of Atf6 , FVB/N background  
Xbp1-pBI-L  Line for conditional over-expression  own line 
   of Xbp1(s), FVB/N background 
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3. METHODS 
 
3.1 General methods 
 
3.1.1 Working with RNA 
 
RNA can easily be destroyed by ubiquitous RNases. All works with RNA were 
therefore performed with gloves and RNase-free pipette tips. RNA solutions were 
produced and diluted with RNase free water (QIAgen, either from the RNeasy + Kit 
or the Reverse transcription Kit). To further reduce the activity of RNases, works 
with RNA were generally performed on ice, unless this possibility was excluded by 
experimental necessities. RNAs were either stored at -20 or -80 °C, if long term 
storage was necessary. 
 
3.1.2 Centrifugation 
 
Centrifugations in volumes < 2 ml were performed in an Eppendorf (Centrifuge 
5426) table top centrifuge or a Hettich Micro 200R cooling centrifuge. For bigger 
volumes a Heraeus Varifuge 3.0R cooling centrifuge was used. Vacuum 
centrifugation was performed in a Montreal Biotech Univapo 150H centrifuge with 
an attached Vacuubrand RC6 vacuum pump. The same centrifuge was also 
utilized to spin down reaction mixes in qPCR plates.  
 
3.1.3 Clonal amplification, preparation and storage of plasmid DNA 
 
For clonal amplification of plasmids, chemo-competent E. coli cells (Top10, 
invitrogen) were transformed with 0.5 µl of the concentrated plasmid solution or 
5 µl of a ligation mix following the enclosed protocol. 50 µl of the bacterial culture 
were directly spread on an LB-agarose plate with 0.1 % amp (10 %) or kan 
(30 mg/ml) with the help of a Drigalski-spatula (self made out of a glass pole). If 
higher bacterial concentrations were required, the remaining bacteria were 
centrifuged down (1000g, 5 min), resuspended in 50 µl LB-medium and then 
spread on a second LB-agarose plate. The plates were pre-dried for 1 h and then 
incubated bottom-up at 37 °C in a Biometra OV3 or Infors HT (unidentified model) 
incubator over night (ON). Clones picked from these plates were incubated in 
small volumes of LB-medium with the appropriate antibiotic [96well plate, 37 °C, 
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220 rpm (revolutions per minute), 5 h]. If required, 5 µl of this pre-culture were 
taken out for Polymerase Chain Reaction (PCR)-screening.  
50-200 µl E. coli from this pre-culture or alternately directly from existing cryo 
stocks containing the plasmid of interest, were transferred into 200 ml LB-medium 
with amp or kan (depending on the resistance cassette of the plasmid, 
concentrations as described in the material chapter) in a 500 ml Erlenmeyer tube. 
The culture was then incubated in an Infors HT (unidentified model) rotation 
shaker at 37 °C and 220 rpm ON. If required, 800 µl of this bacterial solution were 
mixed with 200 µl glycerol (sterile) and frozen at -80 °C as a new bacterial stock. 
The remaining culture was transferred into 50 ml Falcon (centrifugation tube) and 
spinned down 30 min at 4000 rcf (relative centrifugal force). The plasmid was then 
isolated with a QIAgen Endofree plasmid maxiprep-Kit following to the 
manufacturers instructions except for the precipitation of the plasmid, which was 
done by centrifugation for 1 h at 4000 rcf. The plasmid-pellet was resuspended in 
100 µl dd-water and stored at -26 °C in non-pyrogenic 1.5 ml tubes. Plasmid DNA 
was kept sterile by working next to a Bunsen-burner or in a sterile bench. 
 
3.1.4 Culturing, melting and freezing of different cell lines 
 
MLE12, MLE15 and MEL188 (Human SK MEL-188 Melanoma Cells) cells were 
kept in 10 cm cell culture dishes with 10 ml MLE12-Medium (for MLE12 and 
MLE15) or MEL188-Medium. The cells were cultured in an incubator at 37 °C with 
5 % CO2. For maintaining the culture, the cells were split 1:10 (MLE12 and 
MEL188) or 1:5 (MLE15) on Mondays and Fridays. For splitting, the medium was 
sucked away with a sterile Pasteur pipette attached to a vacuum pump. Then the 
cells were washed with 10 ml PBS and harvested by incubating for 1-5 min in the 
37 °C-Incubator with 3 ml Trypsin / EDTA followed by knocking the plates to a 
solid surface until the cells were de-attached. Then 7 ml culture medium was 
added and they were transferred to a 50 ml Falcon. The cells were spinned down 
(5 min; 1000 rcf). The medium with the Trypsin was sucked of as described above 
and the cells were resuspended in 10 ml fresh culture medium. The required 
volume (e.g. 1 ml for splitting 1:10) was transferred to a fresh plate.  
MLE12-cells were used no longer than passage fifteen (after purchasing), MLE15 
and MEL188 cells no longer than passage 30. 
When cell-cryostocks from liquid nitrogen had to be thawed, the cells were 
pre-warmed in the hand and transferred completely into culture medium as soon 
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as possible. After 1-2 days the culture medium was changed, and then the cells 
were split normally when they reached full confluence. 
When cryo-conservation of MLE12 or MLE15 cells was required, cells were 
harvested in the described way. The pellet was overlaid with 500 µl Medium 1 
(culture medium and 0.2 M HEPES-Buffer; 9:1) and incubated on ice for 5 min. 
Then the cells were resuspended and transferred into a cryo vial with a pipette. 
500 µl Medium 2 (Medium 1 and DMSO; 4:1) was added. The cells were 
incubated 5 min on ice, then packed into styropor and incubated 2-3 h at -26 °C 
and ON at -80 °C. Then the vials were unpacked and transferred into liquid 
nitrogen for long term storage. Harvested MEL188 were resuspended in a special 
freezing medium (Culture medium, FCS, DMSO; 6:3:1) and then frozen as 
described for the other cells.  
All works with open cells were performed under sterile conditions in a cell culture 
bench.  
 
3.1.5 Counting cells in broncho-alveolar lavage (BAL) 
 
To count cells in murine BAL, 10 µl of cells were transferred into a disposable 
haemocytometer (c-chip) or a Neubauer-haemocytometer then the cells in fife 
large squares were counted under a microscope. The average number of cells per 
square was multiplied by 10000 resulting in cells / ml.  
 
3.1.6 Preparation of enriched mRNA  
 
For mRNA-microarrays and qPCR, enriched mRNA was prepared using the 
QIAgen RNeasy Plus mini-kit according to the standard procedure in the 
applications manual. Cell culture cells were harvested with 600 µl buffer RLT+ and 
homogenized with a QIAshredder. The elution of the mRNA was done with RNase 
free water (30-50 µl, as appropriate). RNA prepared this way was depleted from 
DNA (by cDNA-eleminator columns) and enriched for bigger RNAs because small 
RNAs do not bind strongly to the columns under these buffer conditions.   
 
3.1.7 Reverse transcription (RT) of mRNAs 
 
For the preparation of cDNA, equal amounts of enriched RNA (typically 2 µg) per 
sample were subjected to reverse transcription with the Omniscript RT kit 
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(QIAgen) with oligo-dT-primers. 6µl of the following master mix was added to the 
appropriate amount of RNA: 
 
Master mix: 
10 x Buffer    2 µl    
dNTPs    2 µl     
Oligo-dT primers   0.5 µl    
RNase Inhibitor   0.5 µl    
Reverse transcriptase  1 µl    
 
Before adding RNA and master mix, RNase-free H2O was subjoined to achieve a 
total reaction volume of 20 µl for each sample. The samples were incubated 
10 min at RT (room temperature) for primer annealing and then 65 min in a 
thermocycler at 37 °C for cDNA synthesis. For convenience, the concentration of 
the RNA-template was used as the concentration of the product cDNA in all 
subsequent methods. However, the true cDNA content of the sample could be 
lower because the template is not pure mRNA and the efficiency of the RT is 
never 100 %. 
 
3.1.8 Preparation of protein-extracts  
 
To produce raw protein extract from cells an appropriate amount of lysis-buffer 
(e.g. 100 µl for a well 6-well) was added to the adherent cells, which were washed 
with PBS in advance. After that, the plate was shock-frozen in liquid nitrogen and 
melted at RT three times and then transferred into a centrifuge tube. Alternatively 
cells were scratched of the plate after addition of the lysis buffer, resuspended and 
transferred into a centrifuge tube, which was then treated with liquid nitrogen 
accordingly. Protein raw-extracts from murine lung tissue were either produced by 
grinding in liquid nitrogen with mortar and pestle or by using a Bertin Technology 
Precellys 24 tissue homogenizer. 
When using mortar and pestle, lysis buffer (e.g. 1 ml) was added to the fine, frozen 
lung powder. The mixture was transferred into 1.5 ml tubes after melting and 
incubated on ice for additional 30 min.  
When using the homogenizer, a frozen lung piece was put into a homogenization 
tube with ceramic beads and lysis buffer and then homogenized two times at 
5000 rpm for 30 sec. To get clear extracts, the raw extracts were centrifuged at 
20000 rcf for 10 min at 4 °C. The supernatants were stored at -26 °C or -80 °C.  
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3.1.9 Preparation of total RNA (for miRNA) 
 
For miRNA arrays total RNA including the small RNAs is required. Total RNA was 
prepared with the QIAgen RNeasy Plus mini-kit according to appendix D of the 
applications manual. The different use of buffers (with more Ethanol) allows the 
binding and purification all RNAs, including the miRNA.  
 
3.1.10 Estimation of protein concentrations (BCA) 
 
Protein concentrations were estimated by BCA-assay. The BCA-assay is based on 
the reduction of Cu2+ to Cu1+ by protein in an alkaline medium and a subsequent 
reaction of bicinchoninic acid (BCA) with the reduced (cuprous) cation to a 
purple-coloured product which can be assessed by absorbance at 562 nm (Smith 
et al. 1985). The assay was performed according to the instructions manual of the 
kit. Proteins were diluted 1:5-1:20 in lysis-buffer as appropriate. 1500, 1000, 750, 
500, 250, 125, 62.5, 31.25, 15.625 and 7.813 µg/ml BSA solutions (in lysis-buffer) 
served as reference standard. After incubating the protein solutions for 30 min at 
37 °C with the assay reagent, the protein concentrations were estimated in a 
Tecan SpectrafluorPlus microtiter plate reader at 560 nm. The results were 
multiplied with the appropriate dilution factor.  
 
3.1.11 Measuring nucleic acid concentrations  
 
Nucleic acid concentrations were either measured in a Biotek instruments Uvikon 
922 cuvette-spectrophotometer or in a Thermo Fisher Scientific Nanodrop 2000C 
spectrophotometer. When the cuvette-spectrophotometer was used, the nucleic 
acids had to be pre diluted 1:50 to 1:100 and put into a quartz-cuvette. The nucleic 
acid concentration was calculated from the optical density (OD) at 260 nm: 
 
DNA: 1 OD = 50 µg/ml  
RNA: 1 OD = 40 µg/ml 
 
The estimation in Nanodrop follows the same principles. However, measurement 
and calculations are done automatically by the machine. The Nanodrop also 
allows direct measurement out of 2 µl (or less) of a sample without any dilution 
(concentration range 2 ng/µl to 15 µg/µl), as it adjusts the thickness of the sample 
layer for the measurement.   
METHODS 
_________________________________________________________________ 
- 51 - 
3.1.12 Precipitation and washing of DNA 
 
DNA was precipitated by addition of 10 % sodium acetate solution (3 M, pH 5) and 
three volumes of 100 % ethanol followed by 2 h incubation at -26 °C. Then the 
DNA was pelleted by centrifugation (20000 rcf, 4 °C, 20 min). The liquid was 
removed with a pipette and the pellet was washed by addition of 500 µl 70 % 
Ethanol and subsequent centrifugation (20000 rcf, 4 °C, 5 min). After removing the 
ethanol, the DNA pellet was dried (open tube, RT, 3-15 min). 
 
3.1.13 Preparation of genomic DNA 
 
Genomic DNA from mouse tail clips (provided by CRL) was generally produced 
with the QIAgen DNeasy Blood and Tissue kit following the instructions of the 
manual. Genomic DNA from founder mice was provided as a pellet in 70 % 
ethanol (by EMBLEM) and spinned down, dried and resuspended in 500-1000 µl 
water before further use.   
 
3.1.14 Poly Acrylamid Gel Electrophoresis (SDS-PAGE)  
 
4 x Sample buffer (SB) was added to the protein extracts as required to achieve 
1 x SB. Generally equal protein amounts of 20-50 µg were separated in 
SDS-PAGE. Depending on the target, they were either run reducing (with 
10 % ß-mercaptoethanol in the sample buffer) or non-reducing. Prior to loading, 
the samples were denatured 10 min in boiling water and then chilled on ice. The 
samples were spinned down in a centrifuge and then loaded on self made 
SDS -polyacrylamide gels with a 9-15 % separating gel and a 4 % stacking gel. 
The proteins were separated at 15 mA (per gel).  
 
3.1.15 Western blots and immunostaining of immobilized proteins 
 
The gels from SDS-PAGE were used for WB analysis. The PVDF-membrane and 
blot-papers were cut to gel size. The membrane was activated in 100 % methanol 
for 2 min and then pre-incubated in transfer-buffer. After electrophoresis the gels 
were also pre-incubated in transfer-buffer. Then the blotting machine (Biorad) was 
set up (from bottom to top: three layers of blotting paper, membrane, gel, three 
layers of blotting paper) and the transfer was performed at 25 V for 90 min.  
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The membrane was then incubated in blocking-buffer for 1 h (on a shaker). Then 
the membrane was placed in a sealed plastic bag with about 12 ml 
antibody-solution per gel and incubated ON at 4 °C on a shaker. The membrane 
was washed in a plastic dish with 1 x TBST (4 x 15 min) and incubated with the 
appropriate peroxidase coupled secondary antibody (1:2000, RT, 1-2 h, shaking). 
The membrane was then washed six times with TBST as described above and 
placed in a cut-open plastic disposal bag for enhanced chemo-luminescence 
(ECL)-detection. In the darkroom 3 ml of freshly detection reagent (GE-Healthcare, 
ECL western blot detection system) were applied to the membrane, followed by 
5 min incubation. The membrane was briefly dried between two paper towels and 
then placed in a cut-open disposal bag in a film cassette. Films were put on (and 
developed as described below) for different exposure times depending on the 
required signal intensity.  
 
3.1.16 Developing films 
 
The films were put on the blots in the dark. After variable times of exposure, they 
were transferred into developing solution (1 min), washed in water and transferred 
into the fixing solution for some minutes. The film was then washed in water again 
and dried with a hot air blower.  
 
3.1.17 Immunohistochemistry (IHC) 
 
IHC is based on the localization of antigens in tissue sections by labelled 
antibodies. These primary antibodies are then detected by enzyme-labelled 
secondary antibodies and visualized by the production of a coloured substrate by 
these enzymes.     
For the purposes of this thesis 3 µm paraffin embedded serial sections of 
paraformaldehyde fixed mouse lungs were stained (either by me or under my 
supervision by Dirk Lohfink). Generally every second section was stained for 
pro-SP-C. Sections were deparaffinised at 60 °C for 1 h and then in xylol for 
10 min. They were then rehydrated in alcohol baths with declining concentrations 
(99.6 %, 96 %, 80 %, 70 % and 50 %, each for 3 min) and kept in distilled water 
until further use.  
Antigen retrieval was performed by denaturation in citrate buffer in a microwave 
oven (three times 5 min boiling at 600 W, interrupted by cooling down at RT for 
25 min and refilling with aqua dest up to the original level).  
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The object carriers were then washed with 1 x PBS (3 x 2 min with shaking in 
staining bath), and quickly dried with paper towels without touching the slide.  
The ZytoChem AP fast red kit or HRP- DAP kit were used for further steps. The 
sections were placed in a humid chamber and blocked for ten minutes with two 
drops of blocking solution, followed by washing as described above. Primary 
antibodies (purchased separately) were prepared in 3 % BSA solution in dilutions 
listed with the antibodies. The slides were covered with equal amounts (typically 
100 µl) of this antibody solution and incubated for variable times (typically 1.5 h at 
RT). A negative control (without primary antibody) was included.  
After another washing step, two drops of the biotinylated secondary 
broad-spectrum-antibody solution were put on each slide. After 15 min of 
incubation at RT and another washing step, two drops of Streptavidin-alkaline 
phosphatase solution (or HRP-solution for the DAP-kit) were added followed by 
another 15 min incubation and washing.  
One pill of Fast Red (or two drops of DAP-solution for the DAP-kit) was freshly 
dissolved in a bottle of naphtol (provided) and two drops were put on each slide. 
The slides were incubated up to 20 min depending on the stained protein and the 
desired degree of staining, which was controlled under the microscope. The slides 
were washed in distilled water. Finally the slides were stained with haemalaun for 
30 sec and washed under running tap-water. Sections were then mounted with 
glycerol mounting medium and cover slips and allowed to dry ON. 
 
3.1.18 Microscopy   
 
Stained sections were usually analysed by scanning with Mirax scanner (Carl 
Zeiss). The Mirax viewer software was used for making and analyzing snapshots. 
Alternately a Carl Zeiss Axiovert 25 microscope with light and fluorescence optic , 
was used to view slides as well as cell culture cells and an attached Canon 
Powershot A570 IS digital camera was utilized to produce images. 
 
3.1.19 Agarose gel-electrophoresis 
 
The DNA samples were mixed with loading buffer (final concentration 1 x) and 
loaded onto a self made one or 2 % agarose gel with 1 µg/ml ethidium bromide 
(except for ethidium bromide free gel extraction). 
The separation was performed at 60-100 V until the desired distance of separation 
was reached. Due to their negative charge nucleic acids migrate towards the 
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anode. The migration distance of DNA in a gel depends mainly on its size but can 
vary for circular, especially super coiled DNA. The size of amplified DNA was 
determined by a DNA molecular weight standard (SmartLadder, Eurogentech). 
The agarose gel was visualized and photographed under UV light in a Biorad Gel 
Doc XR+ gel imager. 
The agarose gel-electrophoresis was used to estimate DNA concentrations by 
comparing it with the marker, verifying product sizes from qPCR, identifying the 
products of PCR reactions and for gel purification of DNA-products with the  
QIAquick Gel Extraction Kit (according to the manual). 
 
3.1.20 Polymerase chain reaction (PCR) 
 
PCRs were performed for different purposes, firstly for the PCR-screening of the 
transgenic animals and of plasmid-vectors for the presence of transgene and 
transactivator, secondly as a preparation for the cloning of transgenes into 
different plasmid vectors. Depending on the purpose, different 
Polymerase-systems were used. For PCR-screenings either the QIAgen hot start 
polymerase kit or the Thermo Phire -polymerase system was used.  
 
Reaction mix for QIAgen hot start polymerase: 
reagent µl for 25 µl 
reaction 
10 x buffer  2.5 
dNTP-Mix 0.5 
Forward primer 10 pmol/µl 2.5 
Reverse primer 10 pmol/µl 2.5 
HotStar DNA Polymerase 0.25 
DNA 1  
Water 15.75 
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Reaction mix for Phire polymerase: 
reagent µl for 10 µl 
reaction 
5 x Buffer 2 µl 
Forward primer 10 pmol/µl 0.5 µl 
Reverse primer  10 pmol/µl 0.5 µl 
dNTPs 0.2 µl 
Phire Polymerase 0.2 µl 
Water 5.6 µl 
Template 1 µl  
 
PCR amplifications for cloning were performed with QIAgen HotStar HiFidelity 
PCR-Kit.  
 
Reaction mix for QIAgen HotStar HiFidelity polymerase: 
reagent µl for 50 µl 
reaction 
5 x Puffer (incl. dNTPs) 10 
Forward primer 100 pmol/µl 0.5 
Reverse primer 100 pmol/µl 0.5 
HotStar HiFidelity DNA Polymerase 1 
Template  (100 ng) 
water ad 50 µl 
 
The PCR conditions were depending on the Polymerase System and on the 
target.  
 
Conditions for PCR with luciferase primers and QIAgen polymerase: 
hot start 1 x 20 min 95 °C 
denaturing 30 sec 94 °C 
annealing 30 sec 61 °C  
elongation 
30 cycles 
60 sec 72 °C 
final Elongation 1 x 10 min 72 °C 
Primers: Luc-RT-FORW / Luc-RT-REV 
 
Conditions for PCR with pBI-L insert-primers / dsRed-insert primers and QIAgen 
polymerase: 
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hot start 1 x 20 min 95 °C 
denaturing 60 sec 94 °C 
Annealing 60 sec 53 °C / 55 °C  
Elongation 
30 cycles 
60 sec 72 °C 
final Elongation 1 x 10 min 72 °C 
Primers: pBI-L-Seq-FORW / pBI-L-Seq-REV; pIRES2dsRed2-Seq-FORW / 
pIRES2dsRed2-Seq-REV 
 
Conditions for PCR with luciferase and SP-C-rtTA primers and Phire polymerase: 
hot start 1 x 30 sec 98 °C 
denaturing 5 sec 98 °C 
annealing 5 sec 62 °C 
elongation 
30 cycles 
20 sec 72 °C 
final Elongation 1 x 1 min 72 °C 
Primers: Luc-RT-FORW / Luc-RT-REV; SP-C rtTA –FORW / SP-C rtTA –REV 
 
Basic conditions for PCR with QIAgen HotStar HiFidelity polymerase: 
hot start 1 x 5 min 95 °C 
denaturing 15 sec 94 °C 
annealing 60 sec 53 °C 
elongation 
45 cycles 
65 sec 72 °C 
final Elongation 1 x 10 min 72 °C 
These conditions were further optimized for the individual cloning-reactions as 
follows:  
Pre-amplification of the Atf4-insert: elongation: 80 sec; annealing 51 °C   
Pre-amplification of the Atf6-insert: elongation: 80 sec; annealing 48 °C   
Xbp1-PCR with cloning Primers: annealing 55 °C   
 
Primers: ATF4-FOR-AMPL / ATF4-REV-AMPL; ATF6-FOR-AMPL / 2nd-ATF6-
REV-AMPL; CHOP-AMPL-FORW / CHOP-AMPL-REV; ATF4-FORW-CLON-NheI-
Koz / ATF4-REV-CLON-NotI-pBI-L; ATF4-FORW-CLON-NheI-Koz / ATF4-REV-
CLON-XmaI-pIRES2dsRed2; ATF6-FORW-CLON-NheI-Koz /ATF6-REV-CLON-
NotI-pBI-L; ATF6-FORW-CLON-NheI-Koz / ATF6-REV-CLON-XmaI-
pIRES2dsRed2; Xbp1-FORW-CLON-NheI-Koz / Xbp1-REV-CLON-NotI-pBI-L; 
Xbp1-FORW-CLON-NheI-Koz / Xbp1-REV-CLON-XmaI-pRES2dsRed2; CHOP-
FORW-CLON-NotI-Koz; CHOP-REV-CLON-SalI-pBI-L 
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3.1.21 Quantitative PCR (qPCR) analysis 
 
Quantitative PCR (qPCR) was performed for relative quantification of mRNA and 
genomic DNA (screening for homozygousity) levels. For each reaction the 
following mix was prepared on 96-well PCR-plates: 
  
reagent µl for 20 µl 
reaction 
BIORAD Sybergreen Mix  10 
Forward primer 10 pmol/µl 0.5  
Reverse primer  10 pmol/µl 0.5  
Water 8  
Template (10 ng/µl) Je 1 µl (10 ng) 
 
The reaction mix was prepared as a master mix without the template. Per well, 
19 µl of the mix were put on the PCR plate, then 1 µl of the respective 
DNA-template (10 ng/µl) were mixed in with a pipette. The plates were sealed with 
a Biorad microseal ´B´ film and centrifuged to remove air bubbles and concentrate 
the sample at the bottom of the plate. Then the plate was placed in a Biorad 
iCycler with MyiQ detection system and incubated according to the following 
protocol: 
       
 1 x 3 min 95 °C 
denaturing 15 sec 95 °C 
annealing 
40 cycles 
30 sec 60 °C detection 
 1 x 10 sec melting curve 
analysis 
 
For some targets, the conditions had to be adjusted. Individualized annealing 
temperatures are listed with the primers. The Xbp1(s) reaction sometimes 
produced multiple products. In those cases twenty touchdown-cycles were 
performed before the detection phase, where the annealing temperature was 
reduced in each step by 0.5 °C starting with 70 °C.    
 
Quality control: 
Results from qPCR were only accepted when they matched several quality 
standards. Firstly, for each individual cDNA sample of a –RT control had to be 
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negative. For that purpose 10 ng of the template RNA was taken as template for 
the same qPCR-reaction as the cDNA (either with the primers for a reference gene 
or for the transfected transgene). Samples were accepted when the cycle of 
threshold (CT) of those samples was at least three below the CT of its cDNA. 
Secondly, equal amplification efficiencies of the different samples from one 
reaction had to be guarantied. This was estimated by observation of the 
amplification curves in the region of the threshold. Only curves which appeared to 
be parallel were accepted. Thirdly the reference genes had to be equal. Samples 
in which a reference gene was three CT-values away from the mean were not 
accepted. Fourthly, the first derivation of the melting curve was observed. 
Reactions with more then one peak (representing multiple products or primer 
dimmers) were not accepted.  
For some reactions additional quality controls were performed in advance: The 
first was the separation of the product on an agarose gel to check the product 
identity (by size). The second was the comparison of the CT of a reaction with 10 
and 20 ng template to verify that a quantitative analysis with the used 
concentrations was possible.  
 
Data analysis: 
The primary results of a qPCR are the CT-values (the cycle-number in which the 
light signal reaches a certain threshold value which lies in the early exponential 
phase of the reaction). By subtraction of the CT-values from those of reference 
genes, smaller differences in template quality and concentration can be corrected. 
All qPCRs of murine cDNA were normalized against the mean CT of ß-actin, 
Hmbs and ß-microglobulin. GDNA qPCRs were normalized against Hmbs (Hmbs 
E4-primer) and human cDNAs were normalized with ß-Actin. When appropriate 
the delta CT (dCT) -values of a given treatment were further normalized against 
the untreated or control treatment (by subtraction of the control dCT from the 
target gene dCT), leading to the delta-delta CT-value (ddCT). Delta CT values only 
have a meaning when compared to one or more references, whereas ddCT values 
directly represent an up- or down-regulation.   
 
3.1.22 Sterile work 
 
Many methods had to be performed under sterile conditions therefore the following 
sterile techniques were performed for the indicated purposes. 
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technique   application 
Autoclaving Sterilization of LB-medium (before addition of 
Antibiotics)  
    Bacterial and cell culture waste disposal 
    sterilization of containers, pipette tips, etc.  
    Sterilization of glycerol  
Sterile filtration    Sterilization of cell culture media and reagents with 
Syringe-filters for volumes <100 ml and bottle top filter 
and vacuum pump for larger volumes  
Disinfection with 70 % general decontamination of working surfaces also  
ethanol    preparation for sterile work; disinfection of pipettes  
Work next to a running Work with bacteria (except harvesting) and fresh  
Bunsen-burner  bacterial culture media 
Flaming with Bunsen local sterilization of glassware when working with  
Burner bacteria  
 
3.2 Cloning 
 
This chapter serves as an overview over the method. Details are described in the 
chapter PCR and primer sequences are documented in the material part (2.6.2). 
 
3.2.1 Overview and amplification of the inserts 
 
The following constructs were cloned: 
insert reference plasmid vector 
Atf4 Uniprot Q06507 (sequence according 
to the indicated QK sequence conflict 
pBI-L 
Atf6 N-terminal domain Uniprot Q8BZ84 nucleotides 1-1098 
+tgt 
pBI-L 
Xbp1(spliced) Uniprot O35426, isoform 2 pBI-L 
Ddit3 (Chop) Uniprot P35639 pBI-L 
Atf4 Uniprot Q06507 (sequence according 
to the indicated QK sequence conflict 
pIRES2dsRed2 
Atf6 N-terminal domain Uniprot Q8BZ84 nucleotides 1-1098 
+tgt 
pIRES2dsRed2 
Xbp1(spliced) Uniprot O35426, isoform 2 pIRES2dsRed2 
 
METHODS 
_________________________________________________________________ 
- 60 - 
The basis material for Atf4, Atf6 and Chop-constructs was murine cDNA. Template 
for spliced Xbp1 was the plasmid TETO/CMV/pUC19-Xbp1 (obtained from 
Prof. T. Weaver, Cincinnati). For Atf4, Atf6 and Chop a pre amplification of a larger 
sequence, containing the open reading frame was performed and then used as a 
template for the actual cloning PCR to enhance amplification efficiency and 
specificity of the product. The cloning primers (for all the constructs) were 
designed with the following features:  
Forward primer composition: 
- Six unspecific base pairs - sequence for the cleavage of a restriction 
endonuclease which is also present in the multiple cloning site of the plasmid but 
not in the insert – Kozak sequence – start codon and additional bases 
complementary to the insert sequence - 
Reverse primer composition:  
- Additional bases complementary to the downstream region of the insert 
sequence ending with the Stop codon - sequence for the cleavage of a restriction 
endonuclease which is also present in the multiple cloning site (downstream of the 
restriction site of the forward-primer) of the plasmid but not in the insert six 
unspecific bases -  
 
3.2.2 Digestion of inserts and vectors 
 
To enable forced orientation cloning, the inserts and the respective vectors were 
cut with the same two restriction endonucleases, leading to homologous single 
stranded ends of the vector and the insert (for that purpose only restriction sites for 
such endonucleases which produce “sticky” ends were chosen). To enable an 
optimal ligation in the next step the restriction cuts had to be as complete as 
possible. At the same time unspecific digestion had to be kept at a minimum. The 
two digestions were performed independently. After the first digestion the DNA 
was purified with the QIAgen PCR-purification kit (the matrix of the contained spin 
columns does not bind small fragments and the cut of ends of the primer 
sequences are therefore removed). The second digestion was purified with gel 
extraction (QIAgen gel extraction Kit). This allowed removing the larger cut out 
fragments from the MCS of the plasmid as well as it enabled the purification of the 
inserts from most unspecific amplification products.  
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3.2.3 Ligation of inserts and vectors 
 
The linearized vectors and purified inserts were ligated in molar ratios of roughly 
1:3. Two different ligase systems (depending on availability in the laboratory) were 
used for this step. The constructs containing Atf4, Atf6 and Xbp1 were ligated with 
NEB T4 DNA ligase, the Chop-construct with Promega ligase.  
 
Ligation with NEB-ligase: 
digested insert   linearized plasmid  ligase ligase 
buffer 
water reaction 
100 ng 25 ng    1 µl 2 µl ad 
20 µl 
16 °C, 
ON 
 
Ligation with Promega-ligase: 
digested insert   linearized plasmid  ligase ligase 
buffer 
water reaction 
100 ng 25 ng    0.5 µl 1 µl ad 
10 µl 
16 °C, 
ON 
 
3.2.4 From ligation to vector 
 
The ligated plasmids were then cloned into E. coli. The procedures of this step are 
described in the chapter “Clonal amplification, preparation and storage of plasmid 
DNA”. As indicated there, 5 µl of small bacterial cultures derived from the picked 
clones were used for a PCR screening. The method is described in the chapter 
“Polymerase chain reaction (PCR)” as screening for the insert of pIRES2dsRed2 
of pBI-L respectively. However, for this special case, the template was 5 µl of a 
bacterial culture instead of 1 µl DNA-solution and the volume of the water in the 
reaction was adjusted accordingly. When big amounts of plasmids from maxipreps 
were available, an aliquot was send to GATC-Biotech for sequencing. The primers 
used for the PCR-screening of the insert were also used for sequencing in forward 
and reverse direction. The sequences were then compared to the expected insert 
sequence as obtained from a databank with the aid of different bioinformatics’ 
tools, available in the www (EBI Pairwise Sequence Alignment, EMBOSS 
Transeq, Uniprot, Reverse-complement). 
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procedure name of the tool 
Reverse complementation of 
the sequence obtained with 
the reverse primers 
Reverse complement 
Comparison of sequences EBI Pairwise Sequence 
Alignment 
Translation of RNA to protein 
sequences 
EMBOSS Transeq 
 
When the sequence was correct, the plasmids for cell culture work were ready to 
use. For generation of transgenic animals the constructs were further processed 
as described in the Chapter 3.5.1.  
 
3.3 Transient transfections and drug treatment in cell 
culture 
 
3.3.1 Transfection of plasmids  
 
The following plasmids were transfected into cell culture cells for different 
experiments: 
  
plasmid purpose 
pIRES2DsRed2 Control transfection as a reference for the following three 
plasmids 
Atf4-pIRES2DsRed2 Constitutive over-expression of ATF4  
Atf6-pIRES2DsRed2 Constitutive over-expression of p50Atf6 
Xbp1-pIRES2DsRed2 Constitutive over-expression of XBP1(s) 
pEgfp-N1 Control transfection as an additional reference and (due 
to a strong EGFP-expression) a tool to estimate the 
transfection efficiency 
 
Plasmids were transfected mainly into MLE12 cells and for some experiments 
MLE15 and MEL188-cells. The transfection was done with Lipofectamine2000 
(invitrogen) on 12-well and 6-well plates, generally according to standard 
conditions of the manual, but with some adjustments. 
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Optimized transfection conditions:   
1.) DNA-Lipofectamine complexes were incubated for 40 min before putting on 
the cells 
2.) MLE12 and MLE15 cells were transfected in a transfection medium 
containing of 50 % culture medium and 50 % Optimem. 
3.) 4-6 h after transfection the transfection mix was replaced by fresh culture 
medium   
 
To estimate the transfection efficiency, cells transfected with pEGFP-N1 were 
observed under a fluorescence microscope with UV light a filter for green 
fluorescence and normal light respectively. The expression of the marker dsRed2 
was to week and irregular for this purpose. 
Transfected cells were used to check for transgene expression, downstream 
signalling, cell death and cell growth.   
 
3.3.2 SiRNA-transfection 
 
MLE12-cells were transfected with siRNAs against Atf4, Atf6 (final concentration of 
siRNA: 0.1µM). The transfection was performed with Darmafect 1 reagent 
(Dharmacon) according to the instructions. First two siRNAs against each gene 
(out of four delivered) were chosen considering their individual knockdown 
efficiency and specificity (not shown, sequences in 2.9). Then a combination of the 
“best” two against each gene was used. The total amount of siRNA per 
transfection was not altered. Therefore a siAtf4/Atf6 transfection contains only half 
the siRNA against Atf4 and Atf6 respectively like the single transfection. SiRNA 
transfected cells were generally harvested 48h after transfection.  
 
3.3.3 Treatment with Thapsigargin (TG) and Brefeldin A (BFA) 
 
1 µM TG (used as a 1 mM Stock in 100 % ethanol) and 10 µg/ml BFA 
(Stock: 10 mg/ml in DMSO) were used for chemical induction of ER-stress. The 
appropriate amount of the reagents was added with a micropipette into the cell 
culture medium. The plates were shaken by hand and put back into the 
CO2-incubator. 
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3.4 Monitoring growth of MLE12 
 
To monitor the effects of Atf4, Atf6 and Xbp1, cells transfected with those 
transgenes (and pIRES2dsRed2, pEGFP-N1 and WT-cells as controls) were 
counted on the culture dish at different time points. In detail, three independent 
transfections for each transgene were performed. Then one tenth of each 
transfection was transferred to a new well (6-well) with fresh culture medium. Fife 
spots for counting were labelled on the lid of the dish in a circle of 1 cm diameter 
around the middle of each well. For counting the middle of a microscopic light field 
(camera magnification: 12 x, Objective 20 x) was centred over a label, and 
adjusted for a clear picture. All cells in the digital images, that appeared to be 
adherent, were counted and the average of the fife countings was calculated. The 
same spots were photographed and counted after ON incubation (=0) and 9, 25 
and 30 h later. Mean cell numbers and standard deviations were depicted in a 
logarithmic growth curve. The slopes of the three independent regression lines 
were used for statistics (t-test). 
 
3.5 Transgenic mice 
 
The vectors Atf4-PBI-L, Atf6-PBI-L, Xbp1-pBI-L and Chop-pBI-L were cloned as 
described above. For generation of transgenic animals they had to be further 
processed as described later in this chapter. The finalized constructs were then 
sent to EMBLEM (Monterotondo, Italy) for pronuclear injection and delivery of 
transgenic founder animals which were screened for transgene integration as 
described above. The offspring were then sent to CRL (Kisslegg, Germany) for 
breeding according to my instructions. For experiments the mice were sent to our 
facility.  
 
3.5.1 Finalization of the constructs  
 
To enable genomic integration of the constructs after oozyte injection, they were 
linearized. Furthermore the plasmid sequences of bacterial origin were removed to 
exclude all possible influences of these sequences. This was achieved by cutting 
with one or two restriction endonucleases which were chosen to cut out most of 
the amp resistance cassette and the E. coli ORI but not the other parts of the 
plasmid or the insert. The sites were identified with the aid of the program 
“NEB-cutter” which is public available in the internet.  
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vector restriction 
endonucleases 
reaction conditions 
Atf4-pBI-L BsrBI 32 µl ATF4-pBI-L, 7 µl BsrBI, 10 µl NEB2 buffer, 
37 °C ON and one additional h with + 2 µl 
enzyme, reaction volume 100 µl 
Atf6-pBI-L BsrBI 32 µl ATF6-pBI-L, 7 µl BsrBI, 10 µl NEB2 buffer, 
37 °C ON and one additional h with + 2 µl 
enzyme, reaction volume 100 µl 
Xbp1- pBI-L AatII and DrdI 32 µl ATF6-pBI-L, 2 µl AatII and 6 µl DrdI, 10 µl 
NEB4 buffer, 37 °C ON and one additional h 
with + 2 µl of both  enzymes, reaction volume 
120 µl 
Chop- pBI-L AatII and AseI 30 µl Chop- pBI-L, 4 µl AatII, 10 µl NEB4 buffer, 
37 °C ON and two additional h with + 2 µl 
enzyme, reaction volume 100 µl then PCR-
purification and 
230 µl digested plasmid, 4 µl AseI 30 µl NEB3 
buffer, 37 °C ON and two additional h with + 2 µl 
enzyme, reaction volume 300 µl 
 
The largest fragment was isolated by gel purification. Gel purification is described 
in the “general methods” part. To keep up the required purity for oozyte injection, 
the electrophoresis-chamber was cleaned carefully and filled with fresh buffer. 
Furthermore the construct for the injection must not contain any Ethidiumbromid 
(ETBr). Therefore ETBr-free gel purification was performed. To detect the position 
of the desired fragment the sides of the gel were cut of and stained with ETBr. On 
a UV-table the bands were detected and labelled by a knife cut. Then the 
ETBr-stained slices were packed in disposal bags and placed next to the 
unstained part of the gel. The region with the biggest fragment (containing the 
transgene) was cut out. Then the purification proceeded as described.  
To ensure that the fragment was sterile, particle free and dissolved in injection 
buffer at the appropriate concentration of 50 ng/µl, additional procedures were 
performed:   
The eluate from gel-purification was diluted in 1 ml water. A 0.22 µm (PES) filter 
was washed with 1 ml water. Then the fragment was filtrated through this (now 
particle-free) filter into a 50 ml Falcon. Material remaining in the filter was washed 
into the filtrate with one additional ml water. The DNA was precipitated, washed 
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and air-dried. Finally it was resuspended in 200 µl injection buffer and the 
concentration was adjusted to 50 ng/µl (with injection buffer). The quality of the 
finalized construct was controlled on an agarose gel. At least 15 µg of each final 
construct were sent for oocyte injection.  
 
3.5.2 From the construct to animal experiments 
 
As mentioned above, the constructs were sent to EMBLEM for oocyte injection. 
EMBLEM provided isolated DNA of the potential founders for screening. New 
founders were screened with the PCR-procedures described in the “general 
methods” part. Specifically, PCRs against the luciferase part (usually with both 
described polymerase systems) and the insert part were performed, to verify the 
integration of the full length construct. The animals were then kept at CRL 
laboratory for breeding of double heterozygous (+-/+-), homozygous (++) and 
double homozygous (++/++) animals (explained in more detail below). All steps of 
the breeding program were performed according to my direct instructions. 
The screening of the offspring for transgene-presence was generally a screening 
against the luciferase region of the construct (see chapter 3.1.20). The majority of 
the transgene integration screenings and screenings for SP-C-rtTA presence (the 
transactivator), including the preparation of genomic DNA, were kindly performed 
by Silke Händel.  
++ mice were selected with qPCR, following the general method described above 
and further explained in the following chapter. Specifically the primer pair 
Hmbs-E4-forward and Hmbs-E4-reverse was utilized for the reference qPCR. 
Transgene homozygousity was investigated with the primers Luc-RT-PB-forward 
and Luc-RT-PB-reverse and SP-C-rtTA with the same primers also used for the 
general screening. These results were then verified by back breeding with WT 
animals. 
 
3.5.3 The breeding program  
 
The breeding of the transgenic animals had different aims, firstly the expansion of 
the respective line. It was desired to get more than one stable line for each 
transgene to enable the investigation of the effects of different integration sites. 
Secondly ++ lines should be generated to get a basis in which different 
transactivators can be bread in later on. Thirdly ++/++ mice (with the respective 
transgene and SP-C-rtTA as transactivator) should be generated for experiments. 
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And finally ++/++ lines were required for experiments and to get stable lines for 
later use.  
Therefore two different data had to be obtained separately for the transgene(s) 
and the transactivator: Is the mouse positive or negative for the construct and if it 
is positive, is it also ++? The first question was addressed by a conventional 
PCR-screening against SP-C-rtTA for the transactivator and against luciferase for 
all the transgenes. When homozygousity was possible the positive animals had to 
be further screened. As long as the integration site of the transgene is not known, 
only back breeding of the animals with wild type and subsequent screening of the 
offspring can prove homozygousity. If a larger number of pups is 
transgene-positive and none are transgene negative the parent is probably ++ as 
given by Mendel’s law. However, statistically the majority of offspring from a +- 
breeding is not ++. Even if the negative animals are sorted out by conventional 
PCR-screening, the back breeding of the remaining (2/3) would require enormous 
cage capacities and unnecessary killing of many negative and heterozygous 
animals which could not be utilized. Therefore an additional qPCR based 
screening for homozygousity was established to select ++ animals. Only the 
animals identified as ++ by this method were than subject to an additional 
back-breeding and only those confirmed were regarded as truly ++. The qPCR 
was designed to differentiate between one and two copies (or 2 and 4 copies, in 
cases with tandem integrations of the transgene, which are also possible) of 
luciferase or SP-C-rtTA in the mouse genome which should lead to a 
CT-difference of one. The pre-selection was good enough to reduce the non- ++ 
animals in the back breeding to 1/3 (estimation).  
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Figure 5: Screening of transgenic animals (continued). 
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Figure 5 continue: 
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Figure 5: Screening of transgenic animals. 
The scheme depicts the process of a homozygousity-screening for a group of 
offspring from heterozygous (+-) Xbp1 animals. The method is independent of the 
inserted transgene. A) A conventional PCR-screening against luciferase (which is 
part of the constructs for all my transgenic mouse lines) revealed that all fife 
animals were positive for the transgene band at 600bp (see chapter 3.1.20 for the 
method). B) Therefore they were all included in the next step, the screening via 
qPCR (see Chapter 3.1.21). As the signal for No. 2765-2767 was about one dCT 
higher than for 2768 and 2769 the first three animals were preliminary categorised 
as homozygous (´++ or ´++? where lower dCT and a quite high SD of the three 
replicates left more doubts) and C) subjected to backbreeding. The animals 2766 
and 2767 had offspring and as they were all transgene positive (the conventional 
screening to confirm that is the same method as depicted above and not shown 
here again), animals 2766 and 2767 were categorised as “confirmed homozygous 
(´++).     
 
 
 
Preliminary Genotyp Number of offspring transgene positive offspring confirmed 
(qPCR screening) from backbreeding from backbreeding genotype
2765 ´++? not successful - not confirmed
2766 ´++ 6 6 ´++
2767 ´++ 11 11 ´++
2768 ´+- no backbreeding - not confirmed
2769 ´+- no backbreeding - not confirmed
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3.5.4 In vivo experiments, sampling and readout parameters 
 
Available animals from breeding were sent to our facility for experiments. Animal 
experiments were authorized by “Regierungspräsidium Gießen” (V54-19c20-
15(1)Gi20/10 Nr. 12/2009). 
I generally set up experimental groups of five Dox-induced + five non-induced 
mice. These groups were littermate and gender matched. Furthermore the 
average weight of the mice at the beginning of the experiment was as equal as 
possible. The mice were taken into the experiment as young as possible, so they 
were usually 6-10 weeks old.  The following table is an overview of the diverse 
experimental groups: 
 
Table 1: Experimental animal groups 
line  genotype time of induction 
ATF4  +-/+-  4 weeks 
ATF4  +-/+-  16 weeks 
ATF4  +-/+-  32 weeks 
ATF4  ++/++  4 weeks 
ATF4  ++/++  32 weeks 
ATF6  +-/+-  4 weeks 
ATF6  +-/+-  16 weeks 
ATF6  +-/+-  32 weeks 
ATF6  ++/++  4 weeks 
XBP1  +-/+-  4 weeks 
XBP1  +-/+-  8 weeks 
XBP1  +-/+-  32 weeks 
 
Experimental groups were containing different lines (as only one line for each 
transgene was subject to experiments yet, only the name of the inserted transgene 
is listed here) of different genotypes (either +-/+- indicating animals heterozygous 
for transgene and transactivator or ++/++, which stands for double homozygous 
animals) and different times of transgene induction (4, 8, 16 of 32 weeks). With 
few exceptions (listed in the supplementary tables 1-6) the groups consisted of fife 
non-induced and fife Dox- fed animals. For details about the composition of the 
groups please refer to the text of this chapter.   
 
Dr. Ingrid Henneke was kindly taking care of the experiments with the living 
animals and the sampling. She provided the raw data on death of animals, lung 
compliance, running time in the treadmill, body weight, the cell differentiation, 
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partly of the cell numbers in the BAL and the IVIS-signal intensity, as well as 
isolation and preparation lungs and other organs, H&E (Haematoxylin & Eosin) 
and Trichrome stained lung histological slides and the paraffin embedded slides 
for Immunohistochemistry. Which parameters were assessed from which samples 
can be taken from the processed data in the supplementary tables 2-6. 
 
3.6 Microarrays 
 
Microarrays based on Agilent technology were performed under supervision of Dr. 
Jochen Wilhelm with samples I provided. The general statistical analysis including 
some general readouts Gene Set Enrichment Analysis (GSEA) and preparation of 
diverse graphics (heat maps and correlation charts), following a design which was 
developed together, was also performed by Dr. Jochen Wilhelm. The Exon-arrays 
were performed by Dr. Alexander Sigrüner (Uniklinikum und Institut für klinische 
Chemie, Regensburg) and the general analysis was again undertaken under 
supervision of Dr. Jochen Wilhelm. 
 
3.6.1 Overview 
 
Four different experiments based on microarray technology were included in this 
thesis.  
The first experiment was the gene regulation of MLE12 cells as downstream effect 
of Atf4, Atf6 and Xbp1(s). For this purpose MLE12 cells were transfected as 
described in the “General methods” chapter and the RNA was harvested after 
different times (22 h, 44 h and 66 h after transfection). The vector pIRES2dsRed2 
served as a transfection-control (the reference against which the gene expression 
changes were calculated). As a positive control for strong ER-stress, cells 
transfected with this vector were treated with 1 µM TG 22 h after transfection and 
harvested 22 h later. This experiment was done with n=6.  
A second experiment was designed to assess the gene regulation induced by 
early ER-stress. ER-stress was induced by 1 µM TG and the RNA was harvested 
after 0.5, 1 and 6 h (n=4 for treated cells, n=12 for controls).  Only for the purpose 
of correlation analysis the two first microarray results were analyzed together. The 
gene expression changes and pathway analysis were done separately.  
Thirdly, the effect of the transgenes (Atf4, Atf6, Xbp1 and pIRES2dsRed2 as 
reference, n=3) on miRNA expression was assessed by miRNA-arrays. For that 
purpose the cells were transfected with the respective plasmids and the RNA 
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containing miRNAs was isolated after 24 h (as described in the general methods 
part).  
In a last microarray-experiment the effects of equal transfections as for the miRNA 
experiments (n=3) on mRNA splicing were assessed. Enriched mRNAs from the 
mentioned transfections (“first experiment”) were used for 400K exon-arrays 
(pooled, n=3).   
 
3.6.2 Technical details 
MRNA-arrays: 
Purified total RNA was amplified and Cy-labeled using the dual-color QuickAmp 
labeling kit (Agilent, P/N 5190-0444) following the kit instructions. Per reaction, 
1 µg of total RNA was used. The samples were labeled with either Cy3 or Cy5 to 
match a balanced dye-swap design. Cy3- and Cy5-labeled aRNAs were 
hybridized ON to 4 x 44K 60mer oligonucleotide spotted microarray slides (Mouse 
Whole Genome 4 x 44K; Agilent Technologies, P/N G4122F). Hybridization and 
subsequent washing and drying of the slides were performed following the Agilent 
hybridization protocol. The dried slides were scanned using the GenePix 4100A 
scanner (Axon Instruments, Downingtown, PA). Image analysis was performed 
with GenePix Pro 5.1 software and calculated values for all spots were saved as 
GenePix results files. Stored data were evaluated using the R software and the 
limma package from BioConductor. The intensity values were quantile normalized 
before averaging. Genes were ranked for differential expression using a 
moderated t-statistic. Candidate lists were created by adjusting the false-discovery 
rate to 5 %. Pathway analyses were done using the function geneSetTest from 
limma on the ranks of the t values. 
MiRNA arrays 
Purified total RNA was amplified, labeled and hybridized using the miRNA 
Complete Labeling and Hyb Kit (Agilent, P/N 5190-0456) following the kit 
instructions. Per reaction, 200 ng of total RNA was used. The Cy5-labeled aRNA 
were hybridized ON to 8 x 11K 60mer oligonucleotide spotted microarray slides 
(Mouse miRNA Microarray Release 15.0, 8 x 15K, P/N G4471A-029152). 
Hybridization and subsequent washing and drying of the slides were performed 
following the Agilent hybridization protocol. The dried slides were scanned using 
the GenePix 4100A scanner (Axon Instruments, Downingtown, PA). Image 
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analysis was performed with GenePix Pro 5.1 software, and calculated values for 
all spots were saved as GenePix results files. Stored data were evaluated using 
the R software and the limma package from BioConductor. The intensity values 
were quantile normalized before averaging. Genes were ranked for differential 
expression using a moderated t-statistic. 
Exon-array-analysis  
400k exon arrays (Affymetrix) were performed by Dr. Alexander Sigrüner 
(Regensburg). The basis for the data analysis by Dr. Jochen Wilhelm was the 
column "gProcessedSignal" of the provided text files, containing the results of the 
image analysis of the scanned slides. The Evaluation was done in R, version 
2.12.2 (R Development Core Team 2011) with the package "limma" (Smyth 2005). 
The annotation of the spots followed the attached gene annotation list. The 
intensity-values were normalized in quantiles and subject to logarithmic 
transformation before further use. For the analysis of the (mean) differential 
expression (DE) of the genes, the means of all probes belonging to a gene were 
calculated. The calculation of the DE was done by a linear model, using the 
function "lmFit" for the contrasts "Atf4-dsRed", "Atf6-dsRed" and "Xbp1-dsRed". 
The calculation of the test-statistics for H0: DE=0 was done by the function 
"eBayes" about moderated t-statistics. Selection of DE exons was performed with 
a false discovery rate (FDR) of 5 % (Benjamini 1995). 
 
3.7 Statistics  
 
Statistics (with the exception for the statistics of the microarrays which were 
performed by Dr. Jochen Wilhelm and are discussed in 3.6.2) were performed as a 
heteroscedastic t-test by the Microsoft Excel function “ttest”. T-tests were generally 
performed as a two-directional test. Knockdown and over-expression were tested 
by unidirectional t-tests. In “Results” and “Discussion” p-values <0.05 are called 
“significant”. This has to be understood as “assuming normal distribution of the 
samples, these results were significant”. The p-values were not corrected for 
multiple testing. Statistics were generally performed for “independent” 
experiments, but the term can stand for different degrees of independence.  
The RNAs for the study of single Atf4, Atf6 and Xbp1 over-expression were 
generated by transfection of three sets of cells (from the same passage number), 
independently thawed and put into culture in different weeks. At each of the 
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time points two “independent” pools were generated. The RNAs were also isolated 
in three steps. For other cell culture experiments, independent transfection means 
“transfection with separately mixed transfection mixes at the same time point”. In 
animal experiments the term stands for “data generated from different animals”.  
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4. Results  
 
4.1 Verification of experimental tools 
 
In the context of this chapter, experimental tools, procedures and animals which 
were “produced” de novo to enable the research are described. The question, in 
how far these “tools” are generally functional is also addressed. The headline was 
only chosen to make clear, that these results are “technical” results and do not 
bear new scientific information by themselves. The utilized mice are, of course, not 
objects but living animals, which have to be treated with respect.  
 
4.1.1 Vectors for transfection in vitro 
 
For the purpose of in vitro studies, plasmid vectors for over-expression of murine 
ATF4 (Uniprot Q06507, sequence according to the indicated amino acid (AA) 345, 
KQ sequence conflict), p50ATF6-α (Uniprot Q8BZ84, AA23-389) and the spliced 
form of Xbp1 (Uniprot O35426, isoform 2), based on the plasmid pIRES2-DsRed2 
(Clontech) depicted below were produced.  
 
Figure 6: The vector used for cell culture experiments. Each transgene 
sequence was inserted in to the multiple cloning site (MCS) of the depicted vector 
as described in detail in chapter 3.2. It is then transcribed together with the internal 
ribosomal entry site (IRES) and the fluorescent marker DsRed2 sequence and a 
SV40 poly A sequence on one cistron driven by the indicated CMV promoter. The 
translation of the transgene is then done as a transcript, separately from the 
DsRed2 (for which the IRES is necessary). The pUC origin of replication (ori) and 
the Kanamycin resistance cassette (driven by an SV40 promoter and tailed by 
HSV TK poly A) are required for propagation of the plasmid in E. coli. The f1 ori 
indicated, does not play a role for my applications. The vector (continued) 
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Figure 6 (continue): map was taken from the pIRES2-DsRed2-datasheet 
provided with the vector (Clontech)   
 
The bi-cistronic vector allows transcription, driven by the CMV-promoter, of the 
respective transgene and the fluorescent reporter dye dsRed2 on one cistron. The 
dye is not attached to the transgene, but expressed separately by an internal 
ribosomal entry site (IRES). A Kozak-sequence (Kozak 1987) was cloned in front 
of the start codons of the transgenes to enhance ribosome binding and thereby the 
translation of the protein.  
ATF4, ATF6 and XBP1 were successfully over-expressed in MLE12 after 
transfection of the respective plasmid vector (see figure 7). Furthermore the 
transfection efficiency was estimated to range between 80-100 % as assessed by 
parallel transfection with a green fluorescent marker (pEGFP-N1, not shown). An 
induction of the ATF4 and XBP1-protein was clearly detected 24 h after 
transfection. ATF6 appeared to be reduced by transfection with the empty vector 
and initially also by the ATF6-vector. However, ATF6 accumulated when 
over-expressed and after 48 h its levels surpassed those observed in the 
untreated and empty-vector-controls (see figure 7 D+E) 
On mRNA-level, expression levels were assessed at three different time points 
after transfection. 22 h after transfection, the expression of the transgenes was at 
its maximum (ddCT for Atf4: 2.94; for Atf6: 9.51; for Xbp1: 7.38). After 44 h the 
transgene-levels had declined but were still significantly increased as compared to 
the vector control (ddCT for Atf4: 1.41; for Atf6: 6.39; for Xbp1: 4.88). This 
tendency continued and 66 h after transfection, Atf4 was no longer significantly 
increased (ddCT for Atf4: 0.76; for Atf6: 3.49; for Xbp1: 2.28). Double and triple 
transfections with these factors were also effective, as assessed after 22 h. As a 
lesser amount of the individual plasmids was transfected in the combinations, the 
transgene expression-level was then also lower than in the single transfections 
(ddCT for Atf4: 1.98-2.92; for Atf6: 7.88-8.46; for Xbp1: 5.43-6.73) (see 
figure 7 A-C).  
RESULTS 
_________________________________________________________________ 
- 76 - 
A
Atf4 expression
p=0.45
p=0.78
p=0.035
p=0.0002
p=0.24
p=0.31
p=0.00002
p=0.74
p=0.0008
p=0.002
p=0,25
p=0.75
p=0.0003
p=0.11
-0,5 0 0,5 1 1,5 2 2,5 3 3,5 4
Atf4 22h
Atf6 22h
Xbp1 22h
Atf4+ATF6 22h
Atf4+Xbp1 22h
Aft6+Xbp1 22h
Atf4+Atf6+Xbp1 22h
Atf4 44h
Atf6 44h
Xbp1 44h
Thapsigargine 44h
Atf4 66h
Atf6 66h
Xbp1 66h
tr
an
sf
ec
te
d 
ge
n
e 
o
r 
tre
a
tm
en
t
ddCT + SD
     
B
Atf6 expression
p=0.49
p=0.0002
p=0.058
p=0.0047
p=0.0004
p=0.0001
p=0.00005
p=0.13
p=0.17
p=0.54
p=0.003
p=0.397
p=0.82
p=0.015
-2 0 2 4 6 8 10 12
Atf4 22h
Atf6 22h
Xbp1 22h
Atf4+ATF6 22h
Atf4+Xbp1 22h
Aft6+Xbp1 22h
Atf4+Atf6+Xbp1 22h
Atf4 44h
Atf6 44h
Xbp1 44h
Thapsigargine 44h
Atf4 66h
Atf6 66h
Xbp1 66h
tr
a
n
s
fe
c
te
d 
ge
n
e
 
o
r 
tre
a
tm
e
n
t
ddCT + SD
 
Figure 7: Expression of Atf4, Atf6 and Xbp1 in MLE12-cells (continued). 
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Figure 7: Expression of Atf4, Atf6 and Xbp1 in MLE12-cells. (continued) 
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Figure 7: Expression of Atf4, Atf6 and Xbp1 in MLE12-cells. A-C) MLE12 cells 
were transfected with the cell culture constructs for Atf4, Atf6 or Xbp1(s) (see 
4.1.1) for 22 h, 44 h or 66 h as indicated or with half the amount of a combination 
of two transfection mixes or one third of the three together (for 22 h). Transfections 
with the empty plasmid (pIRES2dsRed2) for the same durations served as a 
reference to calculate the ddCT. TG treatment (black bars) was done on top of 
22 h empty vector transfection and another 22 h incubation, leading to the 
indicated 44 h. Red indicates a qPCR for Atf4, blue for Atf6 and green for Xbp1(s). 
Samples where the respective transgene was part of the transfection mix were 
highlighted with dashed bars (n=3). D+E) Protein expression of ATF4 and Xbp1 
24 h after transfection (D) and ATF6 at the indicated time points. ATF4 and Xbp1 
were exclusively detected when transfected and not in WT (untreated), mock (only 
transfection reagent without DNA) or transfection with the other UPR transcription 
factors. P50ATF6 was already present in WT cells and decreased upon 
transfection with the empty plasmid. However, transfection with the ATF6 plasmid 
even though primarily also leading to an ATF6-decrease as compared to WT, was 
leading to increased ATF6-levels at least after 48 h (earlier as compared to empty 
plasmid transfection). Actin served as a control for equal loading.   
    
4.1.2 Vectors for generation of transgenic animals 
 
For the generation of transgenic animals with conditional over-expression of 
murine ATF4 (Uniprot Q06507, sequence according to the indicated AA 345 KQ 
sequence conflict), p50ATF6-α (Uniprot Q8BZ84 AA23-389) the spliced form of 
Xbp1 (Uniprot O35426, isoform 2), and CHOP (Uniprot P35639), vectors based on 
the plasmid pBI-L (Clontech) were cloned. 
 
 
Figure 8: The vector used for oozyte injection. The transgenes were cloned 
into the indicated multiple cloning site (MCS). The bidirectional (continued) 
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Continue figure 8: promoter (pbi-l) consists of a minimum CMV promoter and 
repetitive tetracyclin- responsive elements (tetO7). It is inactive unless rtTA with 
bound doxycycline (Dox) (provided by other sources) binds to the tetO7. Also 
depicted are diverse sequences for polyadenylation (SV40 poly A and ß-globin 
poly A) propagation in E. coli (Col E1 ori) and selection during propagation (Ampr= 
Ampicillin resistance cassette). Ampr and Col E1 ori were cleaved out by digestion 
with restriction endonucleases before oozyte injection. The vector map was taken 
from the pBI-L-datasheet provided with the vector (Clontech).   
 
The bidirectional vector allows inducible transcription of luciferase and the 
respective transgene on different cistrons, but driven by the same promoter. 
Activation of the promoter requires the presence of the transactivator rtTA and the 
binding of the antibiotic Dox to the rtTA. The transactivator can be added by 
transfection with an additional vector in cell culture systems or by crossbreeding 
with a transactivator line in vivo. The Dox can be added to the cell culture as a 
solvent and to the transgenic animals as an injection or (as in this work) by 
nutrition.   
 
4.1.3 Confirmation of generation of transgenic mouse lines and current 
status of the breeding program 
 
The vectors for the transgenic animals were linearized and send for oozyte 
injection as described in “material and methods” (see 3.5.1 and 3.5.2). The pups 
generated by this method were screened for the insertion of the transgenes as 
described in 3.1.20 and 3.5.3. Up to now, mouse lines with confirmed integration 
of the described constructs for ATF4, ATF6 and XBP1 over-expression were 
confirmed, whereas the oozyte injections for CHOP did not yet lead to success3.  
At the end of July 2011 the situation of the Atf4, Atf6 and Xbp1 lines was the 
following:  
Lines from two Xbp1-founders existed. The first line was stable and some ++ 
males and females lived and were in breeding. However, the ++ situation was not 
yet stable and there was no transactivator breed in. Subsequently, no experiments 
have been performed with that line.  
For the second Xbp1 line, experiments with a lot of +-/+- mice from backbreeding 
(see 3.5.3 for backbreeding and table 1 for an overview of the experimental 
groups) of ++/++ mice were performed. After that the breeding success stopped 
and many mice died. Only three mice of the line survived and are all in breeding 
for colony expansion.  
                                                 
3
 One founder for the line was obtained lateron. 
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There was only one line for Atf6 available, for which ++ and ++/++ animals exist. 
Animals of this line were already used for experiments and a +-/+- (5+5) group and 
a smaller ++/++ (3+3) group was still in the experiment.  
Atf4 was represented in two lines. The first one was stable ++/++. Animals from 
this line were used for experiments (see table 1). The second Atf4 line consisted of 
limited numbers of ++ and single or double +- animals. The line as such was 
stable but sufficient numbers of animals for experiments could not be achieved.    
As a side product of the breeding of the first ATF4 line, a transgene-negative but 
transactivator ++ line was generated, which was breeding nicely and can be used 
to speed up the generation of double-positive mice.  
  
4.1.4 Transgene expression in conditional transgenic lines  
 
Because of the current status of the breeding, the assessment of transgene 
expression of the Atf4, Atf6 and Xbp1 transgenic mouse lines is not yet fully 
completed. The existing lines of evidence for a successful generation are 
summarized here: The first line of evidence stems from the results of the in vivo 
imaging. The DNA-constructs for in vivo application are designed to express the 
respective transgene and the reporter luciferase as separate mRNAs, driven by 
the same bidirectional promoter. The level of luciferase expression should 
therefore correlate with the (mRNA) level of the transgene. In vivo detected 
luciferase-activity should therefore be an indirect line of evidence for a successful 
transgene insertion and activation. Only those organs, where the luciferase (and 
therefore the transgene as well) is expressed should emit light from a luciferin-
luciferase-reaction. For convenience in vivo the signal from the whole mouse was 
quantified. When available, the signal from taken out organs was observed 
additionally to check for the location of the induction. For all the three observed 
Atf4, Atf6 and Xbp1-lines there was at least a tendency for a lung-specific 
luciferase-induction in +- mice. However, the effect size and level of significance 
was very different for the lines. The induction in Atf4-mice was poor and not 
significant. Atf6 mice had a significant, but low induction after 4 and 16 weeks. The 
light emission in the Xbp1-mice was by far the highest observed, however it was 
only significant in the 8 and 32-weeks induced groups.  
In some individual induced ATF4 mouse-lungs quite strong signals could be 
detected but the effect was not significant. There was no strong signal from any 
other organs than the lung in these animals. ++ ATF4-mice were showing a much 
stronger and significant induction after 4 and 32 weeks. The same holds true for 
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the ++ 4-weeks Atf6-mouse group. Paradoxically most of the signal from these 
mice was gone after taking out the organs. The remaining signal however was 
lung specific and significant. In Xbp1-mice the strong signal observed in the whole 
mouse could be confirmed in the mouse lung, where the induction is also 
significant. In brain and thyroid of this line, a moderate uninduced signal could be 
observed (see figure 9).      
 
A  
 
B  
Figure 9: In vivo imaging of Atf4, Atf6 and Xbp1 transgenic mice employing 
the luciferase reporter gene (continued) 
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Continue figure 9: 
C  
D  
E  
Figure 9: In vivo imaging of Atf4, Atf6 and Xbp1 transgenic mice employing 
the luciferase reporter gene (continued) 
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Continue figure 9: 
F  
Figure 9: In vivo imaging of Atf4, Atf6 and Xbp1 transgenic mice employing 
the luciferase reporter gene. The emitted light from mice was quantified as the 
signal of an equal rectangular frame around the mice and referenced to a 
reference field next to the mice (A, C, E). The organs were placed in a 6-well cell 
culture dish and quantified as the signal from the well (where no organ except the 
lung gave a signal, the values are expressed as a mean, containing the signal 
from for liver, thyroid / heart, spleen, brain and kidney) (B, D, F). All mice of a 
distinct genotype and, treatment (induced / non-induced) were summarized in one 
bar, when the IVIS-screening was performed at the indicated time point. +-/+- = 
heterocygous for transgene and transactivator; ++/++ = homocygous for transgene 
and transactivator. 
 
The best indicator for successful induction of the transgene induction is the 
comparison of protein expression. For this purpose WBs were performed with lung 
homogenates, not with isolated AECII. For the investigated Atf4-line, a specific 
ATF4 band was detected. However, there was no sign for a robust increase in 
expression of ATF4 detectable as a result of Dox-feeding in +- or ++ animals 
(figure 10 A). +-/+- Atf6-mice were showing increased levels of ATF6 for the four 
weeks group, but not for the 16 weeks group (see figure 10 B). This was shown in 
blots with pooled samples and confirmed in additional blots with single mouse 
samples (not shown). ++ ATF6 mice had an increased basic ATF6-level which 
could clearly be enhanced by Dox-nutrition (see figure 10 C+D). The Xbp1 
antibodies tried, failed to give a clear specific signal in WB of lung homogenates 
(Data not shown). 
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Figure 10: Western blots for transgene expression in heterozygous and 
homozygous ATF4 and ATF6-mice (continued). 
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Continue figure 10: 
 
 D  
 
Figure 10: Western blots for transgene expression in heterozygous and 
homozygous ATF4 and ATF6-mice. A) WB for ATF4 in pooled lung 
homogenates of ATF4 mice after the indicated time in the experiment. I=induced, 
N=non-induced. The reference pool consists of a mixture of homogenates from 
non-induced Atf4, Atf6, Xbp1 and FVBN mice. B) WB for ATF6 in pooled lung 
homogenates of +- ATF6 mice after the indicated time in the experiment. 
I=induced, N=non-induced. The mixture of two FVBN-mouse lung homogenates 
serves as a control. C) WB for ATF6 in pooled lung homogenates of ++ ATF6 mice 
after four weeks in the experiment. A pool of two FVBN mouse homogenates and 
the pool of +- -mouse homogenates induced lung homogenates from B serve as 
controls. The numbers 138-147 are the ear tag numbers of the individual mice. D) 
Densitometric quantification of C.  
 
Immunohistochemistry (IHC) is less reliable for quantitative analysis as compared 
to Western blots. But it allows a localization of the protein of interest within a 
certain cell type by staining of a cell specific marker in parallel sections (here: 
pro-SP-C, which stains alveolar type II cells). IHC-slides for ATF4 revealed a 
generally strong and not AECII-specific signal for ATF4. Therefore they did not 
allow conclusions about the induction of the transgene (Data not shown). A robust 
ATF6 signal was specifically detected in induced ATF6-mouse slides but not in 
uninduced mice or FVBN control slides. Parallel pro-SP-C staining confirms that 
AECII are the primarily affected cell population. Additionally, a population of 
bronchial epithelial cells expressed the transgene in induced but not in 
non-induced animals. Furthermore it could be shown that the ATF6-downstream 
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target BIP was highly expressed in AECII of induced ATF6-mice specifically, 
indicating functionality of the transgene.   
Xbp1 IHC-slides revealed a similar expression pattern. An increased Xbp1 
expression was detected in AECII and a population of bronchial epithelial cell of 
induced Xbp1 animals. 
 
A) Controlmice – no transgene 
 
ATF6proSP-C
 
Figure 11: Immunohistochemistry of ATF6 (A-E) and Xbp1 (F-H)-mice 
(continued) 
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Continue figure 11: 
B) ATF6 transgenic mice,+-, no induction with doxycyclin 
ATF6proSP-C
 
 
C) ATF6 transgenic mice,+-, 4 weeks on doxycyclin 
 
ATF6proSP-C
 
 
Figure 11: Immunohistochemistry of ATF6 (A-E) and Xbp1 (F-H)-mice 
(continued) 
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Continue figure 11: 
D) ATF6 transgenic mice,+-, 4 weeks on doxycyclin 
 
Pro SPC ATF6
 
 
E) ATF6 transgenic mice,+-, 4 weeks on doxycyclin 
 
BIPPro-SPC
 
Figure 11 
: Immunohistochemistry of ATF6 (A-E) and Xbp1 (F-H)-mice (continued) 
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Continue figure 11: 
F) Xbp1 transgenic mice,+-, no induction with doxycyclin 
 
G) Xbp1 transgenic mice,+-, 4 weeks on doxycyclin 
 
Figure 11: Immunohistochemistry of ATF6 (A-E) and Xbp1 (F-H)-mice 
(continued) 
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Continue figure 11: 
H) Xbp1 transgenic mice,+-, 4 weeks on doxycyclin 
 
 
Figure 11: Immunohistochemistry of ATF6 (A-E) and Xbp1 (F-H)-mice. 
Representative examples for Immunostainings of ATF6 and Xbp1 mouse lung 
slides. On the left hand are the (parallel) pro-SP-C stained sections on the right 
hand the sections stained for the antigen of interest (A-D: ATF6; E: BIP, F-H: 
XBP1). Staining for pro-SP-C, ATF6 and BIP was performed with fast red, staining 
for Xbp1 with DAP (brown). Nuclear staining was done with Haemalaun for 30 sec.  
A) FVBN-control, B) non-induced ATF6-mouse (4 weeks, +-), C) induced 
ATF6-mouse (4 weeks, +-), D) bronchiolar region of an induced ATF6-mouse (4 
weeks, +-), E) induced ATF6-mouse (BIP-staining) (4 weeks, +-) (BIP staining of 
control mice developed for the same time was negative, data not shown). F) 
Non-induced Xbp1-mouse (4 weeks, +-), G) induced Xbp1-mouse (4 weeks, +-), 
H) bronchiolar region of an induced Xbp1-mouse (4 weeks, +-). Negative controls 
for BIP induction and the induction of ATF6 and XBP1 in the bronchiolar region are 
not shown. Enhanced ATF6 / Xbp1 expression is present in the Type II cells and a 
population of bronchial epithelial cells but not in the controls. Enhanced BIP 
expression was observed in the AECII of ATF6 over-expressing mice. 
 
4.1.5 Functionality of siRNAs and effects of TG / BFA in siRNA-experiments 
 
SiRNA-transfections of MLE12 were performed and assessed as described in the 
methods part (3.3.2). Atf4-siRNA transfection reduced the base line (NT, non-
targeting siRNA) and the induced Atf4-mRNA-levels (BFA or TG [NT+BFA, 
NT+TG]) about one CT value and had a similar efficiency when used in 
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combination with Atf6-siRNA. Atf6-siRNA was as efficient as Atf4-siRNA. The 
effect on TG-induced Atf6-expression was slightly higher (about 1.5 CT-values 
difference). Singular siRNA transfection with Atf4-siRNA also significantly reduced 
Atf6 levels and Atf6-siRNAs also reduced Atf4 (off-target-effects). However, none 
of those siRNAs altered the level of (induced or non-induced) Xbp1(s). Treatment 
with TG strongly increased the Atf4-levels (about two CT-values) and the Xbp1(s)-
levels (more than 5 CT-values) but hardly the level of Atf6 (about 0.5 CT-values). 
BFA only moderately increased Atf4 levels (about 0.5 CT-values) and did not 
induce Atf6. However, the BFA-treatment was sufficient to increase the 
Xbp1(s) expression-level about two CT-values.  
The changes in protein levels of ATF4 and ATF6 in this experiment were not 
assessed. However, cells treated with TG or BFA for 3 h in a control experiment 
did not reveal induction of p50ATF6 or induction of ATF4 by TG, but a robust 
protein induction of ATF4 by BFA (see supplementary figure 2).  
 
A    
Figure 12: Silencing of Atf4 and Atf6 in vitro (continued) 
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Continue figure 12: 
B  
 
C  
Figure 12: Silencing of Atf4 and Atf6 in vitro (continued) 
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Figure 12: Silencing of Atf4 and Atf6 in vitro. MLE12 cells were transfected with 
siRNA against ATF4 or ATF6 or a combination of both. NT (non-targeting siRNA) 
served as a reference, WT (untreated) as an additional control (massive bars). 
Treatment with Thapsigargin (TG) or Brefeldin A (BFA) was held up for 2 h and 
started after a preincubation either with NT or Atf4 / Atf6 siRNA combitransfection 
(dashed bars). The harvested and reverse transcribed RNA was subject to qPCRs 
for Atf4 (A), Atf6 (B) or Xbp1(s) (C); n=4.  
 
4.2 Transgenic expression of Atf4, Atf6 and Xbp1 did not result in 
development of lung fibrosis in vivo  
 
As discussed above, the extent of transgene induction is not fully assessed for the 
mouse lines mentioned above and additional lines for Atf4 and Xbp1 have not yet 
been subjected to experiments. Therefore, the following data on the effects of the 
transgenes has to be regarded as a preliminary result.  
 
4.2.1 General characterization of in vivo models  
 
With two exceptions no significant changes in body weight or levels and 
composition of immune cells in the BAL of induced vs. non-induced transgenic 
mice could be detected. The weight of the three animal lines developed 
inconspicuous (see supplementary table 2). The cell numbers in the BAL were 
very different between individual animals and also between the experimental 
groups (Range: 57500-429900) but no systematic changes could be observed 
(see supplementary table 3, upper part). The BAL of mice which were 4 weeks in 
the experiment revealed an average macrophage content of 95.2 %-99.7 %. In the 
elder groups the average macrophage count ranged at 82.5 %-95 %, the rest 
representing lymphocytes and PMN (polymorph nuclear cells). However, most of 
the individual elder mice also had macrophage counts of 98-100 % (see 
supplementary table 3, lower part).  
During the experimental phase of feeding with Dox, four out of 115 mice and out of 
four different groups died. Two of them were induced, two of them Atf4-transgenic 
mice and another two Atf6-transgenic-mice (see supplementary table 4). The 
average lung compliance ranged between 5.7 and 9.7 ml/kPa*Kg and was typically 
increased with age (see supplementary table 5). The average running time on the 
treadmill increased between 0.7 and 7.6 min during the experiment and maximum 
exercise was observed in some cases after four, in others after sixteen or 32 
weeks (see supplementary table 6). Within the different lines, there were no 
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significant differences with regard to death, lung compliance and running time as a 
result of Dox feeding (supplementary tables 4, 5 and 6).  
The appearance of the lungs in histologic slides was rather normal and differences 
between induced and uninduced animals (of any line) were not observed (see 
figure 13). An exception of the general normal appearance of the lungs was the 
“canon shot” phenotype, discussed in the next chapter (4.3.2). IHC-detection of 
CHOP and cleaved caspase-3 did not reveal a specific signal in induced and 
non-induced Atf6 and Xbp1-mice but was detected in some cells of BLEO-treated 
mice, stained in parallel (Data not shown).  
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              Induction with doxycycline         no induction 
 A    E  
 B   F  
C   G  
 D   H    
 
Figure 13: Morphology of transgenic mouse lungs. The images are 
representative examples for the morphology of transgenic animal lungs with (A-D) 
and without (E-H) Dox-induction. A+E: +-/+- Xbp1 mice after four weeks; B+F: +-
/+- Xbp1 mice after 32 weeks; C+G: +-/+- Atf4 mice after sixteen weeks; D+H: 
++/++ Atf6 mice after 4 weeks. Scalebar: 100 µm, staining: Trichrome.  
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4.2.2 The “canon shot“-phenotype 
 
In some microscopic lung sections from experimental animals, a special 
phenotype was observed, which is here addressed to as “canon shot” phenotype. 
The lungs had holes, typically appearing perfectly round.  
 
 
 
Figure 14: The “canon-shot” phenotype. Example for a “canon-shot” in an Atf4 
and SP-C-rtTA- +-, non-induced mouse. Age: 12-weeks. Scalebars: 500 µm 
(overview) and 100 µm (caption). Staining: Haemalaun. 
 
To elucidate what might be the cause of the phenotype, the available IHC, 
Trichrome and H&E stained slides were searched for the phenotype. The findings 
are listed in table 2 below.  
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Table 2: Frequency of the “canon-shot“ phenotype 
 
Canonshot observed Animals in the group %
Total 29 85 34.12
ATF4 11 40 27.50
ATF6 11 20 55.00
XBP1 7 25 28.00
induced 15 43 34.88
non induced 14 42 33.33
in ++/++ animals 5 10 50.00
in +-/+- animals 24 75 32.00
in 4 weeks group 14 40 35.00
in older mice 15 45 33.33
 
 
The phenotype was not observed in lungs from nine different founders and several 
SP-C rtTA negative offspring and (with one exception) not in FVBN mice. 
 
The common feature of the mice with the phenotype is the existence of the 
transactivator (SP-C rtTA), not Dox or the induction or presence of one of the 
transgene-inserts.  
 
4.3 ER-stress and UPR in vitro: a general characterization based 
on microarrays 
 
4.3.1 Effects of Atf4, Atf6 and Xbp1 on mRNA expression in MLE12 cells 
 
13254 probes were regulated significantly by Atf4, Atf6, Xbp1 and / or TG. 1362 of 
those genes were at least regulated with a log fold change (lfc) of +1. A complete 
list of regulated genes exceeds the space of this work but an excerpt from the 
microarray results, containing such genes which gain importance in the discussion 
can be found in the appendix (Supplementary table 7). TG was leading to the 
strongest regulation, followed by Atf6 and Xbp1. The initially high(er) number of 
regulated downstream genes of Atf4, Atf6 and Xbp1 was declining 44 h and 66 h 
after transfection (see figure 15).   
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A  
Figure 15: Extend of the response of MLE12 cells to UPR- transcription 
factor over-expression and Thapsigargin treatment (continued). 
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Continue figure 15: 
B  
Figure 15: Extend of the response of MLE12 cells to UPR- transcription 
factor over-expression and Thapsigargin treatment. A) Numbers of 
significantly regulated genes. B) Numbers of strongly (lfc>1) and significantly 
regulated genes. The logarithmic scale depicts zero as one.  
 
A heat map of the strongly regulated genes reveals a similar signalling of Atf4, Atf6 
and Xbp1 if we look at the same time point after transfection. The clustering and 
inclusion of the depicted genes of the two heat maps depends on the included 
contrasts, leading to a diverse appearance (figure 16). But the early signalling of 
the transgenes (22 h) is obviously partly the reverse than the later signalling (44 h 
and 66 h), indicating a counter regulation against the initial effects. We can also 
observe similarities and dissimilarities between TG treatment of diverse duration 
and transgene effects. 
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Figure 16: Time dependent UPR-transcription factor and Thapsigargin 
effects. The upper heat map includes the effects of TG and the effects of the 
transgenes (selection for both: genes with p<0.05 and lfc>1 in one contrast). In the 
lower one, exclusively the effects of the transgenes are depicted. The clustering 
and inclusion of the depicted genes of the two heat maps depends on the included 
(continued)  
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Continue figure 16: contrasts, leading to a diverse appearance. DsRedThaps44 – 
control 44 stands for 22 h TG treatment after 22 h of transfection with the 
pIRES2dsRed2-vector. TG t0.5, TG t1 and TG t6 stands for 0.5, 1 and 6 h of TG 
treatment of non-transfected cells. “Control” stands for pIRES2dsRed2-transfected 
cells and WT for untreated cells.  
 
The correlation chart depicted in figure 17 A shows a moderate positive correlation 
between the early transgene effects and the effect of TG which is also reflected in 
the Venn-diagram below. This correlation in between the transgene effects is 
much stronger for the down-regulated genes (figure 17 C). On the other hand, the 
stronger correlation between transgenes and TG can be observed for the 
up-regulated genes (figure 17 B). Focusing on the very early TG-effects (t0.5) and 
the early effects of Atf4, Atf6 and Xbp1, we cannot observe a robust correlation in 
between these contrasts. However, if we limit our observation on the up-regulated 
genes, the correlation of the early TG effects especially with the Atf4-effects is 
much more pronounced.  
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 Significiantly regulated 
  
A  
Figure 17: Correlation of the effects elicited by over-expression of ATF4, 
ATF6 and XBP1 and TG-effects (continued). 
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Continue Figure 17: 
 Significantly up-regulated 
 
B  
Figure 17: Correlation of the effects elicited by over-expression of ATF4, 
ATF6 and XBP1 and TG-effects (continued). 
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Continue Figure 17: 
 Significantly down-regulated 
 
C  
Figure 17: Correlation of the effects elicited by over-expression of ATF4, 
ATF6 and XBP1 and TG-effects (continued). 
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Figure 17: Correlation of the effects elicited by over-expression of ATF4, 
ATF6 and XBP1 and TG-effects. A) All significantly regulated genes are included 
(p < 0.05 and lfc > 0). B) Only up-regulated genes are included. On the right hand 
the numbers of included genes are depicted. C) Only down-regulated genes are 
included. On the right hand the numbers of included genes are depicted. The 
upper part of A, B and C are colour coded correlation charts representing all 
treatments and transfections: DsRedThaps44-control 44 stands for 22 h TG 
treatment after 22 h of transfection with the pIRES2dsRed2-vector. t0.5, t1 and t6 
stands for 0.5, 1 and 6 h of TG treatment of non-transfected cells. “Control” stands 
for   pIRES2dsRed2-transfected cells and WT for untreated cells. The lower parts 
of A, B and C are Venn-diagrams for the time point 22 h after transfection and 
DsRedThaps44 – control 44 depicting the numbers of the probes significantly 
regulated (in the indicated direction) and the percentage of the probes belonging 
to this group. Where percentages for overlaps are depicted they represented the 
smallest group. E.g. 20 % overlap for Atf4 and Atf6 depicted in A means that 20 % 
of the genes regulated by Atf4 are also regulated by Atf6, while a much lower 
percentage of the (larger number of) genes regulated by Atf6 are also regulated by 
Atf4.    
 
The gene set enrichment analysis (GSEA) revealed that the gene regulation 
affected a lot of biochemical pathways. In total, 59 % of all investigated KEGG 
(Kyoto Encyclopedia of Genes and Genomes) pathways were significantly 
regulated in at least one of the contrasts (adj. p<0.05, including the analysis of the 
early TG response) indicating a very broad spectrum of cellular responses to 
ER-stress (see supplementary table 1). 
 
Some potential downstream genes of Atf4, Atf6 and Xbp1 were also investigated 
by qPCR. The regulation of the transgenes themselves and of Chop is shown 
elsewhere (4.4.1), results for the mRNA-regulation of Bip, Grp94, VCP, Ppib, 
Edem1, Atf3, Nfe2l2, and Bad, are summarized in figure 18 (following pages). No 
significant regulations were found for Dnajc10, Atg12, Chkb and Nf-y a (Data not 
shown).  
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Figure 18: Verification of microarray results by qPCR (continued). 
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Continue Figure 18: 
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Figure 18: Verification of microarray results by qPCR (continued). 
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Continue Figure 18: 
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Figure 18: Verification of microarray results by qPCR (continued). 
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Continue Figure 18: 
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Figure 18: Verification of microarray results by qPCR (continued). 
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Figure 18: Verification of microarray results by qPCR. Changes in A) Bip, B) 
Grp94, C) Vcp, D) Ppib, E) Edem, F) Atf3, G) Nfe2I2, H) Bad as a result of single 
or combined over-expression of Atf4, Atf6 and Xbp1 (blue bars) and TG-treatment 
(green bars). The gene expression changes are expressed as ddCT-values with 
standard deviation. I) The changes in gene expression by qPCR of the genes 
shown above plus Atf4, Chop, Dnajc10, Atg12, Chkb and Nf-y in qPCR (+ 
standard deviation) are plotted against the changes as assessed by microarrays. 
A linear regression line and the corresponding indicator R2 show the linear 
dependency of both values. 
 
The qPCR data can be looked upon as a confirmation of the microarray results. 
Figure 18 I shows a good linear dependency between the lfc in the microarrays 
and the ddCT from the qPCR. Included were all results from the qPCRs mentioned 
in this thesis, except Atf6 and Xbp1, because the microarrays cannot identify 
spliced Xbp1, like the qPCR and the probes for Atf6 are not correct. Taken 
together the qPCRs (in addition to the microarray results) confirm the general 
functionality of the transgenes by their effect.  
 
4.3.2 Effects of Atf4, Atf6 and Xbp1 on miRNA expression 
 
MiRNA-arrays of MLE12 cells transfected with Atf4, Atf6 or Xbp1 revealed only a 
few candidates (adj. p <0.05) for regulated miRNAs and most of these candidates 
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showed rather small lfc (<0.5). The best candidates are miR-130b and miR148a 
(see table 3).  
 
Table 3: Hit list for miRNAs regulated differentially by ATF4, ATF6 and XBP1. 
 
Hit list: 
 
 
Depicted are such miRNAs with an adjusted p (adj.p) <0.2 for at least one of the 
transfections (ATF4, ATF6 and Xbp1). For some miRNAs (Symbol) more than one 
probe (ProbeID) matched these criteria. Significant changes are highlighted in 
blue. 
 
Nevertheless, the overall regulation of miRNAs by Atf4, Atf6 and Xbp1 was quite 
similar, as the correlation analysis reveals (see table 4).  
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Table 4: Correlation of miRNA expression in ATF4, ATF6 and XBP1 
transfected MLE12 cells 
 
correlation 95 percent confidence interval regression line
Pearson´s r lower upper  intercept slope
Xbp1 vs. ATF4 0.43 0.39 0.46 0.00 0.58
Xbp1 vs. ATF6 0.61 0.58 0.64 0.01 0.69
ATF4 vs. ATF 6 0.54 0.51 0.58 0.01 0.45
correlation without extreme values(|coef| > 0.2)
Xbp1 vs. ATF4 0.42 0.38 0.46 0.01 0.43
Xbp1 vs. ATF6 0.55 0.52 0.58 0.01 0.52
ATF4 vs. ATF 6 0.49 0.46 0.53 0.01 0.57
 
 
The table lists indicators (Pearson’s r + upper and lower confidence interval) for a 
correlation between the miRNA expression changes as a result of over-expression 
of Atf4, Atf6 and Xbp1. The depicted (positive) slope of the regression line 
indicates that the changes compared are not zero. The lower part of the table does 
not include the miRNAs with “stronger” regulation (coefficient >0.2). 
 
4.3.3 Effects of Atf4, Atf6 and Xbp1 on mRNA splicing 
 
Splicing of target mRNAs was assessed 24 h after over-expression of Atf4, Atf6 
and Xbp1(s) respectively in 400K-Exon arrays. Genes where the lfc of an 
individual probe was at least three different from the mean were preselected as 
candidates for alternative splicing (52 after Atf4-transfection, 64 after 
Atf6 transfection and 108 after Xbp1(s) transfection). There was a big overlap of 
the candidates of alternative splicing between the three transfected transgenes. 
For the purpose of this thesis only a more restricted list of “top candidates” shall be 
presented (see table 5). Only such genes, where the outlier-probe had a log2 of 
the signal intensity >5 (which is an argument for robust expression of the 
candidate gene) and the 63 % confidence interval did not touch the zero-line are 
included.   
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Table 5: Top candidate genes for alternative splicing initiated by ATF4, ATF6 
or XBP1 over-expression 
 
 
 
Depicted are such genes with exons with an lfc of > three (as compared to the 
mean of al exons of the gene) and were the log2 signal intensity of this exon was 
> 5 and the 63 % confidence interval did not touch the zero line. The right column 
indicates whether the respective exon was up or down-regulated (as compared to 
the other exons of the gene) and if more than one exon was affected (if two 
neighbour probes were regulated in the same direction they were counted as one 
exon here). 
 
Some potential functions of those candidates shall be named here: The first four 
candidates can directly be linked to the topic of ER-Stress. Derl3 is involved in the 
ERAD. Cep290 was described to be an activator of Atf4-mediated transcription. 
Sec24a and Zw10 are involved in ER to Golgi – trafficking. Gtf3c3, Ncoa2, 
Rps6ka1, Zfp653 and Nfrkb are involved in regulation of transcription and Hnrnpa3 
is involved in nuclear mRNA splicing. The results for those genes are depicted 
here in more detail (see figure 19, following pages). In case of the top-candidates 
RESULTS 
_________________________________________________________________ 
- 114 - 
which were found after transfection with different transgenes (also those not 
shown in detail in figure 19), the same outlier- probes were regulated in the same 
direction.   
 
            
 
A) Differential regulation of Nfrkb and Hnrnpa3- Exons by Atf4  
 
Figure 19: Selected top candidates for alternative splicing as a 
result of Atf4, Atf6 or Xbp1-transfection (continued). 
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Continue figure 19: 
 
  
 
 
B) Differential regulation of Cep290, Der3 and Gtf3c3- Exons by Atf6 
 
Figure 19: Selected top candidates for alternative splicing as a result of Atf4, 
Atf6 or Xbp1-transfection (continued). 
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Continue figure 19: 
  
 
  
 
 
C) Differential regulation of Sec24a, Rps6ka1 and Zfp653-Exons by 
Xbp1 
 
Figure 19: Selected top candidates for alternative splicing as a result of Atf4, 
Atf6 or Xbp1-transfection (continued). 
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Continue figure 19: 
  
 
 
D) Uniform regulation of Ncoa2- Exons by ATF4 and Atf6  
 
Figure 19: Selected top candidates for alternative splicing as a result of Atf4, 
Atf6 or Xbp1-transfection (continued). 
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E) Uniform regulation of Zw10- Exons by ATF4, Atf6 and Xbp1 
 
Figure 19: Selected top candidates for alternative splicing as a result of Atf4, 
Atf6 or Xbp1-transfection (continued). 
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Figure 19: Selected top candidates for alternative splicing as a result of Atf4, 
Atf6 or Xbp1-transfection. Each transgene was leading to an individual set of top 
candidates for alternative splicing (A, B and C) but there were also candidates 
which were regulated uniformly by more than one of the transgenes (D+E). Red 
(scale on the right hand): log2 of the signal intensity; Blue (scale on the left hand): 
change of expression of individual probes in response to the transfection with Atf4, 
Atf6 and Xbp1 (relative to the mean) with 63 and 95 % confidence interval. On the 
X-Axis the regulation of the individual probes (representing exons or parts of them) 
are depicted. 
 
4.4 Specific cellular responses to over-expression of ATF4, ATF6 
and XBP1 in vitro 
 
4.4.1 CHOP induction by Atf4, Atf6, Xbp1 and the ER-stress inducers 
Brefeldin A (BFA) and Thapsigargin (TG) 
 
ER-stress is supposed to cause CHOP induction via the three transcription factors 
ATF4, ATF6 and XBP1 (Szegezdi et al. 2006). This could not be observed in the 
alveolar epithelial cell line MLE12. On protein level, CHOP induction could only be 
observed after treatment with the ER-stress inducing agent TG (see figure 20).  
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Figure 20: CHOP-protein expression in Atf4, Atf6 and Xbp1 transfected 
MLE12-cells. The controls are WT (untreated cells), mock (treated with 
transfection reagent without DNA), plasmid (control transfection with the plasmid 
pIRES2-dsRed2) and TG (1 µM on WT-cells), the sample was loaded on the same 
gel, unrelated lanes are cut out. The incubation time between TG treatment / 
transfection and harvesting was 24 h.  
 
The lack of CHOP-induction was not limited to the protein level. Even though a 
certain (in some cases significant) tendency of CHOP induction could be observed 
for the three transgenes, the effect was minimal as compared to the 
CHOP-induction caused by TG.  
Also the combined transfection of these factors did not lead to a robust induction 
of Chop (see figure 21). 
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Figure 21: Chop-mRNA expression in Atf4, Atf6 and Xbp1 transfected 
MLE12-cells. A-C) MLE12 cells were transfected with the cell culture constructs 
for Atf4, Atf6 or Xbp1(s) (see 4.1.1) for 22h, 44 h or 66 h as indicated or with half 
the amount of a combination of two transfection mixes or one third of the three 
together (for 22 h). Transfections with the empty plasmid (pIRES2dsRed2) for the 
same durations served as a reference to calculate the ddCT. TG treatment (black 
bar) was done on top of 22 h empty vector transfection and another 22 h 
incubation, leading to the indicated 44 h. N=3. 
 
To check whether this lack of response is limited to the MLE12 cell line, another 
alveolar epithelial cell line MLE15, and, a human keratinocyte cell line MEL188, 
were similarly transfected with Atf4, Atf6 and Xbp1. A robust Chop induction could 
not be observed in both systems (see supplementary figure 1).   
 
In a separate experiment, MLE12 cells were treated with high doses of BFA 
(10 µg/ml). The expression of Atf4, spliced Xbp1 and Chop was monitored by 
qPCR 0.5, 1, 2 and 3 h after the treatment. The induction of these factors could be 
observed simultaneously after 2 h at similar levels. After 3 h the induction of Chop 
was surpassing the Atf4 and Xbp1 induction. 
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A  
B  
 
Figure 22: Time dependent induction of UPR-transcription factors and Chop 
after chemically induced ER-stress. A) The mRNA-levels of Chop, Atf4 and 
Xbp1(s) from cells incubated with BFA for 1, 2 and 3 h were assessed by qPCR 
(control: DMSO treatment, reference for ddCT calculation: untreated cells). N=3. 
B) Expression changes of Chop and Atf4 as assessed by microarrays, 0.5 h, 1 h 
and 6 h after TG-treatment (n=4 for treated cells and 12 for controls).   
 
Treatment with 1µM TG (as assessed in microarrays) was leading to a robust 
induction of Chop and Atf4 after 1 h. After 6 h the induction of Chop was clearly 
stronger. A minor induction of Atf4 was already observed 0.5 h after transfection. 
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4.4.2 Atf4 and Atf6 knockdown is not sufficient to block CHOP-induction by 
TG and BFA 
 
If Atf4 and Atf6 were required for Chop induction, a knockdown of these factors 
should reduce the inducibility of Chop by ER-stress generating agents. MLE12 
cells were transfected with siRNAs against Atf4 and Atf6 and the reduction of their 
mRNA-levels was confirmed by qPCR (4.1.5). The base line level of Chop (as 
compared to NT-siRNA transfection) was moderately but significantly decreased in 
response to Atf4 and Atf4+Atf6 knockdown. However, a double knockdown of 
Atf4+Atf6 did not result in a reduction of Chop, induced by treatment for 2 h with 
BFA or TG.  
 
Figure 23: Effects of Atf4 / Atf6 knockdown on induced and non-induced 
Chop-expression. MLE12 cells were transfected with siRNA against ATF4 or 
ATF6 or a combination of both. NT (non-targeting siRNA) served as a reference, 
WT (untreated) as an additional control (massive bars). Treatment with TG or BFA 
was held up for 2 h and started after a preincubation either with NT or Atf4 / Atf6 
siRNA combitransfection (dashed bars). The harvested and reverse transcribed 
RNA was subject to qPCR for Chop. N=4.  
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4.4.3 Over-expression of Atf4, Atf6 and Xbp1 does not induce epithelial cell 
death in vitro 
 
Atf4, Atf6 and Xbp1 are supposed to induce genes which help cells to overcome 
ER-stress. On the other hand they were described to induce Chop, which leads to 
apoptosis. To assess whether cell death was the result of the expression of these 
transgenes, lactate dehydrogenase (LDH)-assays were performed. 48 h after 
transfection, a high level of cell death could be observed as a result of the control 
transfection. None of the transgenes or their combination, but only treatment with 
TG, increased the cell death caused by the transfection. On the opposite, the 
effect of the transgenes was significantly beneficial (except for the combination of 
Atf4 and Xbp1 where only a tendency was encountered) (see figure 24 A). The 
experiment was repeated with the triple amount of DNA / Lipofectamine mix in the 
transfection. Thereby the cell death was further increased but the transgene 
effects were very similar (Data not shown). 
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Figure 24: Effects of UPR-transcription factors on cell death in different cell 
types (continued). 
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Continue figure 24: 
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Figure 24: Effects of UPR-transcription factors on cell death in different cell 
types. Cell death of cells transfected with Atf4, Atf6 or Xbp1 (or combinations of 
them) was assessed by LDH assay. Transfection with the empty plasmid 
pIRES2dsRed2 (dsRed, dashed line) serves as the reference against which the 
p-values were calculated. MLE12 cells A) (n=3) were transfected with one, two or 
three of the transgenes. WT (untransfected) cells and cells treated with TG for 
24 h (either WT of dsRed2-transfected cells) served as controls. The incubation 
time after transfection was 24 h. For MEL188 (n=6) B) and MLE15 (n=4) C) cells 
WT and EGFP-transfected cells served as a control (transfection for 72 h).  
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Transfection of MEL188 and MLE15-cells for 72h with these transgenes did not 
lead to robust changes in cell death as compared to empty vector control and 
transfection with an EGFP-plasmid (see figure 24 B+C).  
 
To assess whether the effects of Atf4, Atf6 and Xbp1 could be driven into a 
maladaptive direction, the cells were challenged with peroxide and / or grown in 
starving medium after the transfection. The three challenges all caused a 
significant increase in cell death (about 5 %). But the transgenes did not have a 
robust, negative impact under these stress conditions (see figure 25).  
 
Effect of different stressors on cell death of 
transfected cells 
 p=0.042
 p=0.29
 p=0.006
p=0.9
 p=0.001
 p=0.030
p=0.66
 p=0.41
 p=0.5
 p=0.045
 p=0.014
 p=0.041
 p=0.049
 p=0.27
p=0.007
 p=0.038
p=0.22
 p=0.6
 p=0.41
 p=0.08
0 10 20 30 40 50 60 70
Xbp1
Atf6
Atf4
Egfp
dsRed
w t
tr
a
n
s
fe
c
tio
n
cell death [%] +SD
 normal medium
 normal medium +
Peroxide
 starving medium
 starving medium +
Peroxide
 
Figure 25: Effects of ATF4, ATF6 and XBP1 on stressed MLE12-cells. Cell 
death of transfected and untransfected MLE12 cells with or without additional 
challenges was assessed by LDH assay. Transfection with the empty plasmid 
pIRES2dsRed2 (dsRed) serves as the reference against which the p-values were 
calculated. Egfp transfection serves as an additional control. The cells were 
incubated for 72 h after transfection. Treatment with peroxide and / or starving 
medium started 24 h after transfection. N=3. 
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4.4.4 Influence of Atf4, Atf6 and Xbp1 on cell growth 
 
Cell growth in response to transfection with Atf4, Atf6 and Xbp1 was assessed as 
described in the methods part (see 3.4). It was compared to WT-cells, empty 
vector and EGFP-transfected cells. The transfection as such strongly reduced the 
cell number at the beginning of the observed growth phase but only caused a 
minor decrease in the slope of the growth curve as compared with the empty 
vector control. No other significant changes in the growth rates were observed 
(see figure 26).  
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Figure 26: Effects of ATF4, ATF6 and XBP1 on cell growth. MLE12-cells 
were transfected with Atf4, Atf6 or Xbp1 or dsRed2 (reference) or left 
unchallenged (WT). After plating on a fresh cell culture dish, the cells were 
counted at four time points. The cell numbers are depicted in the upper part of 
the diagram. The slopes of the regression lines (logarithmic scale) from three 
independent transfections are compared in the table below. P-values refer to 
the differences of the slope of regression lines from those of the reference 
transfections. 
 
mean slope regression line p= (for difference to dsRed)
WT1 0.058 0.045
dsRed-1 0.044 1.000
ATF4-1 0.062 0.069
ATF6-1 0.057 0.371
Xbp1-1 0.057 0.059
EGFP-N1 1 0.050 0.315
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5. DISCUSSION 
 
The purpose of this research project was to further elucidate signalling pathways 
and cellular consequences of endoplasmic reticulum stress in alveolar Type II 
(AECII) cells in vivo and alveolar epithelial cell lines (MLE12, MLE15) in vitro. The 
focus was on ATF4, ATF6 and XBP1 induced signalling, as these factors 
represent the three branches of the unfolded protein response (UPR). The 
underlying hypothesis was that, when over-expressed, these factors would, 
amongst others, induce the pro-apoptotic mediator CHOP and subsequently lead 
to apoptosis of the affected cells. In vivo this would result in chronic alveolar 
epithelial injury and, finally, initiation of an aberrant repair process, leading to lung 
fibrosis. This mechanism was proposed as a trigger of the fatal lung disease IPF. 
 
5.1 Considerations about the model systems 
 
As a substitute for primary isolated AECII, mainly MLE12 cells were used. For 
some control purposes MLE15 cells were utilized. Both cell lines are monoclonal 
and derived from murine lung tumors (generated in mice, harbouring the viral 
oncogene simian virus 40 under transcriptional control of a promoter region from 
human SP-C) and both share features of their progenitor cells (AECII). However, 
the two lines differ in tumorigenicity, expression and processing of surfactant 
proteins. In MLE12 cells, secretion of mature SP-C but not SP-B was detected. 
Secretion of phospholipids from MLE12 cells in response to ATP was limited to 
earlier passages. MLE12 cells do not express SP-A and do not contain lamellar 
bodies (Wikenheiser et al. 1993). Isolation of primary AECII is expensive and time 
consuming. As isolated AECII (from murine origin) do not proliferate, the 
availability of these cells is limited. In addition the purity of the cultures is difficult to 
guaranty (Corti et al. 1996; Roper 2003) and once taken in culture these cells 
differentiate and loose features of AECII. The view that this process is a 
trans-differentiation to an AECI-like phenotype is not supported by transcriptome 
profiling (Gonzalez et al. 2005). Also the efficiency of transfection is typically low 
for murine AECII. In contrast to that, optimal transfection efficiencies could be 
achieved with all utilized cell culture lines in this work and expression of the 
transgenes was high (figure 7). 
For all these reasons, MLE cell lines are commonly used in lung research (Lozon, 
Altemeier 2009; Zhong et al. 2010; Yoshida et al. 2010; Sisson et al. 2010; 
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Mulugeta et al. 2007) and were also considered a sufficient substitute for AECII in 
my in vitro studies.  
MEL188 cells are a human skin derived cell line which was used as a 
non-AECII-derived but also secretory control cell line, which shows distinct 
morphological similarities, such as lamellar bodies due to synthesis and secretion 
of lipids.  
In spite of the many advantages of MLE – cell lines it has to be taken into account 
that they are not identical to AECII. The possibility can not be excluded that they 
react different on ER-stress signalling and especially differ in the mechanisms of 
apoptosis induction. It can also not be excluded that AECII behave different in the 
context of an intact lung as compared to cell culture systems. Consequences of 
transgene expression on the tissue and organ surrounding of the directly affected 
cells can only be investigated in vivo anyways.  
Another potential problem is the transfection with the additional markers dsRed2 
(in vitro) and luciferase (in vivo). Over-expression of transgenes can generally lead 
to ER-stress, as demonstrated for the lens by (Reneker et al. 2011). It therefore 
has to be considered, that the results do not reflect the effect of ATF4, ATF6 and 
XBP1 respectively in naive cells but likely in such with a certain amount of 
ER-stress. In vitro there was increased early cell death caused by transfection 
(figure 24+25). However, there was no detectable CHOP induction caused by the 
transfection (figure 20) and the amount of cleaved ATF6 was even decreased 
(figure 7 E). The observed cell death was rather an immediate effect of the 
transfection than ER-stress induced apoptosis.  
We must also consider the way the transfected transgenes normally act and how 
they are integrated in the respective UPR-pathways. ATF4 (translation) is 
activated as a direct result of eIF2α phosphorylation and then activates target 
gene expression. Some of these targets are other transcription factors. However, it 
is still possible that other transcription factors are also directly activated by eIF2α 
phosphorylation (reviewed by Ron 2002). ATF4 is required for eIF2α 
dephosphorylation, involved in reactivation of protein synthesis and BIP-protein 
synthesis after TG treatment. ATF4 directly binds the Gadd34 promoter at its ATF-
site and activates it. As discussed elsewhere the ATF4 downstream target ATF3 is 
also involved in Gadd34 regulation. Gadd34 (This study: Myd116: ATF6 22h: 
-0.91; TG 22h: +2.40; TG 6h: +2.39)4 dephosphorylates eIF2α (Ma, Hendershot 
                                                 
4
 The values are data from my microarrays depicting the regulation of the indicated gene by ATF4, ATF6, 
XBP1 or TG after the indicated time-points after treatment with the reagent or after transfection. The format 
is subsequently generally used to repeat microarray results. Generally the gene name from the micrarrays is 
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2003). ATF4 does not necessarily present the complete pathway and the negative 
feedback loop can potentially shut down the endogenous ATF4 production and 
reduce CHOP-induction (Novoa et al. 2001).  
ATF6 activation includes its transport from the ER to the Golgi. Other folded 
proteins are transported together with ATF6, but there is no leak of unfolded 
proteins in that pathway as they are effectively retained in the ER (Nadanaka et al. 
2004). Reduced C-terminal glycosylation of p90-ATF6 on N-linked glycosylation 
sites has been identified as a factor for ATF6 activation (Hong et al. 2004). 
However, the effects of over-expression of the ATF6-N-terminal domain should not 
be influenced by a reduced glycosylation. These features are therefore not of any 
concern in my system.  
IRE1 is not only responsible for XBP1-splicing, but also cleaves mRNA-targeted to 
the ER and thereby reduces the ER-load (reviewed by Eizirik, Cnop 2010). In light 
of this observation it is the more surprising that over-expression of XBP1(s) 
without induction of this protective mechanism did not induce apoptosis in my 
system.  
On the other hand, XBP-1 production is essential for the proper function of 
specialized secretory organs, such as liver, pancreas, salivary gland and plasma 
B-lymphocytes (Zhang et al. 2005), in which a high rate of protein synthesis 
constitutes an endogenous source of stress (reviewed by Hetz, Glimcher 2008). It 
is therefore per se unlikely that pro-apoptotic signalling in these cells should 
depend on increased XBP1(s) levels. 
CHOP action is not under all circumstances pro-apoptotic. Posttranslational 
modifications of CHOP (Halterman et al. 2010) and the influence of protective 
factors against the downstream effects of CHOP (Gotoh et al. 2004) were 
indicated to play a role here (also see 5.3). 
The house mouse has several advantages that make it an almost perfect model 
organism for geneticists. Mice are easy to keep and breed all year round, with a 
short generation time (10–12 weeks). Unlike many other species, inbreeding is 
well tolerated (Guenet, Bonhomme 2003). Due to large litters and prominent 
pronuclei which facilitate microinjection of DNA, the inbred line FVB/N was 
especially recommended for generation of transgenic animals (Taketo et al. 1991). 
The generation of transgenic mice with inducible and AECII specific 
over-expression of ATF4, ATF6, XBP1 and additionally CHOP was a necessary, 
                                                                                                                                                    
used in this context, even if a more common name is used in the text. So in this example Myd116 is another 
name for Gadd34.  For convenience this data is also summarized in Supplementary table 7. 
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but not yet fully completed, part of this work5. To achieve specificity and inducibility 
the TET-on system was utilized (for explanations see 4.1.2 and 3.5 for technical 
details). 
ER-stress responses including CHOP induction are age dependent. Ageing 
generally decreases levels of ER chaperones but increases CHOP levels (reviews 
by Naidoo 2009 and van der Vlies et al. 2003). CHOP-induction and apoptosis is 
increased in aged hepatocytes (reviewed by Puzianowska-Kuznicka, Kuznicki 
2009). In another system CHOP levels were significantly lower in the aged than 
the adult brain (Sandhir, Berman 2010). Cell culture cells were therefore used in 
defined passage numbers and the age of mice going for transgene induction was 
also identical (see 3.1.4). It was not assessed weather older MLE12 cells reacted 
differently on the UPR-inducer transfections.   
 
5.2 Broad Effects of ER-stress and the UPR 
 
The current understanding of the UPR is that it leads to a general translational 
inhibition, enhances the folding capacity of the ER and up-regulates factors of the 
ERAD. In case of maladaptive ER-stress, it can also induce apoptosis. These 
components of the UPR are well confirmed by numerous publications and were 
extensively reviewed (Kapoor, Sanyal 2009; Ron 2002; Schröder, Kaufman 2005; 
Szegezdi et al. 2006; Xu et al. 2005; Zhao, Ackerman 2006). Examples for 
expected targets are Bip, Grp94 (chaperones), VCP (integral component of ERAD 
and cellular stress pathways induced by the UPR) (Vij et al. 2006), Ppib, Edem1 
and Atf3 (qPCR results in figure 18). Of note ATF4, even though influencing 
folding, sorting and degradation pathways (supplementary table 1) regulated none 
of these factors. 
If we look a bit closer, we see that the response to ER-stress can go far beyond 
those canonical effects. Some authors also already highlighted much broader 
effects, like Acosta-Alvear as “unexpected pathways” (Acosta-Alvear et al. 2007). 
In my work 55 % of all tested pathways (KEGG-Pathways which exist in the 
mouse) and 32 % of all probes were significantly regulated by Atf4, Atf6 or Xbp1 
over-expression or TG-treatment (a bit more if we also consider additional 
candidates from microarrays with short term TG-treatment). Some known 
non-canonical pathways were identified in my microarrays. As an example 
ER-stress has been indicated to play a role in dysfunction of gap junctions by 
                                                 
5
 See the Chapter 5.5 In vivo studies 
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down-regulating connexin 43 (Huang et al. 2009). This was also observed in my 
microarrays (This study: Gja1: TG 6h: -1.78). Consistently, the gap junction 
pathway was regulated by TG (22h) and ATF4, ATF6 and Xbp1 (see 
supplementary table1). Another example is Trib3, which is up-regulated in 
neuronal cell death scenarios (including TG induced cell death) and was identified 
as a binding partner of ATF4. It is able to activate CRE-dependent transcriptional 
activity of ATF4, without altering the degradation of ATF4 (Ord, Ord 2003). Trib3 is 
robustly up-regulated by ATF4 and TG (This study: Trib3: ATF4 22h: +1.05; TG 
22h: +3.1; TG 6h: +3.69) and moderately by ATF6 (This study: Trib3: 22 h: +0.50). 
One well known function of ATF6 is the induction of Xbp1-mRNA (Yoshida et al. 
2001). This cannot be observed in the qPCR because the primers used, 
specifically bind the spliced form of XBP1. However, the microarrays revealed a 
robust Xbp1- induction (This study: ATF6 22h: +1.84). 
Other known pathways were not entirely regulated the way the literature suggests. 
ATF4 can bind Nrf2. The dimer is able to induce the heme oxygenase1 (This 
study: Hmox1: ATF6 22h: -0.39; TG 22h: +1.62) gene and further up-regulate 
ATF4 (He et al. 2001). Nfe2l2 (gene for NRF2) was not significantly regulated by 
single over-expression of ATF4, ATF6 of XBP1, but mildly down-regulated by any 
combination of those factors or TG (see figure 18 G). 
Weak ER-stress was demonstrated to cause dedifferentiation and EMT in thyroid 
cells (Ulianich et al. 2008). In AECII, lower levels of ER-stress cause EMT, not 
apoptosis. This was demonstrated by down-regulation of E-cadherin (This study: 
Cdh1: TG22h: -1.35; TG 6h -1.14) and zonula occludens-1 (This study: Tjp1: ATF6 
22h: -0.49) levels and up-regulation of α-smooth muscle actin (This study: Acta2: 
TG 22h: -0.61; TG 6h: -0.88) (Zhong et al. 2010). The robust down-regulation of 
Cdh1 by the strong apoptotic ER-stress of TG-treatment and the almost complete 
lack of regulation of these factors in response to ATF4, ATF6 and XBP1 
over-expression observed in my system do not support this view.  
ER-stress can also trigger autophagy (Yorimitsu et al. 2006). Atf4 was indicated to 
induce Atg12 and thereby also autophagy (reviewed by Hoyer-Hansen, Jaattela 
2007). On the basis of a qPCR significant regulation of Atg12 was not observed in 
my work. However, on level of microarrays a minor effect of Xbp1 (This study: 
Atg12: XBP1 22h: +0.47) and more robustly TG (This study: Atg12: TG 22h +0.37, 
TG 1h: +0.45; TG 6h: +1.11) was observed. 
Toll-like receptor signalling pathway was found to be regulated by ATF4, ATF6 
and XBP1 in the microarray experiments but not by TG at any investigated time 
point (see supplementary table 1). One well described example is TLR2, which 
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was reported to be up-regulated in epithelial cells by ER-stress especially via 
ATF4 (Shimasaki et al. 2010). However, in MLE12-cells this is only partly true. 
Indeed, ATF4 up-regulated TLR2 (This study: Tlr2: ATF4 22 h: +0.73). But 
regulation by TG was limited to a very weak (This study: Tlr2: TG 1h: +0.54) 
up-regulation, which only occurred 1h after treatment and not sooner or later. 
Moreover ATF6 down-regulated TLR2 (This study: Tlr2: ATF6 22h: -0.64). The 
absence of robust TLR2 regulation by TG-treatment might therefore represent a 
combined effect of ATF4 and ATF6 signalling pathways.  
These results are drawing an image of an extremely broad signalling in the context 
of ER-stress and the UPR, which is in no way limited to the canonical issues of the 
UPR and can differ from results generated in other models. On the first glance, the 
three UPR-transcription factors were regulating a common set of transcripts. 
Focussing specifically on the up-regulated genes, we found a much lower 
correlation between the effects of the transgenes, but a higher correlation with the 
TG-effect (see figures 27 in 5.3 and 16+17 in 4.4.1). This indicates, that the three 
factors are not just redundant systems but work together to induce the expression 
of all the genes which are required in the context of the UPR (and therefore all 
induced by TG). This view is supported by previous reports. For example, Xbp1(s), 
but not ATF6, have been reported to induce phosphatidylcholine production 
(Sriburi et al. 2004). Surprisingly, for the down-regulated genes, the signalling of 
Atf4, Atf6 and Xbp1 was much more similar (figure 17 B+C). It has been 
demonstrated for Xbp1, that the primary effect of Xbp1-binding to a gene promoter 
is generally up-regulation of the respective gene (Acosta-Alvear et al. 2007). If 
down-regulation only occurs as an effect further downstream, it might be well 
attributed to the action of miRNAs. The conducted miRNA-arrays still require 
confirmation experiments, so conclusions about individual miRNAs have to be 
considered as preliminary. The majority of the potential changes in miRNA –
expression is weak (and not significant in these experiments) and therefore likely 
of minor practical relevance if looked upon as individual events. The best two 
candidates are miRNA 130b and 148a, both significantly, but rather moderately, 
up-regulated by ATF6 and XBP1 (but not by ATF4). MiRNA148a is suppressed in 
various types of cancer (Zheng et al. 2011; Zhou et al. 2012) and mostly 
associated with inhibition of cell cycle (Liffers et al. 2011; Guo et al. 2011) and 
promotes apoptosis by targeting Bcl-2 (Zhang et al. 2011). However, Bcl2 was not 
found to be down-regulated in the microarray experiments in response to ATF6 or 
XBP1 over-expression. MiRNA130b decreases glucocorticoid receptor expression 
and causes resistance to glucocorticoid induced apoptosis (Tessel et al. 2011). It 
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also moderately down-regulates the negative growth regulator CCN3 (This study: 
Nov: TG 22h: -0.31; TG 6h: -0.34) (Suresh et al. 2011) and tumor suppressor 
RUNX3 (This study: Runx3: ATF4 22h: -0.41; ATF6 22h: -0.35) (Lai et al. 2010). It 
is associated with higher resistance to chemotherapeutic agents, enhanced 
tumorigenicity in vivo, and a greater potential for self renewal by reducing 
TP53INP1 (Yip et al. 2011; Ma et al. 2010). None of the potential targets named 
here was strongly regulated by ATF6 or XBP1 (Supplementary table 7). The 
finding that the general regulation of miRNAs by Atf4, Atf6 and Xbp1 is 
significantly (positively) correlated, may already serve as a possible explanation 
for the similar down-regulation of mRNAs by these factors. Despite the effect of 
ATF4, ATF6 and XBP1 on miRNA expression occurs to be rather weak and 
without big individual effects, practical significance of the subtle regulation of many 
miRNAs can therefore not be excluded. 
The results of the exon-arrays (for which confirmations with independent methods 
are still required) indicate that the effects on mRNA might go far beyond different 
expression levels but could also include a broad spectrum of alternative splicing 
events. The potential effects of alternative mRNA-splicing are very complex and 
diverse. Alternative splicing can completely change the function of the affected 
protein. An example is the generation of transcription factor isoforms with different 
activities and DNA-binding specificities (reviewed by Rio 1993). As mentioned in 
the results part (4.4.3), some of the top candidates for alternative splicing can be 
linked to important processes like ERAD (Derl3) (Oda et al. 2006) activation of 
Atf4-mediated transcription (Cep290) (Sayer et al. 2006a) or ER to Golgi – 
trafficking (Sec24a and Zw10) (Sharpe et al. 2011; Hirose et al. 2004) or 
regulation of transcription and mRNA-splicing. Therefore the findings about the 
regulation of alternative splicing have the potential for practical importance and the 
consequences of the found events (if they can be confirmed) should be further 
investigated. ATF6α mRNA is alternatively spliced during reducing stress in 
lymphocytes. This shorter ATF6alpha message lacks exon 7 and may have a 
regulatory role in the UPR (Lemin et al. 2007). My exonarrays did not reveal this 
event as a result of UPR-transcription factor over-expression. 
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5.3 Are ATF4, ATF6 and XBP1 inducing CHOP and subsequent  
apoptosis?  
 
Maladaptive ER-stress can induce apoptosis. The question if ATF4, ATF6 or XBP1 
induce CHOP-mediated apoptosis consists of two parts. Firstly: Is CHOP induced 
by ATF4, ATF6 and XBP1? 
ATF4, p50ATF6 and XBP1(s) have been described as the transcription factors for 
induction of a pro-apoptotic mediator linking ER-stress to apoptosis, called CHOP, 
in different models. Indeed over-expression of p50ATF6 was demonstrated to 
cause a robust CHOP-induction in Hela-cells (Yoshida et al. 2000) and ATF4 
over-expression was shown to have some activating effect on the Chop-promoter, 
especially the C/EBP-ATF-motive (Fawcett et al. 1999). In other cell culture 
models utilizing ER-stress inducing agents, an induction of ATF4, cleavage of 
ATF6 and splicing of Xbp1 was observed in parallel to a robust CHOP-induction 
(Magne et al. 2011). Adachi et al. 2008 compared the transcriptome of MEFs from 
ATF6+/+ and ATF6-/- mice and thereby identified ER-chaperones, 
ERAD-components and ER-proteins as specific ATF6-target proteins. In their 
system the induction of CHOP was also found to be impaired (from about 5-fold to 
3 fold) in the ATF6-/- cells (Adachi et al. 2008). Celecoxib induces Chop in an 
ATF4 dependent manner (Oh et al. 2010). 
In cells with expression of dominant negative PERK, the inducibility of ATF4 is 
gone, while CHOP induction is delayed. Hyperoxia (95 % oxygen) is sufficient to 
induce ATF4 and CHOP, including a strong induction on protein level in MLE12 
cells and primary murine AECII. This effect was mediated by activation of eIF2α 
kinase PKR and did not include activation of the other UPR-arms (Lozon et al. 
2011). ATF6 cleavage and Xbp1-splicing are strongly enhanced in these cells 
(Yamaguchi et al. 2008). 
All these observations were leading to the general view, that the UPR-transcription 
factors ATF4, ATF6 and XBP1 are the main and sufficient factors for 
CHOP-induction (reviewed by Oyadomari, Mori 2004). 
However, there are several examples from the literature questioning this view. Su 
et al. 2008 transfected HEK293T-cells with HA-tagged ATF4 and were unable to 
detect CHOP in nuclear extracts 36 h afterwards. They also immunoprecipitated 
the over-expressed ATF4, but were unable to detect co-precipitated CHOP unless 
they over-expressed CHOP as well (Su, Kilberg 2008). In neuronal cell models of 
hypoxia, Salubrinal (inhibitor of eIF2α dephosphorylation) was enhancing the 
induction of ATF4 as expected, but did not affect the CHOP-levels. It also reduced 
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induction of ATF6-cleavage (Halterman et al. 2008). This is another example were 
ATF4-levels failed to influence CHOP. In human SH-SY5Y neuroblastoma cells, 
simultaneous hypoxia plus salubrinal reduced CHOP induction induced by 
hypoglycaemia (Kögel et al. 2006). This suggests that the low inducibility of CHOP 
by hypoxia + Salubrinal mentioned above might represent a special feature of 
hypoxia models. Artificially sustained IRE1 signalling was reported to enhance cell 
survival in prolonged ER-Stress (Lin et al. 2007). XBP1 deletion results in 
apoptosis of differentiated Paneth cells in vivo. This included a robust induction of 
CHOP (about 10fold). The authors did not investigate whether this was 
accompanied by increased levels of ATF4, ATF6-cleavage or eIF2α 
phosphorylation (Kaser et al. 2008).  
The PERK-ATF4 pathway is often regarded as the main CHOP-inducing pathway. 
However, studies with ß-amyloid induced ER-stress and either activation of the 
pathway with Salubrinal or deactivation via PERK-knockdown, suggest that the 
anti-apoptotic effects of the pathway are also dominating this model in human 
neuroblastoma cells (SK-N-SH). This was assessed by cell viability and 
caspase-3+4 activity tests. Again, the specific influence of ATF4 was not 
investigated in this context (Lee et al. 2010). A beneficial role of the PERK-
pathway was also reported by Harding et al. 2000. 
The mode of action of salubrinal is not completely resolved. Initially protective 
effects of the drug against ER-stress inducers and viral assault were reported 
(reviewed by Wiseman, Balch 2005). In contrast, Drexler et al. 2009 showed a 
synergistic apoptosis induction by salubrinal and proteasome inhibitors or TG. This 
could easily be understood as the increased ER-load, combined with an induction 
of the pro-apoptotic pathway initiated by eIF2α, if they had not proven at the same 
time that salubrinal did not increase eIF2α phosphorylation (but ATF4 and 
CHOP-induction) in their system (Drexler 2009). 
A cytosolic isoform of GRP78 induces eIF2α phosphorylation. In this model ATF4 
induction by TG was increased but CHOP induction was not altered (Ni et al. 
2009). 
The common view is, that ER-stress is leading to apoptosis, when it is too strong 
or prolonged (Araki et al. 2003; Bernales et al. 2006). Rutkowski et al. 2006 
performed a series of experiments with different exposure times and 
concentrations of stress inducers (TG and TM). Their results showed a threshold 
for the intensity of ER-stress to become maladaptive. But doses of TG and TM 
which were sub-lethal at short term exposure were rather leading to an adaptive 
response, which was even protective against stronger stress at a later time point. 
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The mild ER-stress activated all ER-stress sensors but did not lead to apoptosis 
because the expression of apoptotic proteins was short lived whereas the 
pro-survival proteins (chaperones) were more persistent because of higher mRNA 
and protein stabilities (Rutkowski et al. 2006). 
The cells (MLE12, MLE15, MEL188) utilized for this work, were reacting in the 
described, apoptotic manner in response to ER-stress inducing agents (mainly 
TG). However, in my experimental settings, the over-expression of Atf4, cleaved 
Atf6 and Xbp1(s) was not sufficient to induce CHOP on protein level and only had 
a minor effect on Chop mRNA-levels as compared to the effects of TG (see figure 
21). The expression of the transgenes however, was comparable or higher than 
the inductions achieved with TG. The difference is even more striking, when we 
express the data as fold changes: CHOP-induction by TG was approximately 
16-fold, whereas transgene-expression typically did not result in a more than 2-fold 
increase (calculation based on an assumed amplification efficiency of 2 in the 
underlying qPCRs). Consequently, the over-expression of Atf4, Atf6 and Xbp1 was 
not leading to increased cell death (see figure 24) and cell growth was not affected 
(see figure 26). Even more combined over-expression of ATF4, ATF6 and XBP1 
was not changing matters, still there was almost no Chop-induction (see figure 
24). The transgenes were rather helping the cells to overcome the transfection 
stress (see figure 24 A). As the transfection generally included the over-expression 
of a fluorescent reporter protein (either EGFP or DsRed2), it is generating an 
increased protein load which could contribute to the negative effects of the 
procedure. This problem could of cause be eased by the expression of ATF4, 
ATF6 and XBP1. Microarray analysis clearly confirmed the general functionality of 
the transfected transcription factors. For many targets, the extent of the regulation 
was comparable to the effects of TG. An insufficient dose or impaired general 
function of the transcription factors can therefore be excluded as an explanation 
for their inability to induce CHOP in my system.  
The possibility that the optimal growth and survival-conditions in the cell culture 
medium were counteracting the pro-apoptotic action of Atf4, Atf6 and Xbp1 
resulted in conductance of an experiment, where “starving medium” and medium 
with peroxide addition (or a combination of both) were used as a second hit. Even 
though these treatments were leading to a moderate increase in cell death 
(typically about 5 %), over-expression of the transgenes were not enhancing those 
effects (see figure 25). At this step we can therefore draw the following two 
conclusions.  
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Firstly: In spite of the results of this work, Atf4, Atf6 and Xbp1 may be able to 
somewhat contribute to CHOP induction and subsequent cell death but they are 
not sufficient to cause CHOP-induction or cell death in the utilized models. It is 
therefore likely that important other factors, which are not generated by the 
UPR-transcription factors but by pro-apoptotic ER-Stress inducers such as TG, 
exist.  
Secondly: the postulated missing factor(s) do not just occur as a result of any 
unfortunate condition. This indicates that they are specific for an overwhelming 
ER-stress situation.  
The notion that there might be more factors than ATF4, ATF6 and XBP1, with 
central roles in UPR-signalling, is not new. Shang et al. 2004 reported a 
“discordance of UPR signalling by ATF6 and Ire1p-XBP1 with levels of target 
transcripts”. In this study, based on the treatment of fibroblasts with diverse 
ER-stress inducers, the authors concluded: “our data with the dermal fibroblast 
appear to refute the hypothesis that activation of ATF6 and / or Ire1p determines 
the levels of mRNAs derived from target transcripts. Rather, the results imply the 
existence of other ER-stress-sensitive factors that serve this function.” The authors 
proposed ATF4 as the factor to fill the gap but also mentioned stress dependent 
interactions of ATF6 with YY1 and NF-Y (Shang, Lehrman 2004). Potential 
alternative mechanisms of CHOP induction are discussed in a separate chapter 
(5.4).  
Furthermore a knockdown of Atf4 and Atf6 (at least on mRNA-level) was not 
sufficient to reduce the Chop-induction by subsequent treatment with TG or BFA 
(see figure 23). Assuming that the knockdown also reduced the 
ATF4 / ATF6-protein level this would implicate that an increase in ATF4, ATF6 and 
Xbp1 levels is not even necessary for Chop induction in these cells. Another 
argument for a rather weak impact of the three UPR-transcription factors on Chop 
induction is the limited overlap between early TG effects and Atf4, Atf6 and Xbp1-
signaling. If ER-stress signalling is mainly mediated by transcription of Atf4, Atf6 
and Xbp1-targets, the effects of these transcription factors should correlate nicely 
with the effects of an ER-stress inducing agent like TG. This should especially be 
true for the very early effects of TG, where ongoing cell death does not yet play a 
role. However, a moderate positive correlation of the early TG effects and the 
downstream signalling of the three UPR-transcription factors was exclusively 
detected for Atf4 and only when the analysis was limited to up-regulated genes 
(highlighted by figure 27).  
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Figure 27: Correlation between very early Thapsigargin effect and effects of 
UPR-transcription factors. A) Heat map: Overall signalling as a result of 
UPR-transcription factor transfections and the very early (0.5 h) effects of TG. B) 
Correlation chart: Overall correlation between the three transcription factors and 
different time points after TG-challenge. C) Correlation chart including genes 
down-regulated in the first compared contrast (and the number of included genes 
on the right side). D)  Correlation chart including genes up-regulated in the first 
compared contrast (and the number of included genes on the right side). The 
scale bar on the lower left is valid for B, C and D. 
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Treatment with TG also activates the pathways of the ER-overload response 
(reviewed by Knorre 2001), which are rather not related to ATF4, ATF6, XBP1 
signalling. This could partly explain differences between TG treatment and 
transgene over-expression as assessed by correlation analysis. A potential effect 
on CHOP-induction is discussed in chapter 5.4. Furthermore the expression of 
Atf4, Atf6 and XBP1(s) mRNA after TG or BFA challenge did not precede the 
induction of Chop but started rather simultaneous one (TG) or two (BFA) h after 
challenge. On protein level, treatment of MLE12 cells with TG for 3 h was not 
sufficient to induce detectable levels of ATF6 cleavage or ATF4 protein and BFA 
only induced ATF4 even though the siRNA-experiments described above indicated 
an enhanced Chop-mRNA expression 2 h after the same treatment. Of cause this 
observation is not sufficient to exclude an induction of Chop by already existing 
ATF4, ATF6 or Xbp1. It can also not be absolutely excluded that minor changes in 
the expression of these factors, below detection limit, contribute. But at least it 
indicates that other, earlier occurring factors are likely to be involved. The earliest 
signalling after TG treatment (after only 0.5 h) was neither dominated by Chop, nor 
by Atf4, Atf6 or Xbp1 up-regulation (see figure 27). However, none of the very 
early regulated genes in the microarrays serves as easy explanation for 
Chop-induction either (at least at quick glance). 
Finally the concept that the very same three transcription factors should mediate 
both, the pro-survival as well as the pro-apoptotic ER-stress responses, always 
suffered a lack of inherent logic. Schröder et al. 2005 called this problem “an 
unsolved and unaddressed mystery” (Schröder, Kaufman 2005). A cell can either 
survive or commit apoptosis, not both. There are also examples for constitutively 
active UPR-signalling (Teodoro et al. 2011; Acosta-Alvear et al. 2007). If no simple 
dependency like concentration or combination is involved, the same three factors 
can never be responsible for the decision between both contrary directions (which 
is not excluding a role in the execution of both). 
As described, the transgenes were over-expressed in high doses and all 
combinations and did never increase cell death in my hands, which makes such 
simple mechanisms very unlikely. Cellular models, where the effect of these 
factors on the pro-apoptotic downstream pathways is not of main importance could 
be useful to elucidate what generally triggers the decision between death and 
survival in ER-stress. Regardless of the general consequences for our view on 
ER-stress, these observations have consequences for the model of IPF 
pathogenesis of sporadic (and some familial forms of) IPF (as further discussed in 
chapter 5.6).  
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The in vitro experiments for this thesis were mainly performed in the MLE12 
cell-line and only partly (lack of CHOP induction and no increased cell death after 
Atf4, Atf6 and Xbp1 transfection) confirmed with MLE15 and MEL188 cells. This 
raises the question in how far the findings discussed in this chapter are applicable 
to a general model of ER-stress signalling. The relevance of the findings might 
partly be limited to AECII derived cell lines (MLE12 and MLE15) or AECII. It is also 
possible, that the observed features are more general specialties for secretory 
cells (as the results for MEL188 would suggest).  
 
Taken together we can state, that ATF4, ATF6 and XBP1 seem to play only a 
minor role in the induction of CHOP in my system. This leads us to the second part 
of this chapter: Does CHOP induce apoptosis? 
CHOP was mainly described as an obligate mediator of apoptosis but it is not 
necessarily always inducing cell death and it can play much broader roles. CHOP 
and ATF4 can interact and cooperate in decreasing activation by the CRE-motive 
and the HTLV-I proximal Tax-responsive element (Gachon et al. 2001). The 
function of CHOP is not limited to cell death decisions. For example, CHOP is 
crucial for Il23 transcription in dendritic cells (Goodall et al. 2010) and, in 
Podocytes, CHOP reduces expression of ß1 and α3-integrin and enhances cell 
adhesion to collagen IV-coated plates (Morse et al. 2010). CHOP is also involved 
in the regulation of iron homeostasis (Oliveira et al. 2009). 
In a model of hypoxia induced cell death CHOP even played a protective role. This 
was also true for TG-treatment in this set of experiments. The authors suggested 
that posttranslational modifications of CHOP are responsible for the switch 
between an adaptive and a pro-apoptotic response to CHOP (Halterman et al. 
2010). Mice lacking CHOP had increased lung permeability (not associated with 
differences in neutrophil recruitment) and decreased survival in response to 
hyperoxia (Lozon, Altemeier 2009; Lozon et al. 2011). The authors also concluded 
that CHOP can play a cytoprotective role in this model but did not investigate the 
fate of individual cell types in vitro or in vivo to confirm this view. 
The apoptotic effect of CHOP can also be regulated downstream as demonstrated 
in macrophages over-expressing HSP70 as a protective factor. HSP70 reduced 
apoptosis by inhibiting the migration of Bax into mitochondria in this system (Gotoh 
et al. 2004). HSP70 (gene name: Stch) is up-regulated by ATF6, XBP1 and TG 
(This study: Stch: ATF6 22h: +0.55; XBP1 22h: +1.16; TG 22h: +0.69). 
CHOP is also not the only mediator of ER-stress induced apoptosis. 
Benzodiazepinones were shown to specifically inhibit ER-stress mediated 
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apoptosis but not apoptosis by inducers of extrinsic (tumor necrosis factor) or 
intrinsic (mitochondrial) cell death pathways. The reagents were reducing ASK1 
levels but not CHOP-expression. ASK1 (gene name Map3k5) knockdown by 
siRNA was also reducing apoptosis, indicating ASK1s important role in ER-stress 
mediated apoptosis (Kim et al. 2009). The factor is only moderately 
down-regulated by ATF6 and TG (This study: Map3k5: ATF6 22h: -0.35; TG 22h: 
-0.25; TG 1h -0.36; TG 6h: -0.52) indicating a minor role in my system. 
In models of force induced apoptosis, eIF2α phosphorylation and activation of 
CHOP-expression, but not, activation of the XBP1 and ATF6-pathways, have been 
observed. However, apoptosis (as shown by caspase-3 cleavage) was relying on 
PERK, but neither on eIF2α phosphorylation or CHOP induction in this model. The 
authors consequently proposed the existence of an alternative, PERK-, but not 
CHOP-dependent apoptosis pathway (Mak et al. 2008). Neither the mechanism 
nor its role in ER-stress induced apoptosis is known yet.  
On the contrary CHOP has been shown to clearly play a pro-apoptotic role in 
many models. CHOP induces apoptosis in rat embryonic heart-derived H9c2 cells 
(Han et al. 2005) and over-expression of CHOP in mouse osteoblasts in vivo was 
leading to increased osteoblast apoptosis and osteopenia (Pereira et al. 2007).  
 
In experiments performed under my supervision in the context of a practical 
training, CHOP was successfully induced in MLE12 cells by co-transfection with 
my Chop-pBI-L-plasmid and a transactivator plasmid (pTet-On Advanced, 
Clontech) and subsequent induction with Dox. This was leading to a 6 % increase 
in cell death assessed by LDH-assay, confirming the described role of CHOP as a 
mediator of ER-stress induced cell death also for the utilized cell line (Serdar 
Uzunzas, personal communication).  
.  
5.4 Alternative mechanisms of CHOP induction 
 
Chop is mainly regulated on transcriptional level (reviewed by Oyadomari, Mori 
2004). The transcription factors and binding sites for CHOP activation differ from 
cell type to cell type and depend on the inducing stress. CHOP is also inducible by 
amino acid starvation or arsenite treatment, manipulations that lead to eIF2α 
phosphorylation without causing ER-stress or activating PERK (reviewed by 
Harding et al. 2002). 
In PC-3 and MCF-7 cells, Brefeldin A is inducing Chop via the AARE, ERSE, and 
AP-1 elements (Kwok SC, Daskal I 2008). In a model of mitochondrial UPR 
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induced by over-expression of a mutant mitochondrial protein (a different reaction 
than the ER-UPR), CHOP was induced via the AP-1 element, in contrast to 
Tunicamycin, which required ERSE (Horibe, Hoogenraad 2007). 15-deoxy-
Delta (12, 14)-prostaglandin J is inducing CHOP and apoptosis in HELA-cells 
depending on the C/EBP-site and the ERSE sequence of the Chop promoter 
(Saito et al. 2003). Consequently, ER-stress responses to the same external 
stimulus can be very different from tissue to tissue. For example, amphetamine 
increases Atf4 and Hspa5 / Grp78 mRNA in striatum but, unlike in parietal cortex 
and meninges and associated vasculature, not Pdia4 and Nfkb11. Chop is only 
increased in striatum and parietal cortex (Thomas et al. 2010). 
 
If the three UPR-transcription factors are not sufficient to induce a robust 
pro-apoptotic signalling, that does not mean that they are not necessary. As 
bZIP-transcription-factors they can heterodimerize with many other factors of the 
same type (summarized by Schröder, Kaufman 2005). Their transcription factor 
activity on the Chop promoter might depend on the sufficient expression of one of 
those factors. A possible candidate is NF-Y. NF-Y binds to the inducible GCACG 
domain of the CHOP promoter and activates CHOP gene expression in response 
to cellular stress (Ubeda, Habener 2000).  
Yoshida et al. 2000 reported that ATF6-binding to the consensus sequence 
GCACG (part of the human CHOP-ERSE-element) requires binding of NF-Y to 
CCAAT 9bp upstream and induces CHOP (Yoshida et al. 2000). The formation of 
a transcription factor complex including ATF6 and NF-Y at their respective ERSE 
is also inducing chaperone production (Yoshida et al. 2000). Insufficient levels of 
NF-Y would therefore be a possible explanation for a limited effect of ATF6 on 
CHOP expression. But neither TG treatment nor over-expression of ATF4, ATF6 
and XBP1 significantly regulated the NF-Y transcript levels in my qPCRs. In my 
microarrays, NF-Y subunits were only mildly regulated by TG of UPR-transcription 
factors (This study: nfya: TG 22 h: +0.41; nfyb: TG 6 h: +0.44; TG; nfyc: ATF6 22 
h: -0.57 TG 6 h: +0.58). 
Yamamoto et al. 2004 additionally showed an NF-Y independent binding of XBP1 
to ERSE and a reduced transcription from ERSE II in absence of XBP1 
(Yamamoto et al. 2004). The ERSE motive is also bound by YY1 (Roy, Lee 1999). 
The regulation of this factor (This study: Yy1: ATF6 22h +0.59; TG 22 -0.38; TG 
1h: -0.75) is moderate, which does not suppose a big impact on differential Chop 
expression.  
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Single copies of ERSE are not sufficient for stress inducibility. Only tandem copies 
are fully functional (Roy, Lee 1999). There is only one copy of ERSE in the 
proximal promoter of murine CHOP. This indicates that other promoter elements 
also play an important role for the induction. 
ATF3 was described as a transcription factor downstream of ATF4. It was 
indicated to be involved in Chop induction by leucine starvation, but not TG 
treatment (where it induced Gadd34) (Jiang et al. 2004). ATF3 was 
down-regulated by ATF6 and Xbp1(s) (This study: Atf3: ATF6 22h: -0.98; ATF6 44 
h: -0.58; XBP1 22 h: -0.65) and up-regulated by TG (This study: Atf3: TG 22 h: 
+1.29; TG 0.5 h: tendency for up-regulation: +0.67; TG 1 h: +1.29; TG 6 h: +1.97), 
however the corresponding qPCRs were not significant. Atf3 was only slightly and 
not significantly up-regulated by ATF4 in my system (qPCR: figure 18). As Atf3 is 
regulated very early after TG-treatment it has the potential to be partly responsible 
for the decision for or against Chop induction in my system. ATF4 was shown to 
bind the C/EBP-ATF-site of the CHOP promoter after arsenite treatment of PC12 
cells, and acts as a transcriptional activator there. In the recovery phase, ATF3 
binds this element and represses CHOP transcription including ATF4 mediated 
transactivation (Fawcett et al. 1999). ATF3 was robustly up-regulated by TG-
treatment after 1, 6 and 22h and moderately down-regulated by ATF6 and XBP1 
(22h). This would rather suggest a lower CHOP induction by TG (see 
supplementary table 7).  
Another candidate is ATF5. Yamazaki et al. 2010 showed that ATF5 activates the 
CHOP gene promoter in HepG2 cells and revealed that the amino acid response 
element (AARE)-1 is responsible for ATF5-dependent promoter activation 
(Yamazaki T et al. 2010). ATF5 was robustly up-regulated by TG after 6 and 22h 
(see supplementary table 7) in my microarrays, but not earlier. This indicates its 
potential impact on later CHOP induction but does not provide any explanation for 
the very early CHOP-induction by TG. Another possible candidate is ATF2. It is 
essential for the amino acid responsiveness of the CHOP promoter (Bruhat et al. 
2000). It is not the de novo expression of ATF2, but its phosphorylation, which is 
leading to CHOP activation (Averous et al. 2004). Therefore, the fact that ATF2 is 
not strongly regulated in my microarrays does not exclude that it might play a role 
anyways. Nfκb subunit p65 can repress CHOP-promoter activity (This study: Rela: 
ATF6 22 h: -0.91; Xbp1 22 h: -0.81; TG 6 h: +1.25) and over-expression of Iκb 
(This study: Nfkbie: ATF6 22 h: -0.5; TG 22 h: -0.34; TG 6 h: +1.79 / Nfkbia: TG 22 
h: -0.91; TG 1 h: +1.04; TG 6 h: +1.23) induces CHOP (Nozaki S et al. 2001). 
Except for the transient up-regulation of Nfkbie and Nfkbia by TG, the results 
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about NFκB-signalling would rather imply an increased CHOP induction by ATF6 
and Xbp1 and a decreased one by TG. Therefore it is unlikely that the 
ER-overload response is responsible for the relative inability of the 
UPR-transcription factors to induce CHOP in my system. 
 
 
 
Figure 28: In silico analysis of the murine CHOP- promoter. The figure is a 
representation of the proximal murine CHOP- promoter. Boxes depict the identified 
consensus binding sites. The percentages above stand for the degree of identity 
between the found and the consensus sequence. The arrow shows the 
transcription start and ATG the start-codon for translation. The numbers below the 
line stand for the position relative to the transcription start (in bp). (Martina Korfei, 
unpublished) 
 
An in silico analysis of the proximal murine Chop-promoter, conducted by Martina 
Korfei of our laboratory (unpublished data, personal communication), was 
revealing potential additional transcription factor binding sites not related to Atf4, 
Atf6 and Xbp1 binding (figure 28), namely three copies of GATA1, 2 copies of v-
myb, 2 copies of SP-1 and one copy of MZF and c-ets sites. 
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The independent binding of transcription factors to such sites might enhance the 
effects of the three factors ATF4, ATF6 and XBP1. However, no known candidates 
for binding to such sequences were specifically and strongly regulated in 
comparison of TG and transgene effects.  
 
It is possible that not the de novo expression of a certain transcription factor is the 
trigger for Chop-induction, but other mechanisms like posttranslational 
modifications of existing factors or the presence of a necessary cofactor.  
 
Ca2+ release from the ER is an important step in the mechanism of the execution 
of apoptosis in more than one way. Cytoplasmic Ca2+ can also get into the nucleus 
via the nuclear pore and modulate gene transcription there (reviewed by 
Groenendyk, Michalak 2005). ER-stress induction by TG directly induces a Ca2+ 
release from the ER, where it is required for protein folding. It also directly acts as 
a death stimulus. It is well possible, that it also directly influences the transcription 
of Chop, which would be consistent with the very early Chop induction after 
TG-treatment. In U251MG cells, a combination of amiodarone and TRAIL was 
leading to an apoptotic response, including the up-regulation of ATF4 and CHOP. 
In this setting amiodarone was strongly increasing intracellular Ca2+ levels and the 
sensitivity to apoptosis was highly dependent on the presence of extracellular Ca2+ 
(Kim IY et al. 2011). Influx of extracellular Ca2+ is not inhibiting ER-function like 
TG-treatment. Therefore, a direct transcriptional effect on ATF4 and eventually 
CHOP-levels appears likely. However, in the BFA-system, which was also used 
here, Ca2+ release from the ER should only occur as a result of an ongoing 
pro-apoptotic signalling and cannot dominate its beginning. 
Independently of the exact impact on the CHOP promoter, several other factors 
were reported to influence CHOP expression. None of them could be convincingly 
made responsible for the lack of CHOP induction by ATF4, ATF6 and XBP1 as 
compared to TG in my system. Zhu et al. 2000 presented a model in which the 
activation of p38 MAPK was leading to a transcriptional activation of CHOP (Zhu, 
Lobie 2000). They did not investigate if this was mediated by eIF2α 
phosphorylation or ATF4. The weak regulation of this factor (This study: Mapk14: 
ATF6 22 h: -0.24; TG 22 h: -0.3; TG 6 h: +0.44) does not support a role for it in my 
system, but the activation could, of cause, well happen without transcriptional 
changes. Recent evidence shows that eIF2α-phosphorylation can directly or 
indirectly activate CHOP translation by enabling a ribosomal bypass of the 
upstream open reading frame (ORF) in the CHOP promoter (Palam LR et al. 
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2011). If eIF2α phosphorylation could influence CHOP translation independently of 
ATF4, this would partly explain the low CHOP induction in my ATF4, ATF6 and 
XBP1 over-expression models. However, it does not explain the observed 
differences on transcript level. ERdj5 (This study: Dnajc10: ATF6 22 h: +0.37; 
ATF6 44h: +0.52; TG 6h: -0.55) inhibits TG induced eIF2α phosphorylation and 
the subsequent inhibition of protein synthesis and expression of BIP in SH-SY5Y 
cells and leads to apoptosis. It paradoxically also inhibits ATF4 and CHOP 
expression (Thomas, Spyrou 2009). Again, the weak regulation of this factor does 
not make its impact in my system very likely. PCAF was reported to interact with 
the C-terminal transactivation domain of XBP1(s) and enhance its transcription 
activity, including CHOP transcription (Lew QJ et al. 2011). However, microarray 
probes for Pcaf were not regulated by the UPR-transcription factor 
over-expression and slightly (This study: TG 22 h: -0.40; TG 6 h: -0.62) 
down-regulated by TG-treatment, excluding the possibility that different PCAF 
levels are responsible for the lack of ATF4, ATF6 and XBP1 mediated CHOP 
induction in my system. XBP1s is a target of acetylation and deacetylation 
mediated by p300 and SIRT1 respectively. P300 increases acetylation and protein 
stability of XBP1s, and enhances the transcriptional activity of XBP1s. SIRT1 
deacetylates XBP1s and inhibits the transcriptional activity of XBP1s (Wang et al. 
2010). Sirt1 was supposed to be a negative regulator of UPR-signalling, affecting 
Bip as well as Chop (Li et al. 2011). A reduced XBP1 transcriptional activity and 
stability has the potential to play a role in differential Chop induction. However, 
both factors were slightly down-regulated by ATF6 and XBP1 in my microarrays 
(-0.55 to -0.75). P300 was also down-regulated by ATF4 (This study: ATF4 22h: 
-0.73) and Sirt1 was slightly up-regulated by TG treatment (This study: Sirt1: TG 
22 h: +0.62). Hence, the data does not support a dominant role of Sirt1 / p300 ratio 
for the different Chop induction by UPR-transcription factors and TG. ATF4 
degradation depends on its phosphorylation and subsequent binding by ßTrCP 
(genename: Fbxw11; This study: not regulated) ubiquitin ligase (Lassot et al. 
2001). Increased degradation of ATF4 could reduce its ability to induce Chop. The 
protein FIAT can interact with ATF4 and inhibit its transcriptional activity on the 
OSE1-site of the osteocalcin promoter (Yu et al. 2005). Effects of FIAT-binding on 
ER-stress specific promoter elements has not been investigated but cannot be 
excluded. Increased expression of FIAT could possibly also reduce the ATF4 
dependent activation of CHOP. However, FIAT (gene name: Txlnb) is not 
regulated in my system. Activation of TLR4-signaling by low dose 
lipopolysaccharide can attenuate the translation of ATF4 and reduces CHOP 
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levels without inhibiting eIF2α phosphorylation (Woo et al. 2009). The authors did 
not investigate whether the lower induction of CHOP was dependent on ATF4 
expression. The regulation of TLR4 signalling was not investigated in this work. In 
pancreatic ß-cells Il1 is inducing CHOP. This effect was mainly seen in protein 
level (Shao C et al. 2010). My microarray results do not provide hints for Il1 
involvement (see supplementary table 7) in my system however Il1-protein levels 
were not observed. Ppp1r15b plays an important role in eIF2α dephosphorylation 
(Harding et al. 2009). Decreased expression of this factor might therefore 
influence apoptotic signalling including Chop expression. Only minor 
down-regulation of this factor happened as a result of ATF6 over-expression and 
TG treatment (This study: Il1: ATF6 22 h: -0.35; TG 22 h: -0.42; TG 6h: -0.30). 
Chen et al. 2010 showed that Chop translation can also be triggered by 
eIF4e-phosphorylation. But this mechanism is not involved in TG-mediated 
CHOP-induction (Chen et al. 2010). Therefore, it is unlikely that it is responsible 
for the different induction of CHOP by ATF4, ATF6, XBP1 and TG, which I 
observed. Chop has been demonstrated to be sensitive to nonsense mediated 
decay (NMD). Upf1 knockdown is increasing the stability of Chop-mRNA by 
unknown mechanisms (Gardner 2008). The level of Upf1 was slightly decreased 
after Atf6 treatment (22h) and in TG treated cells 22h after TG-addition but was 
slightly up-regulated 6 h after treatment in the microarrays. Taken together, these 
results are not sufficient to postulate an effect of NMD in my system. However, this 
can also not be excluded. Depletion of D4S234E (a novel, p53 regulated gene, 
murine homolog not known) diminished genotoxic stress induced reduction of Bcl-
2 and augmentation of CHOP (Kudoh et al. 2010). In my experiments the p53 
signalling pathway was influenced by TG and by ATF4, ATF6 and XBP1. An 
influence of this pathway on differential CHOP induction seems possible. 
However, the gene regulation of the p53 pathway by TG-treatment and ATF4, 
ATF6 and XBP1 are positively correlated (data not shown).  
Lack of WFS1 can lead to apoptosis. WFS1 negatively regulates ATF6 levels. 
Therefore it was supposed to play a role in recovery after ER-stress. It also 
negatively influences Bip, Xbp1 and Chop mRNA-levels (Fonseca et al. 2010). 
Wfs1 was robustly up-regulated by ATF6 and XBP1(s) (This study: Wfs1: ATF6 22 
h: +1.68; XBP1 22 h: +1.31) over-expression in my system. In principle it could be 
involved in the low Chop induction by these factors, but TG-treatment also induced 
Wfs1 (This study: Wfs1: TG 22 h: +1.41). Scheuner et al. 2006 reported that PKR 
(This study: Eif2ak2: ATF6 22 h: -0.66; ATF6 66 h: -0.65; TG 22 h: -1.02) 
dependent phosphorylation of eIF2α is activating apoptosis and that a phospho-
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mimetic Ser51 to Asp mutant eIF2α also induces apoptosis. They pointed out that 
PERK mediated eIF2α phosphorylation at the same site was protecting the cells 
from ER-stress (Scheuner et al. 2006). The lower expression of PKR especially by 
TG does not support a pro-apoptotic role for this factor in my system. Backer et al. 
2009 demonstrated that cleavage of BIP via toxin (subunit A of the bacterial AB5-
toxin) induced cell death via apoptosis, synergistically with TG (Backer et al. 2009) 
and over-expression of mutant BIP causes a reduced surfactant protein synthesis 
and CHOP-induction in vivo (Mimura et al. 2007). It is possible that this is 
attributed to activation of the ER-stress sensors by depletion of BIP. Alternatively, 
the loss of BIP might just increase the load of unfolded proteins because its 
chaperone function is gone. But it also proposes the possibility that BIP directly 
acts as an anti-apoptotic agent. In A549 cells (a human AECII-tumor cell line), a 
robust knockdown of BIP was not sufficient to induce UPR-signalling (Gewandter 
et al. 2009). In my system the induction of BIP by TG was stronger (about 4 fold) 
than by any of the transfected transgenes.  
 
5.5 In vivo studies 
 
Transgenic animal lines for conditional over-expression of the ER-stress 
transcription factors ATF4, p50ATF6 and XBP1(s) have been successfully 
generated. Furthermore, a construct for a CHOP-over-expressing mouse line has 
been cloned. This line should become useful to directly induce an ER-Stress 
signalling mediated, apoptotic stimulus, when the other transgenic lines fail to do 
so. First tests for functionality indicate that at least the tested ATF6 line and the 
Xbp1 line really have inducible over-expression of these transcription factors, 
whereas the ATF4 line failed to show enhanced levels of the protein. IHC analysis 
indicates that the over-expression of ATF6 and XBP1 is not absolutely specific for 
AECII, but also occurs in a population of bronchial epithelial cells (see figure 11 
D+H). This is not entirely unexpected as the specificity to AECII of the human SP-
C promoter-rtTA was not proven by the authors which generated the line 
(Tichelaar et al. 2000). This fact has to be considered if a lung-phenotype is 
observed in a later experiment (e.g. with second, pro-fibrotic or ER-stress inducing 
hit, like BLEO or Tunicamycin treatment). Transgene effects on the bronchial 
epithelial cell population might then also contribute to the phenotype. The levels 
and specificity of transgene induction depend on the integration site in the 
genome. Additional lines for XBP1(s) and ATF4 are in the breeding program, but 
were not yet tested for functionality. Due to different transgene integration sites, 
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the phenotypes of separate lines with expression of the same transgene vary 
substantially. Considering the results from different lines with the same transgenes 
therefore generally helps to get a more secure view on the possible effects of an 
individual transgene. It also provides another chance to get a functional line for the 
ATF4 construct and an XBP1(s) -line, with different transgene expression levels, 
for further studies. Another possibility to characterize the transgene effects are 
experiments with longer transgene induction in ++/++ animals (up to now only 
completed for ATF4-line), where the transgene-expression is potentially stronger 
and can be sustained over a longer period of time. The breeding program also 
includes the (partly completed) breeding of transgenic ++ lines without a 
transactivator. After breeding in a different transactivator, the mouse lines can also 
be utilized to study the effects in other tissues than the lung. The approach is only 
limited by the availability of an organ (or cell type) specific transactivator line. This 
possibility extends the usefulness of the mouse lines to other fields were the study 
of the UPR is of interest (e.g. in the field of neurodegenerative diseases).  
The phenotype of the mice and the lungs in response to ATF4, ATF6 and XBP1 
induction in AECII has been broadly observed. The observations included the 
development of body weight, cell countings and cellular composition in the BAL, 
number of animal deaths during the experiment, lung compliance and running time 
in treadmill-test (see supplementary tables 2-6). The histologic appearance of the 
lungs was unaffected. Therefore the application of a fibrotic Ashcroft-score 
(Ashcroft et al. 1988) was unnecessary. On the basis of the assessed parameters, 
there was no change in the phenotype of any of the transgenic mouse lines as a 
result of transgene induction, neither after short term (4 weeks) nor after long term 
(up to 32 weeks) induction. This finding has to be interpreted with caution. On the 
one hand it has not been shown that the transgene induction is sustained over 
such a long period. Even though the results of the in vivo imaging suggest a longer 
expression, ATF6 protein levels in Western-Blot were only induced after 4 weeks 
and Xbp1 expression in Xbp1-mice on IHC-level was only investigated after 4 
weeks of induction. On the other hand long term over-expression experiments with 
the ++/++ lines, which potentially have stronger transgene expression, have not 
been finalized for ATF6 and XBP1 lines. The molecular phenotype was not 
observed in much detail, yet. The induction of BIP in ATF6-mouse AECII 
(observed in IHC) is an argument for the functionality of this transgene. As 
mentioned in the results part (4.2.1), no increased levels of cleaved caspase-3 or 
CHOP could be detected after transgene induction in ATF6 or XBP1 animals so 
far. The lack of a molecular phenotype would of cause also explain the absence of 
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a physiologic phenotype. If the AECII are largely unaffected by the 
over-expression of the transgenes and more specifically do not commit apoptosis, 
there is no reason why the lung morphology or the general fitness of the mice 
should change. Taken together this would fit to the in vitro results were ATF4, 
ATF6 and XBP1 were unable to generate a robust pro-apoptotic effect.  
 
5.6 Implications on the pathogenesis of IPF 
 
The involvement of ER-stress and AECII apoptosis in IPF has been demonstrated 
by other authors. However, expression of the central ER-stress induced 
transcription factors ATF4, ATF6 and XBP1 could not be demonstrated to be 
involved in the apoptotic events, which potentially trigger the disease.  
The chain of events according to the epithelial damage hypothesis is the following: 
ER-stress in the AECII leads to induction of ATF4, ATF6 and XBP1. These factors 
induce Chop and Chop leads to apoptosis of the AECII-cells. The AECI which are 
derived from AECII are also depleted and a continuous alveolar damage and 
general lack of a normal epithelium is the result. The role of newly discovered lung 
stem cells (Kajstura et al. 2011) in this process still has to be determined. This 
leads to a fibrotic remodelling of the lung. The results discussed in this chapter do 
not question (or support) the complete model but indicate that alternative 
pathways from ER-stress to CHOP induction and subsequent apoptosis must be 
identified. This conclusion is valid, as long as it cannot be shown that primary 
AECII in the context of an intact lung do not behave completely different in this 
regard. 
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Figure 29: The epithelial damage hypothesis of lung fibrosis. According to the 
epithelial damage hypothesis alveolar epithelial damage via apoptosis is a 
common feature of different deseases which manifest in lung fibrosis. The 
apoptosis can be caused by Lysosomal stress, DNA damage or chronic ER-stress. 
Some secondary events like respiratory infections, inhalative noxes and cyclic 
stretch caused by alveolar collapse can aggreviate the epithelial apoptosis or 
directly increase the fibrotic remodelling (Andreas Günther, personal 
communication). IPF= idiopathic pulmonary fibrosis; IIP=idiopathic interstitial 
pneumonia. 
 
However, apoptosis is by far not the only result of ER-stress with potential 
connections to IPF-pathogenesis and ER-stress is not the only mechanism which 
is potentially involved in AECII apoptosis. There is also data supporting the 
hypothesis that alveolar epithelial cell death is induced by abnormal lung 
fibroblasts in vivo as it is in vitro (Uhal et al. 1998b). This mechanism is not 
necessarily independent of the ER-stress in the AECII. AECs are the primary 
source for transforming growth factor-ß (TGF-β), a critical cytokine in the 
transdifferentiation of fibroblasts into the activated myofibroblast phenotype 
(reviewed by White et al. 2003). (This study: Tgfb1: ATF6 22 h: -0.74; TG 22 h: 
-0.86 / Tgfb2: TG 6 h: -0.98 / Tgfb3: TG 22 h -1.64, TG 6 h -1.08). AECs produce 
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platelet-derived growth factor (PDGF), a potent mitogen and chemo-attractant for 
fibroblasts (reviewed by White et al. 2003) (This study: Pdgfa: ATF6 22 h: -0.34; 
XBP1 66 h: +0.54; TG 22 h: -1.03 / Pdgfb: ATF6 22 h: -0.49; TG 22 h: -0.83). 
The strong pro-apoptotic ER-stress induced by TG rather seems to decrease 
these factors. TNF-α (Tnf; not regulated in my microarrays) is secreted by 
hyperplastic type II AECs in pulmonary fibrosis and promotes DNA synthesis and 
proliferation of fibroblasts (reviewed by White et al. 2003). Endothelin-1 has also 
been shown to stimulate fibroblast DNA synthesis and proliferation as well as to 
induce transdifferentiation of fibroblasts to myofibroblasts (reviewed by White et al. 
2003) (This study: Edn1: ATF6 22 h: -0.88). Prostaglandin E2 is a potent inhibitor 
of fibroblast collagen synthesis and proliferation and reduced in IPF-patients 
(reviewed by White et al. 2003). The regulation of Prostaglandin E2 (This study: 
Ptges2: ATF6 22 h: -0.7; TG 22 h -0.53; TG 6h: +0.51) by ER-Stress might 
contribute to fibroblast collagen synthesis.  
Another big chapter is the mutual influence of oxidative stress and ER-stress and 
the presence of both in IPF. Accumulation of unfolded protein in the ER lumen is 
sufficient to produce ROS and that both ROS and unfolded protein are required in 
concert to activate the UPR and apoptosis. Antioxidant agents (Glutathione, 
N-acetylcysteine, Apigenin), were reported to reduce CHOP induction and cell 
death by TG and BFA, suggesting an important role of ROS in ER-stress mediated 
apoptosis (Choi et al. 2010; Malhotra et al. 2008; Cullinan, Diehl 2006; Park et al. 
2010). On the reverse, Chop deletion reduces oxidative stress, attenuates UPR 
induction, and prevents apoptosis in hepatocytes during conditions of unfolded 
protein accumulation in the ER lumen (Malhotra et al. 2008). In my hands, 
peroxide treatment was not sufficient to switch the pro-survival response induced 
by ATF4, ATF6 and XBP1 to an increased apoptotic response. The different action 
of TG and these factors is not attributed to generation of ROS.  
Oxidative stress is indicated to participate in the epithelial damage in Idiopathic 
interstitial pneumonia (Kuwano et al. 2003) and antioxidant treatment is 
considered useful in IPF (Kinnula et al. 2005). IPF is characterized by an 
increased spontaneous production of oxidants by lung inflammatory cells (Cantin 
et al. 1987). This and reduced antioxidant levels in the lower respiratory tract have 
been thought to be involved in IPF pathogenesis. Sputum glutathione levels are 
4fold reduced and correlate with disease duration and lung function impairment 
(Beeh et al. 2002). Also Glutathione levels in the IPF BAL are reduced (Montaldo 
et al. 2002). Nrf2 is a critical effector of PERK-mediated cell survival (Cullinan et 
al. 2003). Its activation contributes to the maintenance of glutathione levels, which 
DISCUSSION 
_________________________________________________________________ 
- 153 - 
in turn functions as a buffer for the accumulation of ROS during the UPR (Cullinan, 
Diehl 2004). NRF2 has a critical role in protection against pulmonary fibrosis, 
presumably through enhancement of cellular antioxidant capacity (Cho et al. 
2004). It is moderately down-regulated by combinations of ATF4, ATF6 and XBP1 
transfections and TG (figure 18G). The level of Glutathione synthetase (gene 
name: Gss) is not regulated in my in vitro system. 
Oxidative damage of BAL proteins occurs in non-smoking patients with IPF (Lenz 
et al. 1996). Increased production of NO and peroxynitrite may be responsible for 
the oxidative damage in IPF (Saleh et al. 1997). Extracellular superoxide 
dismutase (gene name Sod3, not regulated in my system) is very low in fibrotic 
areas of UIP, which may further increase the oxidant burden in this disease 
(Kinnula et al. 2006). 
Other factors are Caveolin-1, Gelsolin and plasminogen activator inhibitors. 
Caveolin-1 was proposed as a protective regulator of pulmonary fibrosis. It is 
down-regulated in IPF and an effective treatment in the BLEO model (reviewed by 
Verma, Slutsky 2007). Caveolin-1 is not regulated by ATF4, ATF6 or XBP1 but 
down-regulated by TG (This study: Cav1: TG 6 h: -1.28; TG 22 h: -0.66). This 
indicates a down-regulation by maladaptive ER-stress. Gelsolin expression is 
increased in the IPF alveolar epithelium and necessary for the development of 
modelled pulmonary inflammation and fibrosis, while the caspase-3-mediated 
gelsolin fragmentation was shown to be an apoptotic effector mechanism in 
disease pathogenesis (Oikonomou et al. 2009). Paradoxically, the expression of 
this apoptotic factor is down-regulated in my model (This study: Gsn: TG 22 h: -
1.27; TG 6 h: -1.26). Lack of plasminogen activator inhibitors (allowing greater 
plasmin activity) prevents the formation of significant fibrosis. It is known that 
AECs synthesize both PAI-1 (This study: Serpine1: ATF6 44 h: -0.59; TG 22 h: 
-1.22; TG 1 h +0.65; TG 6 h: -1.13) and urokinase. (reviewed by White et al. 
2003). (This study: Plasminogen activators: Plat: ATF6 22 h: -0.34; TG 22 h: -1.40; 
TG 6 h: -1.42 / Plau: TG 22 h: -0.44).  
 
5.7 Outlook 
 
Over-expression of ATF4, p50ATF6 or spliced XBP1 is obviously not followed by 
robust CHOP induction or initiation of cell death in the models employed in this 
thesis. Instead, the resulting downstream signalling turned out to be rather in 
favour of cellular survival. This is consistent with the finding that there was no 
detectable phenotype in the de novo generated transgenic mouse-lines which 
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conditionally over-express these factors, so far. If one takes into regard results 
from previous publications, the currently used paradigm, according to which 
“overwhelming” and “persistent” activation of the three branches of the unfolded 
protein response (UPR) is decisive for the induction of CHOP and pro-apoptotic 
events in ER-stress, has to be questioned. Several alternative possibilities for 
switching an ER-stress related pro-survival signal into a pro-apoptotic one were 
considered in light of the herein presented data, but these putative explanations 
deserve further investigation in different cell types and categories (such as 
secretory and non-secretory cells). Based on the data of this work, novel concepts 
of ER-stress mediated apoptosis may evolve and underly a more specific 
approach to block the pro-apoptotic part of the ER-stress response. 
With regard to IPF, the genetically engineered mice developed in the context of 
this work and thereafter offer the possibility to address several additional important 
questions. Firstly, mice with over-expression of CHOP based on the construct 
developed in this work, will be employed to rigorously test if pro-apoptotic ER-
stress downstream signalling through CHOP alone is sufficient to induce apoptotic 
AECII death and to cause development of lung fibrosis (currently there is one 
founder mouse being cross-bred)  If this was the case, the model might not only 
serve as proof of principle for ER-stress induced lung fibrosis, but also serve as a 
more reliable and closer model for IPF as compared to the currently widely used 
bleomycin model, which certainly shares some features with IPF, but poorly 
reflects the IPF pathomechanism. Also, in this case, novel treatment modalities 
aiming to block CHOP in AECII will certainly evolve and can be rigorously tested in 
this model. Secondly, the generated mouse lines over-expressing ATF4 (once a 
line with convincing expression levels of this factor is established), ATF6 and 
XBP1 can be used to check the effects of these factors in other models of lung 
fibrosis triggered through induction of ER-stress (like the pepstatin model). The 
crucial question to be answered here would be, if additional activation of UPR 
branches in the context of an existing ER-stress may provoke a rather beneficial 
(cytoprotective) or a rather detrimental (pro-apoptotic) response. This again would 
have direct implications for the development of future therapies, as full blown 
epithelial ER-stress is a hallmark in IPF. 
Thirdly, the tissue and cell type-specific induction of ATF4, ATF6 and XBP1 in the 
transgenic animals depends on the activator line. Especially the existing single 
homozygous sub-lines can easily be used to extend the research about the effects 
of the UPR-transcription factors on organ systems other than the lung. Provided 
that e.g. CHOP over-expression in AECII may result in lung fibrosis, it may be 
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easily asked if over-expression of CHOP in ß-cells may cause diabetes, in 
hepatocytes liver cirrhosis and in renal tubular cells kidney fibrosis.  
Differential regulation of splicing as a part of the unfolded protein response is a 
new and exciting observation made in this thesis. This work revealed a quite large 
set of more than 100 candidates for alternatively spliced mRNAs (still requiring 
verification by alternative techniques). Even though it can be stated that some of 
the affected genes have the potential to play important roles in the UPR, the actual 
effects of the individual events are still completely unknown and should an issue of 
future research.  
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7. APPENDIX 
 
Supplementary figures and tables 
A
MLE15: Expression of transgenes and CHOP
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Supplementary figure 1: mRNA expression of transgenes and Chop in 
MLE15 and MEL188-cells (continued). 
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B
MEL188: Transgene expression
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MEL188: Downstream signaling
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Supplementary figure 1: mRNA expression of transgenes and Chop in 
MLE15 and MEL188-cells. 
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Supplementary figure 1: mRNA expression of transgenes and Chop in 
MLE15 and MEL188-cells. MLE15 and MEL188 cells were transfected with Atf4, 
Atf6 or Xbp1 respectively. For calculation of ddCT-values, pIRES2dsRed2-
transfected cells were utilized. Controls: pEGFP-N1 transfection and WT 
(untreated). A) Expression changes of transgenes and Chop in MLE15-cells. B) 
Expression of transgenes in MEL188 cells. C) Expression of Chop and additional 
downstream targets (Ppib and Edem) in MEL188 cells.       
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Supplementary figure 2: Protein expression of ATF4 and ATF6 after BFA and 
TG challenge. ATF4 and ATF6 Protein expression of MLE12 cells treated with TG 
or BFA (control: WT= untreated cells) for 3 h was assessed in WB analysis. 
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Supplementary table 1: Results of gene set enrichment analysis (GSEA) 
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Continue supplementary table 1: Results of gene set enrichment analysis 
(GSEA) 
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Continue supplementary table 1: Results of gene set enrichment analysis 
(GSEA) 
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Continue supplementary table 1: Results of gene set enrichment analysis 
(GSEA) 
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Continue supplementary table 1: Results of gene set enrichment analysis 
(GSEA) 
 
The first table (three pages) lists the KEGG-pathways significantly regulated (adj. 
p <0.05) in at least one of the contrasts from the arrays. A “y” labels the individual 
contrasts in which the pathway was regulated. TG 0.5 h, TG 1 h and TG 6 h stand 
for the contrasts of TG-treated versus WT- MLE12-cells. The pathway analysis for 
those contrasts was performed separately. The other contrasts are pathways in 
the respective contrast belong to the indicated categories.    
 
Supplementary table 2: Development of body weight in transgenic animals 
 
Body weight
induced control
line genotype time of induction change in weight [g] + n change in weight [g] + n
ATF4 +-/+- 4 weeks 3.9 1.0 5 3.0 0.7 5
ATF4 +-/+- 16 weeks 7.7 1.1 4 5.5 1.8 5
ATF4 +-/+- 32 weeks 7.2 2.0 5 7.0 1.3 5
ATF4 ++/++ 4 weeks 3.2 1.0 5 2.3 1.2 5
ATF4 ++/++ 32 weeks 6.7 1.9 5 8.2 0.8 4
ATF6 +-/+- 4 weeks 1.8 0.5 5 2.5 0.3 5
ATF6 +-/+- 16 weeks 5.8 1.9 4 6.4 0.3 5
ATF6 +-/+- 32 weeks 6.0 2.7 5 5.4 1.7 4
ATF6 ++/++ 4 weeks 6.7 3.3 5 5.7 3.1 5
Xbp1 +-/+- 4 weeks 2.7 1.3 5 2.9 0.6 5
Xbp1 +-/+- 8 weeks 4.9 1.0 3 5.6 0.9 2
Xbp1 +-/+- 32 weeks 6.7 1.4 5 5.9 1.5 5
 
 
The table lists the changes in body weight of the mice in the experiment from 
beginning of the experiment to its finalization after the indicated time of induction + 
the standard deviation, separately for controls and Dox induced animals and the 
number of animals in each group (n). Significant differences (p<0.05) are 
highlighted in blue.  
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Supplementary table 3: Cells countings and cellular composition in the 
broncho-alveolar lavage (BAL) 
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Continue supplementary table 3: Cells countings and cellular composition in 
the broncho-alveolar lavage (BAL) 
 
The tables list the cell numbers in the BAL (upper table) and the result of the 
differentiation (lower table) of BAL-cells body weight of the mice at the end of the 
indicated experimental times of induction, + the standard deviation, separately for 
controls and Dox induced animals and the number of animals in each group (n). 
Significant differences (p<0.05) are highlighted in blue. 
 
Supplementary table 4: Animal deaths 
 
Deaths
induced control
line genotype time of induction deaths deaths
ATF4 +-/+- 4 weeks 0 0
ATF4 +-/+- 16 weeks 1 0
ATF4 +-/+- 32 weeks 0 0
ATF4 ++/++ 4 weeks 0 0
ATF4 ++/++ 32 weeks 0 1
ATF6 +-/+- 4 weeks 0 0
ATF6 +-/+- 16 weeks 1 0
ATF6 +-/+- 32 weeks 0 1
ATF6 ++/++ 4 weeks 0 0
Xbp1 +-/+- 4 weeks 0 0
Xbp1 +-/+- 8 weeks 0 0
Xbp1 +-/+- 32 weeks 0 0
 
 
The table lists the number of animal deaths, separately for each experimental 
group, during the indicated period of transgene induction. 
 
Supplementary table 5: Effects of transgene induction on lung compliance 
 
Compliance
induced control
line genotype time of induction compliance [ml/(kPa*Kg)] + n compliance [ml/(kPa*Kg)] + n
ATF4 +-/+- 4 weeks 5.7 1.1 3 5.8 2.1 3
ATF4 +-/+- 16 weeks 7.4 1.7 2 8.0 0.6 3
ATF4 +-/+- 32 weeks 8.7 1.7 5 8.4 1.1 5
ATF4 ++/++ 4 weeks 6.6 0.9 5 6.2 0.7 5
ATF4 ++/++ 32 weeks 7.1 1.0 5 8.6 1.3 4
ATF6 +-/+- 4 weeks N/A - - N/A - -
ATF6 +-/+- 16 weeks 7.7 1.4 4 7.6 1.2 5
ATF6 +-/+- 32 weeks N/A - - N/A - -
ATF6 ++/++ 4 weeks N/A - - N/A - -
Xbp1 +-/+- 4 weeks 6.3 1.6 3 7.3 0.9 3
Xbp1 +-/+- 8 weeks N/A - - N/A - -
Xbp1 +-/+- 32 weeks 8.1 2.1 5 9.7 1.9 5
 
 
The average lung compliance + standard deviation and the n-numbers are listed 
separately for induced and non-induced mice from each experimental group. 
There are no significant differences between the induced and non-induced groups.  
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Supplementary table 6: Effects of transgene induction on running time in 
treadmill-test 
 
Treadmill
induced control
line genotype time of induction change running time [min] + n change running time [min] + n
ATF4 +-/+- 4 weeks N/A - 5 N/A - 5
ATF4 +-/+- 16 weeks N/A - 4 N/A - 5
ATF4 +-/+- 32 weeks N/A - 5 N/A - 5
ATF4 ++/++ 4 weeks 6.1 2.8 5 6.4 2.6 5
ATF4 ++/++ 32 weeks 7.6 6.6 5 0.7 4.9 4
ATF6 +-/+- 4 weeks N/A - 5 N/A - 5
ATF6 +-/+- 16 weeks 5.7 1.6 4 1.9 3.7 5
ATF6 +-/+- 32 weeks 3.5 8.0 5 2.7 5.1 4
ATF6 ++/++ 4 weeks 3.4 4.8 5 7.2 3.9 5
Xbp1 +-/+- 4 weeks N/A - 5 N/A - 5
Xbp1 +-/+- 8 weeks N/A - 3 N/A - 2
Xbp1 +-/+- 32 weeks 7.6 5.5 5 1.9 2.9 5
 
 
The average running time + standard deviation and the n-numbers are listed 
separately for induced and non-induced mice from each experimental group. 
There are no significant differences between the induced and non-induced groups.  
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Supplementary table 7: Genes of interest and their regulation by ATF4, 
ATF6, XBP1 and TG  
Regulation by ATF4 ATF6 XBP1 ATF4 ATF6 XBP1 ATF4 ATF6 XBP1 TG TG 
treatment /
transfection time 22h  44h 66h 22h / 44h 0.5h 1h 6h
Genename
Acta2 - - - - - - - - - -0.61 - - -0.88
ATF2 - - - - - - - - - 0.51 - - -0.61
ATF3 - -0.98 -0.65 - -0.58 - - - - 1.29 - 1.29 1.97
Atf4 3.38 0.48 - 1.47 - - - - - 2.07 0.56 1.26 1.57
ATF5 0.64 2.09 - - 1.19
Atg12 - - 0.47 - - - - - - 0.37 - 0.45 1.11
Bcl2 - 0.72 - - - - - - - -0.36 - - -0.46
Cav1 - - - - - - - - - -0.66 - - -1.28
Cdh1 - - - - - - - - - -1.35 - - -1.14
Ddit3 - 1.12 - - - - - - - 3.52 - 1.42 2.91
Dnajc10 - 0.37 - - 0.52 - - - - - - - -0.55
Edn1 - -0.88 - - - - - - - - - - -
Eif2ak2 - -0.66 - - - - - -0.65 - -1.02 - - -
Ep300 -0.73 -0.75 -0.75 - - - - - - - - - -
Fbxw11 - - - - - - - - - - - - -
Gja1 - - - - - - - - - - - - -1.78
Gsn - - - - - - - - - -1.27 - - -1.26
Gss - - - - - - - - - - - - -
Hmox1 - -0.39 - - - - - - - 1.62 - - -
Il1a - - - - - - - - - - - - -
Il1b - - - - - - - - - - - - -
Map3k5 - -0.35 - - - - - - - -0.25 - -0.36 -0.52
Mapk14 - -0.24 - - - - - - - -0.30 - - 0.44
Myd116 - ‑0.91 - - - - - - - 2.40 - - 2.39
Nfe2l2 - - - - - - - - - -0.35 - - -1.34
Nfkbia - - - - - - - - - -0.91 - 1.04 1.13
Nfkbie - -0.50 - - - - - - - -0.34 - - 1.79
nfya - - - - - - - - - 0.41 - - -
nfyb - - - - - - - - - - - - 0.44
nfyc - -0.57 - - - - - - - - - - 0.58
Nov - - - - - - - - - ‑0.31 - - -0.34
Pcaf - - - - - - - - - -0.40 - - -0.62
Pdgfa - -0.34 - - - - - - 0.54 -1.03 - - -
Pdgfb - -0.49 - - - - - - - -0.83 - - -
Plat - -0.34 - - - - - - - -1.40 - - -1.42
Plau - - - - - - - - - -0.44 - - -
Ppp1r15b - -0.35 - - - - - - - -0.42 - - -0.30
Ptges2 - -0.70 - - - - - - - -0.53 - - 0.51
Rela - -0.91 -0.81 - - - - - - - - - 1.25
Runx3 -0.41 -0.35 - - - - - - - - - - -
Serpine1 - - - - -0.59 - - - - -1.22 - 0.65 -1.14
Sirt1 -0.55 -0.69 - - - - - - 0.62 - - 1.91
Sod3 - - - - - - - - - - - - -
Stch - 0.55 1.16 - - - - - - 0.69 - - -
Tgfb1 - -0.74 - - - - - - - ‑0.86 - - -
Tgfb2 - - - - - - - - - - - - -0.98
Tgfb3 - - - - - - - - - -1.64 - - -1.08
Tjp1 - -0.49 - - - - - - - - - - -
Tlr2 0.73 -0.64 - - - - - - - - - 0.54 -
Tnf - - - - - - - - - - - - -
Trib3 1.05 0.50 - - - - - - - 3.10 - - 3.69
Txlnb - - - - - - - - - - - - -
Upf1 - -0.73 - - - - - - - -0.53 - - 0.78
Wfs1 - 1.68 1.31 - - 0.55 - - - 1.41 - - -
Xbp1 1.84 5.34 1.58 3.87 1.78 1.77 0.75 2.04
Yy1 - 0.59 - - - - - - - ‑0.38 - -0.75 -
 
The table lists the regulation of selected genes in microarrays in lfc. “-“ = no 
significant regulation. When a gene was represented by more than one probe, the 
strongest regulation is depicted. 
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